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The endosomal network is a central sorting station for transmembrane proteins 
(cargoes) which enter from the cell surface or the biosynthetic pathway. Here, cargoes 
are subject to a major fate decision: degradation versus retrieval and recycling. For 
cargoes fated to be degraded, they are retained within the endosomal limiting 
membrane and sorted into intraluminal vesicles, where they will eventually be 
degraded once late endosomes fuse with the lysosomes. To be reused, cargoes are 
retrieved from this degradative fate and recycled to other cellular compartments, such 
as the plasma membrane or the trans-Golgi network.  
Retromer, a heterotrimeric complex of VPS35:VPS29:VPS26 (VPS26A and VPS26B 
are expressed in mammals), is the best-characterised endosome-localised cargo 
retrieval complex and is responsible for the retrieval of hundreds of different cargoes 
away from the degradative fate. The dysfunction of retromer has been implicated in 
diseases such as Alzheimer’s disease and Parkinson’s disease. To function correctly, 
retromer relies on its association with various proteins and multiprotein complexes. It is 
therefore not surprising that the most common Parkinson’s disease-causing variant of 
retromer, VPS35(p.D620N), exhibits a reduced association with one of its most 
significant interactors: the WASH complex. 
In this thesis I investigated some of retromer’s interactions to gain insight into their 
functional significance. I firstly showed that retromer’s interaction with SNX3, a major 
retromer cargo adaptor, is vital for the establishment of Wnt morphogenic gradients. I 
also identified that SNX3-retromer couples to an evolutionary-conserved flippase 
complex to link cargo recognition with membrane deformation. Secondly, by 
investigating whether other Parkinsonism-associated retromer variants also exhibit 
reduced interactor associations, I showed that the VPS26A(p.K297X) variant causes a 
severe perturbation in retromer’s assembly with another cargo adaptor: SNX27. Finally, 
I identified that retromer couples to the WASH complex through a series of basic amino 
acids located on the carboxyl-terminus of VPS35 in proximity to the ASP620 residue. 
By creating retromer variants which have largely lost the ability to associate with the 
WASH complex, I showed that this interaction appears to be important for the 
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1.1 Overview of membrane trafficking 
 
1.1.1 The principles of membrane trafficking 
Eukaryotic cells are organised into a series of phospholipid bilayer-bound organelles. 
These organelles dynamically communicate, maintain and regulate each other through 
the process of membrane trafficking. Membrane trafficking allows the exchange of lipid 
and protein cargoes from a ‘donor’ compartment to an ‘acceptor’ compartment (Figure 
1.1). This process is spatiotemporally regulated by various multiprotein complexes and 
in principle relies on six steps (Figure 1.1). The cargoes to be transferred are captured 
on the donor compartment by a coat complex, which forms on the cytosolic side of the 
donor membrane. The capture of these cargoes often relies on their sequence-
dependent binding by the coat complexes and their accessory proteins. A budding 
process then takes place through the deformation of the membrane, allowing the 
creation of a cargo-enriched carrier (Hurley et al., 2010). These carriers can be 
vesicular or tubular in nature. Fission of tubulovesicular carriers must then occur for 
their separation from the donor membrane (Campelo and Malhotra, 2012). Motor 
proteins then transport the carriers along cytoskeletal fibres to the acceptor membrane 
(Ross et al., 2008). The carriers are uncoated and are recognised by tethers located on 
the acceptor membrane (Kummel and Ungermann, 2014). Lastly, the membrane 
carrier must fuse with the acceptor membrane in a process which is facilitated by the 
soluble NSF attachment protein receptor (SNARE) family of proteins (Han et al., 2017).  
 
1.1.2 Membrane identity 
Membrane trafficking events (Section 1.1.1) rely on the distinction and recognition of 
different cellular compartments for targeted membrane transfer. Following membrane 
acceptance at the acceptor compartment, the ‘donor membrane’ identity must 
dynamically reorientate into the acceptor membrane’s identity. This process ensures 
the maintenance of organelle identity despite constant membrane flux. Key elements in 
defining organelle identity are phosphoinositides (Section 1.1.2.1) and Rab GTPases 
(Section 1.1.2.2). 




Figure 1.1 The principles of membrane trafficking 
In general, membrane trafficking falls into 6 steps. 1) A membrane coat and its accessory 
proteins are recruited onto a donor compartment and captures luminal and transmembrane 
cargoes. 2) Through membrane deformation, a budding process occurs around the coat 
complex which forms a nascent vesicle. 3) The nascent vesicle is pinched off from the donor 
compartment in a fission process. 4) The coat complex disassociates from the vesicle while it is 
transported to an acceptor compartment. 5) Membrane tethers on the acceptor compartment 
recognise and capture the membrane vesicle. 6) The vesicle fuses with the acceptor 
compartment through SNARE-mediated fusion. Image from the thesis of Boris Simonetti; 
adapted from (Behnia and Munro, 2005).  
 
1.1.2.1 Phosphoinositides 
Phosphoinositides, although a relatively minor component of lipid bilayers, play a 
disproportionately important role in cell signalling, membrane identity and the regulation 
of membrane trafficking (Schink et al., 2016). Phosphoinositides are phosphorylated 
forms of phosphoinositol, which consists of a membrane-embedded diacylglycerol 
group linked to a cytosolic-facing inositol head at the D1 hydroxy group (Cullen, 2011) 
(Figure 1.2A). Only the D3, D4 and D5 hydroxy groups are phosphorylated and form 
mono- bis- or tris-phosphorylated phosphoinositides (Figure 1.2A) (Cullen, 2011).  
 




Figure 1.2 Phosphoinositides and Rab GTPases impart membrane identity.  
(A) D-myo-inositol has a six-carbon ring with hydroxy groups on each carbon atom. 
Diacylglycerol is attached to the D1 carbon to enable membrane association. Phosphate groups 
can be added to or taken away from the other hydroxy groups on the six-carbon ring, by kinases 
(blue arrow) or phosphatases (red) arrow respectively, to form phosphoinositides. Image from 
the thesis of Matt Gallon; adapted from (Cullen, 2011). (B) The Rab-GTPase cycle. Rab-GTP, 
attached to a lipid bilayer by its two geranylgeranyl groups on its carboxyl-terminus, binds to 
effector proteins. GTPase activating proteins (GAPs) hydrolase GTP into GDP. Guanine 
nucleotide displacement inhibitors (GDIs) extract Rab-GDP from the membrane until guanine 
nucleotide exchange factors (GEFs) induce GDP/GTP exchange.  




The functions of phosphoinositides depend on their nonuniform distribution throughout 
cellular compartments. Generally speaking, the Golgi apparatus is enriched in PI4P; 
early endosomes in PI3P; late endosomes and lysosomes in PI(3,5)P2; and the plasma 
membrane in PI(4,5)P2 and PI(3,4,5)P3 (Schink et al., 2016). Although these are the 
major phosphoinositides on these membranes, the picture of minority proportions is 
more complex, with PI4P having been reported on endosomes and the plasma 
membrane, PI(4,5)P2 reported on endosomes and lysosomes, and PI3P having been 
found also on the plasma membrane (Schink et al., 2016).  
The phosphoinositide-mediated recruitment of effector proteins is critical in many 
cellular processes. The role of PI(4,5)P2 in the process of endocytosis is discussed in 
Section 1.2.1. Effectors of endosomal PI3P are also discussed in relation to 
endosomal maturation (Section 1.2.3), ESCRT-mediated cargo degradation (Section 
1.3.1), and endosomal cargo retrieval and recycling (Section 1.4). 
The interconversion of different phosphoinositide species, through the action of kinases 
and phosphatases, is a dynamic process and highly regulated. For example, although 
the endoplasmic reticulum is not particularly enriched in any one phosphoinositide 
species, PI4P is generated at endoplasmic reticulum exit sites during the formation of 
COP-II vesicles and is required for the fusion of these vesicles with the Golgi 
membrane (Blumental-Perry et al., 2006; Lorente-Rodriguez and Barlowe, 2011; 
Schink et al., 2016). The switch from PI3P to PI(3,5)P2 as early endosomes mature into 
late endosomes, as well as the interconversion between plasma membrane and 
endosomal phosphoinositide identity, is discussed in Section 1.2.3.2.  
 
1.1.2.2 Rab GTPases 
The Rab family of small GTPases are instrumental regulators of vesicular trafficking 
and impart membrane identity. They and their effectors are involved in cargo sorting, 
the formation and transport of transport vesicles and membrane tethering and fusion. 
Rabs undergo reversible cycles of GTP loading and GTP hydrolysis into GDP (Figure 
1.2B). This switch in nucleotide binding induces a conformational change which has 
been described as a ‘loaded spring’, where the GTP-bound form causes the 
stabilisation of two ‘switch’ loops in the GTPase domain which can be recognised by 
Rab effectors (Vetter and Wittinghofer, 2001). Following GTP hydrolysis, the loops 
spring back into the GDP-loaded conformation (Vetter and Wittinghofer, 2001). It is 
therefore the ‘activated’ Rab-GTP which recruits effectors to impart and regulate 
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membrane identity. The roles of Rab5 and Rab7 (and their effectors) in early and late 
(respectively) endosome identity will be discussed in Section 1.2.3.3. The role of Rab7 
in the endosomal recruitment of the retromer complex will also be discussed in Section 
1.4.1. 
Guanine nucleotide exchange factors (GEFs) ‘activate’ Rabs by promoting GDP 
dissociation which induces nucleotide exchange (Figure 1.2B) (Muller and Goody, 
2018). Concentration of cytosolic GTP is approximately 10-fold higher than GDP and 
consequently, nucleotide exchange promotes GTP loading of the Rab (Traut, 1994; 
Muller and Goody, 2018). Conversely, Rab GTPase activating proteins (GAPs) 
promote an inactive GDP-bound Rab by the hydrolysis of GTP into GDP (Figure 1.2B). 
Rab proteins intrinsically have GTPase activity, but it is very low (Muller and Goody, 
2018). The role of GAPs is to catalyse this reaction spatiotemporally. The activation 
and inactivation of Rab5 and Rab7 will be discussed in Section 1.2.3.1. 
The addition of two geranylgeranyl lipid groups is required for the reversible membrane 
association of Rab proteins (Muller and Goody, 2018). An inactive Rab is extracted 
from a membrane by guanine nucleotide displacement inhibitors (GDI), which bind to 
one of the ‘switch’ loops in the GDP-bound Rab conformation, stabilising the lipidated 
carboxyl-terminus of Rabs in a hydrophobic cavity (Sasaki et al., 1990; Pylypenko et 
al., 2006). GDI dissociation factors may displace the GDI from the Rab allowing 
membrane reinsertion (Dirac-Svejstrup et al., 1997), although more evidence is 
required to substantiate this model. The GTP-loading of Rabs and effector binding are 
also thought to induce a Rab conformation which is resistant to GDI, therefore 
stabilising it on a target membrane (Barr, 2013).  
 
1.2 The endolysosomal pathway 
The endosomal network is a series of interconnected membranous compartments and 
the sorting hub of numerous endocytic and biosynthetic cargoes (transmembrane 
proteins). Following endocytosis (Section 1.2.1) cargoes are delivered to the early 
endosomes (Section 1.2.2), where they will subsequently be sorted for either 
degradation (Section 1.3.1) or retrieval and recycling (Section 1.3.2). The endosomes 
undergo a maturation process characterised by changes in the enrichment of Rab-
GTPases (Section 1.2.3.1) and phosphoinositide species (Section 1.2.3.2), which 
ultimately leaves them competent to fuse with lysosomes (Section 1.2.3.3).  
 




At the plasma membrane, to internalise cargo (transmembrane proteins) and their 
ligands, a process termed endocytosis occurs. There are various mechanisms of 
endocytosis including: clathrin-mediated endocytosis, caveolin-dependent endocytosis, 
the RhoA-dependent pathway, flotillin-dependent endocytosis, Cdc42-dependent 
endocytosis, the Arf6-associated pathway, fast endophilin A2-dependent endocytosis, 
macropinocytosis and phagocytosis (Mayor et al., 2014; Boucrot et al., 2015). Although 
results vary between studies depending on cell-types and experimental conditions 
(Ferreira and Boucrot, 2018), reports have suggested that in general clathrin-
independent mechanisms have a much lower contribution to cargo internalisation 
compared to clathrin-mediated endocytosis (Bitsikas et al., 2014). Here, I will limit my 
description of endocytosis to clathrin-mediated endocytosis.  
Clathrin-mediated endocytosis is thought to be initiated on the plasma membrane at 
both random (Ehrlich et al., 2004) and non-random sites (such as being concentrated 
at synapses or repeatably being initiated in a specific site) (Nunez et al., 2011; 
Kaksonen and Roux, 2018). Local enrichment in PI(4,5)P2 or cargo (including cargo 
ubiquitination status) may also contribute to the probability of the formation of a 
clathrin-coated pit (Liu et al., 2010; Henry et al., 2012; Kaksonen and Roux, 2018). 
Although clathrin is the defining protein involved in clathrin-mediated endocytosis, over 
50 cytosolic proteins act cooperatively in its orchestration (Kaksonen and Roux, 2018). 
An initial ‘pioneer module’, composed of the adaptor proteins (FCHO1/2, AP2), which 
are partly targeted to the plasma membrane through PI(4,5)P2 binding, and scaffold 
proteins (EPS15, EPS15R and intersectins 1 and 2) which cluster the adaptor proteins, 
is thought to initiate clathrin-mediated endocytosis (Kaksonen and Roux, 2018).  
Specific cargoes are recruited to the endocytic site through direct interactions with 
members of the clathrin coat complex. These direct interactions require specific sorting 
motifs in the cytosolic domains of cargo (the concept of sorting motifs will reappear in 
Section 1.4). For the AP-2 complex (a heterotetramer of α-adaptin, β2-adaptin, μ2-
adaptin and a σ2-chain) sorting motifs include: YxxØ (Ø indicates amino acids with 
bulky hydrophobic side chains and ‘x’ indicates any amino acid) via its μ2-adaptin 
subunit (Collawn et al., 1990; Owen and Evans, 1998) and (D/E)xxx(L/I) via its β2-
adaptin subunit (Letourneur and Klausner, 1992; Kelly et al., 2008). Additional cargo 
selective elements include clathrin associated sorting proteins (CLASPS), which can 
bind to clathrin as well as AP-2 (Traub, 2009). Sorting signals include: [FY]xNPx[YF] 
(recognised by phosphotyrosine-binding domain-containing CLASPS), ubiquitin 
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moieties (recognised by ubiquitin binding domain-containing CLASPS) and 
phosphorylated G protein-coupled receptors (recognised by β-arrestins) (Traub, 2009). 
The clathrin triskelia is recruited by AP-2 and other adaptor proteins (Kirchhausen et 
al., 2014). The simultaneous binding of AP-2 to PI(4,5)P2 and cargo (with tyrosine-
based sorting motifs) has been shown to cause a conformational change in AP-2 which 
reveals a binding site for clathrin (Kelly et al., 2014; Kadlecova et al., 2017). Clathrin 
triskelia polymerise into a cage-like lattice structure which coats the membrane and 
leads to membrane remodelling. It has been proposed that clathrin polymerises onto an 
existing membrane bud, increasingly forming a spherical shape which forms the 
nascent clathrin-coated vesicle (Kaksonen and Roux, 2018).   
The scission of the nascent vesicle is promoted by the large GTPase dynamin 
(Hinshaw and Schmid, 1995; Antonny et al., 2016). Dynamin is recruited by the SH3 
domain of sorting nexin-9 (amongst others such as amphiphysin) (Lundmark and 
Carlsson, 2004), which also contains a BAR domain able to sense membrane 
curvature (see Section 1.4.2) (Kaksonen and Roux, 2018). Dynamin oligomerises 
around the neck of the nascent clathrin-coated vesicles and its GTPase activity induces 
scission (Antonny et al., 2016). Following this scission from the plasma membrane, the 
clathrin coat is disassembled, partly through the dephosphorylation of PI(4,5)P2 (see 
Section 1.2.3.2).The endocytic carriers will subsequently fuse with the early 
endosomes (see Section 1.2.2 and Section 1.2.3.3). 
 
1.2.2 The structure and organisation of the endosomal network  
The endosomal network is a series of interconnected membranous compartments 
which continuously fuse with each other (Figure 1.3) (it should be noted that the 
endosomal network is more complex than Figure 1.3 suggests and contains: APPL1, 
early, late and recycling compartments). Cargo-enriched endocytic carriers fuse (see 
Section 1.2.3.3) with the early endosomes within 1-5 minutes of internalisation 
(Klumperman and Raposo, 2014). Early endosomes are pleiomorphic in structure, 
being composed of a vacuolar section with 2-7 tubules emanating from it (Figure 1.3) 
(Geuze et al., 1983; Klumperman and Raposo, 2014). Cargoes, having entered the 
endosomal network, are either enriched into tubulovesicular carriers for their recycling, 
or within the limiting endosomal membrane for their eventual degradation (Geuze et al., 
1983). A simplified model of endosomes, proposed by (Klumperman and Raposo, 
2014), is their division into two domains: a sorting domain and a recycling domain 
(Figure 1.3).  




Figure 1.3 The endolysosomal pathway 
A schematic which represents the endolysosomal pathway. Endocytic vesicles fuse onto the 
early endosomal compartment, which eventually matures into late endosomes. Late endosomes 
fuse with lysosomes to form endolysosomes. The maturation of the endolysosomal pathway is 
associated with a change in phosphoinositides, Rab GTPases and pH. The molecular 
dimensions were informed through (Klumperman and Raposo, 2014). 
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The sorting domain consists of the vacuolar portion of the early endosome. This is also 
the portion of the early endosomes which will mature down the endolysosomal 
pathway, becoming late endosomes which will eventually fuse with lysosomes. In the 
sorting domain, a major fate decision occurs: cargoes are sorted for either degradation 
(Section 1.3.1) or recycling (Section 1.3.2). Briefly, for cargo recycling, the cargoes 
must be retrieved away from the vacuolar portion of sorting endosomes, into nascent 
tubulovesicular carriers, which detach and are recycled to an acceptor membrane (at 
the cell surface, the TGN or other specialised compartments). To ensure a cargo’s 
degradation, it is actively sequestered into intralumenal vesicles (ILVs) within and 
unconnected to the endosomal limiting membrane (Murk et al., 2003) (Section 1.3.1). 
The loss and replenishment of endosomal membrane is key to understanding the 
morphological changes from early to late endosomes. Endosomal membrane is 
continuously lost as cargo-enriched recycling tubules and transport carriers detach, 
destined for various acceptor membranes. The formation of ILVs is another process by 
which the endosomal limiting membrane surface is lost. Alongside this process, 
membrane and cargo are continuously added to endosomes through the fusion of 
incoming endocytic and biosynthetic vesicles. The continuous fusion events of the 
endosomes (Section 1.2.3.3) is a major process by which sufficient membrane is 
made available for the generation of tubulovesicular carriers for cargo recycling.  
As endosomes mature, the vacuolar portion of the limiting membrane enlarges and 
ILVs accumulate (Figure 1.3). Typically, once the endosome accumulates 5 or more 
ILVs, they are morphologically considered late endosomes or multivesicular bodies; 
they can contain up to 30 ILVs (Huotari and Helenius, 2011; Klumperman and Raposo, 
2014). They are also no longer ‘competent’ to fuse with the early endosomes 
(Klumperman and Raposo, 2014). Instead, they become able to fuse to lysosomes to 
form endolysosomes (Section 1.2.3.3) (Figure 1.3) (Klumperman and Raposo, 2014). 
The contents within the limiting membrane will be degraded by acid hydrolase activity, 
promoted by the pH change imparted by vacuolar ATPases which pump protons into 
the endosomal lumen (Maxfield and Yamashiro, 1987; Huotari and Helenius, 2011). 
Glycoproteins, such as LAMP1 and LAMP2, that line the limiting membrane of the late 
endosomes and lysosomes, are resistant to the degradative capacity of acid 
hydrolases (Huotari and Helenius, 2011). Most degradation is thought to occur in 
endolysosomes (Bright et al., 2016).  
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1.2.3 Endosomal maturation  
As discussed in Section 1.1.2, the main imparters and regulators of membrane identity 
are Rab-GTPases and phosphoinositides. Early endosomes are identified by the 
presence of Rab5 and PI3P whereas late endosomes are identified by Rab7 and 
PI(3,5)P2 . The processes of endosomal Rab and phosphoinositide conversion are 
respectively discussed in Section 1.2.3.1 and Section 1.2.3.2. How the interplay 
between Rabs and phosphoinositides promote endosomal maturation through 
endosomal and lysosomal membrane fusions is discussed in Section 1.2.3.3. 
 
1.2.3.1 Endosomal Rab conversion 
The major Rab proteins imparting membrane identity in the endosomal system include 
Rab5, which marks early endosomes, and Rab7, which marks late endosomes and 
lysosomes (Langemeyer et al., 2018). In recycling pathways, Rab4, Rab11 and Rab14 
are required at early endosomes and Rab9 is required between lysosomes and the 
Golgi (Langemeyer et al., 2018). Here, I will focus on the central endosomal Rabs: 
Rab5 and Rab7. 
On endocytic vesicles, ubiquitinylated cargoes recruit the Rab5 GEF Rabex5, which 
promotes the GTP-loading of Rab5 (Section 1.1.2.2) (Mattera and Bonifacino, 2008). 
The Vps9 domain of Rabex-5 has only a basal nucleotide exchange activity towards 
Rab5 and is only strongly activated upon formation of a complex with the Rab5 effector 
Rabaptin5 (Lippe et al., 2001). The formation of this complex is necessary for the 
Rab5-dependent fusion of early endosomes (Lippe et al., 2001). One recent study has 
suggested that Rabaptin5 is instead a Rab4-GTP effector which acts in a feed-forward 
mechanism to promote Rab5 activation. The inclusion of ubiquitinated cargo into 
intralumenal vesicles may promote Rabex5 membrane dissociation, therefore 
negatively regulating Rab5 activation (Kalin et al., 2016). PI3P synthesis, Rab5 and 
Rabex-5 are thought to recruit the Mon1-Ccz-1 complex, which is also thought to 
promote displacement of Rabex-5 (Poteryaev et al., 2010). Concurrently, the Rab5 
GAP, RabGAP5, induces hydrolysis of Rab5-GTP to Rab5-GDP and therefore its 
membrane extraction by GDI (Haas et al., 2005) (Section 1.1.2.2). The Mon1-Ccz1 
complex also a Rab7 GEF and promotes its activation (Poteryaev et al., 2010). It is 
thought to activate late endosomal Rab7; the mechanism of Rab7 activation on 
lysosomes is unclear (Yasuda et al., 2016). The VPS34/p150 complex (see Section 
1.2.3.2), which is a Rab5 and Rab7 effector, has been reported to recruit the GAP 
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TBC-2, acting as a negative feedback mechanism for both Rab5 and Rab7 (Law and 
Rocheleau, 2017). 
 
1.2.3.2 Endosomal phosphoinositide conversion 
Both Rab5-GTP and Rab7-GTP have been reported to recruit the VPS34/p150 class III 
PI3-kinase complex (Murray et al., 2002; Law and Rocheleau, 2017). VPS34/p150 
recruitment promotes the synthesis of PI3P, the characteristic early endosomal 
phosphoinositide (Schu et al., 1993). In turn, the accumulation of PI3P onto early 
endosomes promotes the recruitment of a cohort of FYVE domain and PX domain 
containing endosomal effectors which play a variety of roles on the endosomal 
membrane, including in promoting a degradative (Section 1.3.1) or recycling (Section 
1.3.2) fate for cargoes.  
The Rab5 to Rab7 switch (Section 1.2.3.1) promotes a phosphoinositide conversion 
from PI3P to PI3,5P2. Firstly, the Rab7-GTP interaction with WDR91 downregulates the 
activity of the PI3K complex, negatively regulating the generation of PI3P (Liu et al., 
2017). The FYVE domain-containing phosphatidylinositol 3-phosphate 5-kinase, 
PIKfyve (Kim et al., 2014), is recruited to its substrate, PI3P, via its FYVE domain 
(Sbrissa et al., 2002). The generation of PI3,5P2 has been reported to be essential for 
sorting cargo into the degradative fate (Odorizzi et al., 1998; Kim et al., 2014), 
modulating Ca2+ release (Dong et al., 2010) and v-ATPase activation (Li et al., 2014). 
Constant membrane flux between the plasma membrane and the endosomal network 
requires continuous interconversion of phosphoinositide identity. Following endocytosis 
(Section 1.2.1), phosphoinositides must be converted from a plasma membrane 
identity into an endosomal identity, through the dephosphorylation of the D4- and D5- 
positions on the inositol head group. Synaptojanin, INPP4A/B and OCRL are the 
phosphatases reported to promote this (Schink et al., 2016). Conversely, in endosome-
to-plasma membrane trafficking, PI3P is converted into PI4P. This is accomplished 
though hydrolysis of the 3-position phosphate by the phosphatase MTM1 and 
subsequently, the phosphorylation of the D4 hydroxy group on the inositol ring by the 
PI4-kinase PI4Kα (Ketel et al., 2016). This process exemplifies the interconnectivity 
between PIs and Rabs: initial PI3P generation activates Rab11, which then recruits 
MTM1 to promote PI conversion (Campa et al., 2018).  
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1.2.3.3 The promotion of membrane fusions in the endolysosomal pathway 
EEA1 contains a Rab5 binding site on one end and a PI3P-binding FYVE domain at 
the other. These two domains at either end of the 200nm coiled coil allows EEA1 to 
function as a tether to bring incoming endocytic vesicles into close proximity to early 
endosomes in a process known as ‘entropic collapse’ (Murray et al., 2016). The dimeric 
coiled-coil is stiff until it is bound to Rab5-GTP. Once flexibility is induced, EEA1 is 
thought to collapse, bringing a tethered vesicle close to an endosome. This process is 
coordinated with another Rab5-effector and coiled-coil tether rabenosyn-5, SNAREs 
and Vps45 (a member of the Sec1p/Munc-18 family) to couple membrane tethering to 
membrane fusion (Nielsen et al., 2000).  
As well as promoting the endosomal fusion with incoming endocytic vesicles, Rab5-
GTP promotes fusion of Rab5-GTP decorated endosomes. The Rab5-effector and 
multiprotein complex tether, the CORVET (Class C core vacuole/ endosome tethering) 
complex is thought to mediate this fusion (Balderhaar et al., 2013). It contains 6 
subunits, including at either end Vps3 and Vps8, which can bind to Rab5, which is 
thought to enable multiple Rab5-containing endosomes to be connected for fusion 
(Balderhaar et al., 2013). In yeast, the CORVET subunit, Vps33, has been shown to 
bind to the syntaxin-like Pep12 protein, which suggests a mechanism for the coupling 
of membrane tethering with fusion (Subramanian et al., 2004).  
Like Rab5, Rab7 promotes membrane tethering by associating with a multiprotein 
tethering complex: the HOPS complex. Rab7-GTP also promotes UVRAG to activate 
the HOPS complex (Sun et al., 2010). The HOPS complex shares four of six subunits 
of the CORVET complex: Vps33, Vps16, Vps18 and Vps11 (Langemeyer et al., 2018). 
The two unique subunits, Vps41 and Vps39, are Rab7-GTP binding which is thought to 
promote the fusion of Rab7-GTP decorated organelles (Langemeyer et al., 2018). This 
includes the fusion of Rab7-decorated endosomes and the heterotypic fusion of 
organelles such as late endosomes and lysosomes.  
 
1.3 Endosomal cargo sorting 
At sorting endosomes, a major fate decision occurs. Cargoes destined for degradation 
are sequestered within the endosomal limiting membrane into intralumenal vesicles, 
where they will eventually be degraded by acid hydrolases once late endosomes have 
fused with lysosomes (Section 1.2.3.3). This process is largely mediated by the 
‘endosomal sorting complex required for transport’ complexes (Section 1.3.1). 
Cargoes which are to be recycled avoid this degradative fate either through sequence-
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independent or sequence-dependent mechanisms (Section 1.3.2). This thesis is 
largely concerned with the sequence-dependent retrieval of cargo by multiprotein 
retrieval complexes (Section 1.4). Interestingly these fate decisions occur on the 
sorting endosomes in segregated retrieval and degradative subdomains (Figure 1.4) 
(McNally et al., 2017; Norris et al., 2017; Cullen and Steinberg, 2018).  
 
 
Figure 1.4 Endosomal retrieval and degradative subdomains are segregated  
On the sorting endosomes, recycling and degradative subdomains are thought to be 
segregated. The degradative subdomain is thought to be marked by the endosomal sorting 
complex required for transport (ESCRT) complexes, which mediates degradative cargo 
recognition and inclusion into intralumenal vesicles. The recycling endosome is marked by 
retrieval and recycling complexes such as retromer, retriever and the WASH complex. The 
WASH complex is thought to polymerise branched actin filaments onto the retrieval subdomain. 
Sequence independent recycling also occurs. Figure adapted from (Cullen and Steinberg, 
2018). 
 
1.3.1 ESCRT-mediated degradative cargo sorting  
To be degraded, transmembrane cargoes are actively sequestered into intralumenal 
vesicles (ILVs) within the endosomal limiting membrane. This process requires cargo to 
have an identifier to mark it for the degradative pathway. The best characterised 
mechanism for this is the monoubiquitination or polyubiquitination of the cytosolic-
facing domains of the cargo (Katzmann et al., 2001; Bishop et al., 2002). This process 
is dependent on a series of four complexes (Table 1.1) known as the endosomal 
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sorting complex required for transport (ESCRT), (ESCRT-0, ESCRT-1, ESCRT-II and 
ESCRT-III).  
 
Figure 1.5 ESCRT-mediated inclusion of degradative cargo into intralumenal 
vesicles. 
(A) The endosomal sorting complex required for transport (ESCRT) complexes ESCRT-0, 
ESCRT-I and ESCRT-II bind to ubiquitinated cargoes and segregate them in endosomal 
degradative subdomains. (B) ESCRT-III is recruited to the degradative subdomains and induces 
membrane deformation towards the endosomal lumen. (C) VPS4, as well as deubiquitinating 
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enzymes, are recruited to the degradative subdomain. (D) The degradative cargoes, having 
been deubiquitinated, are sequestered within the endosomal limiting membrane in intralumenal 
vesicles (ILVs) following a fission process. Adapted from (Cullen and Steinberg, 2018) 
 
Through multiple low-affinity interactions (70-500 nM) with ubiquitin moieties, ubiquitin 
binding domains (UBDs) within ESCRT-0, ESCRT-I and ESCRT-II (Table 1.1) are 
thought to establish the selectivity of the degradative pathway (Frankel and Audhya, 
2018). These low affinity interactions are amplified through the concentration of cargo, 
increasing the avidity and the ability of the UBDs to ‘sense’ ubiquitinated cargo and 
may contribute to the rapid transfer of the proteins between the ESCRT complexes 
(Frankel and Audhya, 2018).  
ESCRT-0 components HGF-regulated tyrosine kinase substrate (HRS) and signal 
transducing adaptor molecule (STAM) are thought to provide the initial recognition of 
ubiquitinated cargoes (Bishop et al., 2002; Raiborg et al., 2002; Bache et al., 2003). 
ESCRT-0 self-associates on membranes through the PI3P-binding FYVE domain of 
HRS and interacts with clathrin (Raiborg et al., 2001a; Raiborg et al., 2001b). ESCRT-0 
is thought to mediate the establishment of degradative subdomains, decorated with flat 
clathrin lattices, on the sorting endosome to segregate ubiquitinated cargoes from 
those which are destined to be recycled (Murk et al., 2003; Cullen and Steinberg, 2018) 
(Figure 1.5A). ESCRT-I and ESCRT-II are subsequently sequentially recruited and 
also contribute to cargo selectivity through UBDs (Frankel and Audhya, 2018) (Table 
1.1).  
ESCRT-III is recruited to the nascent ILV by sensing the density of ESCRT-II 
(Chiaruttini and Roux, 2017) (Figure 1.5B). In an alternative pathway, ESCRT-III can 
also be recruited by ALG-2-interacting protein X (ALIX), which can sense ubiquitinated 
cargoes (Dowlatshahi et al., 2012; Keren-Kaplan et al., 2013; Pashkova et al., 2013), 
but has also been shown to bind cargoes, such as protease-activated receptor 1 and 
the P2Y1 purinergic receptor, in a sequence-dependent manner (using a YPX(3)L 
sorting motif) (Dores et al., 2012; Dores et al., 2016). 
Once recruited, ESCRT-III generates negative membrane curvature (Figure 1.5B) 
(Schoneberg et al., 2017). How this occurs is not fully understood, but it is thought to 
oligomerise into filaments formed from structures with varying curvatures, varying these 
structures dynamically to drive membrane constriction, and a ‘release’ of the imposed 
stress to buckle the membrane (Chiaruttini and Roux, 2017). Deubiquitinating enzymes 
are recruited by ESCRT-III (and STAM) to remove the ubiquitin moieties on 
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degradative cargoes (Figure 1.5C) (McCullough et al., 2006; Kyuuma et al., 2007). The 
scission of the nascent ILV is thought to also require the AAA ATPase, VPS4, which is 
also thought to drive ESCRT-III disassembly (Figure 1.5D) (Babst et al., 1998; Bishop 
and Woodman, 2000; Chiaruttini and Roux, 2017; Mierzwa et al., 2017).  
 
Complex Subunit Ubiquitin-binding domain? 
ESCRT-0 Hrs 
STAM1,2 
Yes (DUIM, VHS) 
Yes (UIM, VHS) 
ESCRT-I TGS101 
VPS28 
VPS37 A, B, C, D 













ESCRT-III CHMP1A, B 
CHMP2A, B 
CHMP3 













Table 1.1 The subunits of the metazoan endosomal sorting complex required for 
transport (ESCRT) complexes 
 
1.3.2 Endosomal retrieval and recycling  
 
1.3.2.1 Sequence-dependent vs sequence-independent retrieval and recycling 
As discussed in Section 1.3.1 cargo not destined for degradation are sorted away from 
sequestration within ILVs to be retrieved and recycled. Historically, it was believed that 
the high surface-area-to-volume ratio of recycling tubules compared to the vacuolar 
sorting domain (Section 1.2.2) preferentially sorts membrane-embedded cargo into a 
recycling route; in the absence of targeting signals for sequestration into ILVs, cargo 
would be recycled (Mayor et al., 1993; Maxfield and McGraw, 2004). This is termed 
‘geometry-based sorting’ or ‘bulk flow’, where transmembrane cargo would be enriched 
in recycling tubules and the relatively high luminal content of the sorting domain would 
cause the enrichment of soluble proteins (Maxfield and McGraw, 2004).  
Chapter 1: Introduction  
18 
 
In recent years, with the discovery of cargo adaptors which recognise specific 
sequences in the cytosolic-facing domains of cargoes (Table 1.2), this model has been 
evolved to include sequence-dependent mechanisms of cargo retrieval and recycling 
(Dai et al., 2004; Cullen and Steinberg, 2018). The sequence-dependent retrieval and 
recycling of cargoes depend on several evolutionary-conserved multiprotein 
complexes. These complexes include: retromer (Section 1.4.1), retriever (Section 
1.4.6), the CCC complex (Section 1.4.6), the WASH complex (Section 1.4.5) and the 
SNX-BAR complex (Section 1.4.2) (Cullen and Steinberg, 2018). All these complexes 
are thought to be located on an endosomal retrieval subdomain, which is separated 
from the degradative subdomain discussed in Section 1.3.1 (Figure 1.4) (Cullen and 
Steinberg, 2018).  
 
1.3.2.2 Avoiding the degradative fate 
Generally speaking, the perturbation of endosomal retrieval complexes leads to cargo 
(whose recycling depend on specific sorting motifs; see Table 1.2), by default, to enter 
the degradative pathway to be degraded (Seaman et al., 1998; Steinberg et al., 2012; 
Steinberg et al., 2013b; Kvainickas et al., 2017a; McNally et al., 2017; Simonetti et al., 
2017; Cullen and Steinberg, 2018). Conversely, inclusion of transmembrane cargo into 
ILVs for degradation is a highly selective process: for ESCRT-mediated inclusion it 
depends on the ubiquitylation of cargo (Section 1.3.1).  
The retrieval complexes may therefore be required for restricting the lateral mobility of 
cargo away from endosomal degradative subdomains. Perturbation of retrieval 
complexes may cause cargo to ‘leak’ into degradative subdomains and be included into 
ILVs. Experimental evidence of this is lacking however and would require an active 



















[E/D]−5 x −4[E/D]−3[S/T]−2 x −1Φ0  GLUT1 (Clairfeuille 
et al., 2016) 
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Table 1.2 Sorting motifs in endosomal cargo adapters 
Adapted from (Cullen and Steinberg, 2018). (Φ indicates an aromatic residue; x indicates any 
amino acid; pS indicates phosphoserine; pT indicates phosphotyrosine). 
 
1.4 Endosomal retrieval and recycling complexes 
 
1.4.1 The retromer complex 
S. cerevisiae has proved a powerful genetic tool in the identification of genes which 
affect specific processes of interest (Forsburg, 2001). Genetic screens identified more 
than 40 ‘vacuolar protein sorting’ (VPS) genes required for the efficient lysosomal 
delivery of acid hydrolases (Bankaitis et al., 1986; Rothman and Stevens, 1986; 
Robinson et al., 1988). Several Vps proteins (Vps29, Vps26, Vps35, Vps5 and Vps17) 
were subsequently shown to form a multiprotein complex and have a role in the 
retrograde transport of the transmembrane protein Vps10p from the endosomes to the 
Golgi; their perturbation resulted in the accumulation of Vps10p in the vacuole (the 
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yeast equivalent of lysosomes) (Horazdovsky et al., 1997; Seaman et al., 1997; 
Seaman et al., 1998). This complex was named ‘retromer’ (Seaman et al., 1998).  
The heteropentameric yeast retromer is formed of two subcomplexes: a heterotrimer of 
Vps35, Vps26 and Vps29 and a heterodimer of Vps5 and Vps17 (Horazdovsky et al., 
1997; Seaman et al., 1998). The highly conserved and ubiquitously-expressed 
mammalian homologues of the Vps35/Vps26/Vps29 heterotrimer are VPS35, 
VPS26A/VPS26B and VPS29 respectively (Haft et al., 2000; Koumandou et al., 2011). 
The differential incorporation of VPS26A or VPS26B into the retromer complex likely 
allows differential cargo sorting abilities, although negligible interactome differences 
have been detected (Bugarcic et al., 2011; McMillan et al., 2016). DSCR3 (Downs 
syndrome critical region 3), also known as VPS26C, is a third VPS26 paralogue but 
does not assemble into the retromer complex (see Section 1.4.6) (Koumandou et al., 
2011; McNally et al., 2017). The VPS35:VPS26:VPS29 subcomplex mediates cargo 
retrieval (Cullen and Steinberg, 2018). How this complex recognises cargo is discussed 
in Section 1.4.3.  
The ancestral Vps5 and Vps17 genes have undergone gene duplication in higher 
metazoans: mammals have two Vps5 homologues, sorting nexin (SNX)-1 and SNX2 
(Horazdovsky et al., 1997; Carlton et al., 2004), while Vps17 has three homologues, 
SNX5, SNX6 and SNX32 (Wassmer et al., 2007; Wassmer et al., 2009; Koumandou et 
al., 2011). Common to Vps5/17 and SNX1/2/5/6/32 are a Phox-homology (PX) domain 
and a Bin/Amphiphysin/Rvs (BAR) domain (Cullen, 2008). They belong to the ‘SNX-
BAR’ family of sorting nexins (Carlton et al., 2004). The SNX-BAR-containing 
subcomplex (discussed in greater detail in Section 1.4.2) is responsible for membrane 
remodelling to promote cargo recycling and has been referred to as the ‘membrane 
deformation complex’ (van Weering et al., 2010; Burd and Cullen, 2014a).  
In contrast to fungal retromer, the metazoan VPS35:VPS26:VPS29 heterotrimer and 
the SNX1/2:SNX5/6/32 heterodimer have not been shown to form a stable complex 
(Norwood et al., 2011). Although these two complexes are thought to cooperate in the 
sorting of many retromer-dependent cargo, they also have independent activities 
(Harterink et al., 2011; Zhang et al., 2011; Kvainickas et al., 2017a; Simonetti et al., 
2017; Cullen and Steinberg, 2018). To distinguish between the two complexes, I will 
henceforth use the term ‘retromer’ for the VPS35:VPS26:VPS29 heterotrimer and 
‘SNX-BAR complex’ for the SNX1/2:SNX5/6/32 heterodimer. I will discuss in greater 
detail SNX-BAR complex-dependent recycling in Section 1.4.2 and will subsequently 
discuss cargo retrieval via different retromers, such as the SNX3-retromer (Section 
1.4.3.1) and the SNX27-retromer (Section 1.4.3.2). 





Figure 1.6 The structure of the retromer complex 
(A) Model of the amino-terminus of VPS35 (red) bound to VPS26A (blue) and SNX3 (green) 
(Lucas et al., 2016). (B) Model of the carboxyl-terminus of VPS35 (red) bound to VPS35 (grey) 
(Hierro et al., 2007). (C) Predicted model of the entire VPS35 (pink): VPS26A(blue): VPS29 
(cyan) heterotrimer derived from (Gershlick and Lucas, 2017). (D) Model of VPS26A (blue) 
bound to the SNX27 PDZ-domain (pink) (Gallon et al., 2014a). 
 
Structural studies have been invaluable for understanding of how the multiprotein 
complex assembles and functions. The VPS35, VPS26, VPS29 heterotrimer 
assembles in a 1:1:1 ratio (Norwood et al., 2011). A high-resolution structure of 
mammalian retromer has not been solved in isolation, but partial structures are 
available: the N-terminal region of VPS35 in complex to SNX3 and VPS26A (Lucas et 
al., 2016) (Figure 1.6A) and the C-terminal region of VPS35 in complex to VPS29 
(Hierro et al., 2007) (Figure 1.6B). Through modelling, it has been possible to combine 
the available structures to reveal the overall architecture of retromer (Lucas et al., 
2016) (Figure 1.6C). VPS35 has a curved α-helical solenoid structure that is formed 
from 33 α-helices, organised into 16 anti-parallel α-helices (known as HEAT 
[Huntingtin/EF3/PP2A/TOR1] repeat domains) (Figure 1.6C). VPS26A has an arrestin-
like fold, consisting of antiparallel β-strands forming paired β-sandwich subdomains 
(Gallon et al., 2014a). VPS26A and VPS26B are structurally very similar and compete 
for the same site on the N-terminus of VPS35 (Collins et al., 2008). VPS29 binds to the 
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C-terminus of VPS35 and adopts a phosphoesterase-like fold (it can bind to divalent 
metals but has no in vitro enzymatic activity) (Collins et al., 2005; Hierro et al., 2007; 
Swarbrick et al., 2011) (Figure 1.6C). Recently, the assembly of the fungal C. 
thermophilium retromer bound to the BAR-domain containing Vps5 on a membrane 
tubule was solved. This will be discussed in greater detail in Section 5.3.2 and Section 
6.1.2.  
 
1.4.2 Cargo recycling by the SNX-BAR complex 
As described earlier (Section 1.4.1), the retromer pathway must couple with the SNX-
BAR complex to link cargo retrieval with membrane deformation and cargo enrichment 
into tubular recycling carriers. The SNX-BAR complex (as defined in this thesis) is 
composed of a heterodimer of SNX1 or SNX2 complexed with SNX5, SNX6 or SNX32 
(Cozier et al., 2002; Carlton et al., 2004; Wassmer et al., 2007; Wassmer et al., 2009). 
The formation of tubules has been observed: emanating from endosomes when SNX1 
or SNX2 are overexpressed in cells (Carlton et al., 2004), or when SNX1 or SNX2 were 
purified and incubated with liposomes in vitro (van Weering et al., 2012). SNX5, SNX6 
and SNX32 incorporate into a heterodimeric complex with SNX1 or SNX2 to promote 
tubule formation (van Weering et al., 2012).  
As described in Section 1.4.1, in addition to a PX-domain, the SNX-BAR complex 
members contain BAR domains. BAR domains contain a hydrophobic dimerization 
interface containing charged residues which add specificity to which SNX-BARs can 
dimerise together (Dislich et al., 2011; van Weering et al., 2012).  Furthermore, on the 
surface of BAR domain’s concave surface there are positively charged residues which 
can electrostatically interact with lipid bilayers (Gallop and McMahon, 2005).  
The SNX-BAR complex is initially recruited to the endosomal membrane through the 
PX-domain ‘coincidence detection’ of endosomal phosphoinositides and membrane 
curvature sensing through the BAR domain (Carlton et al., 2004; van Weering et al., 
2012). Additionally, the SNX-BARs contain amphipathic helices which can be inserted 
into lipid bilayers to robustly associate the complex to the membrane and also induce 
membrane curvature (Pylypenko et al., 2007; Bhatia et al., 2009; van Weering et al., 
2012). Tubule extension is promoted by the dimerization and formation of higher-order 
tubular lattices composed of SNX-BAR complexes (Frost et al., 2008; Mim et al., 2012).  
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1.4.3 Cargo recognition by retromer  
Having first been identified in S. cerevisiae as a multiprotein trafficking complex 
required for the retrograde transport of Vps10p (Section 1.4.1), the mammalian 
retromer has subsequently been shown to sort hundreds of transmembrane cargo 
away from a degradative fate in the lysosomes (Cullen and Steinberg, 2018). In terms 
of endosome-to-TGN cargo sorting, many mammalian functional homologues of 
Vps10p have been identified as being retromer cargoes, including: sortilin (Mari et al., 
2008), SorLA (Fjorback et al., 2012) and SorCS1 (Lane et al., 2010). In recent years, 
the role of retromer in endosome-to-plasma membrane sorting has increasingly 
become appreciated.  
Surface biotinylation of transmembrane proteins and their isolation, coupled to 
unbiased quantitative proteomics, has elucidated hundreds of cargoes which rely on 
retromer for their cell-surface localisation (Steinberg et al., 2013b). The development of 
global and unbiased quantitative proteomic techniques for examining the localisation of 
transmembrane proteins at other intracellular compartments, such as the TGN, will be 
instrumental in uncovering more retromer-dependent cargo. Although retromer has 
been described as ‘cargo-selective’, most cargoes are thought to be retrieved and 
recycled through the formation of larger multiprotein complexes in addition to retromer. 
The concept of retromer as a scaffolding hub for the recruitment of various accessory 
proteins to promote cargo retrieval and recycling, is increasingly being recognised 
(Figure 1.7) (Burd and Cullen, 2014a). The concept of sorting nexin-3 as a cargo 
adaptor is discussed in Section 1.4.3.1 and sorting nexin-27 as a cargo adaptor in 
Section 1.4.3.2. Retromer also binds to the WASH complex (Section 1.4.5), which 
promotes the formation of branched actin networks (Derivery et al., 2009; Gomez and 
Billadeau, 2009; Harbour et al., 2012; Jia et al., 2012).   




Figure 1.7 Retromer associated with various accessory proteins 
Retromer, a heterotrimer of VPS35:VPS29:VPS26 (in mammals, VPS26A and VPS26B is 
expressed), is recruited to endosomal membrane by Rab7 and the PI3P-binding SNX3. SNX3 
and SNX27 act as retromer cargo adapters to increase retromer’s repertoire of cargoes. The 
WASH complex, associated with retromer via an L-F-[D/E](3-10)-L-F motif, induces the 
polymerisation of filamentous branched actin. The Parkinson’s disease causing retromer 
variant, VPS35(p.D620N), reduces retromer’s association with the WASH complex. Adapted 
from (Cullen and Steinberg, 2018). 
 
1.4.3.1 SNX3-retromer 
‘Golgi retention defective’, or ‘grd’ proteins, were identified in a S. cerevisiae genetic 
screen for mutants which resulted in the vacuolar mislocalisation of A-ALP (Nothwehr 
et al., 1996). One of these, ‘Grd19p’, contained a PX domain and is also required for 
the localisation of A-ALP and Kex2p (Voos and Stevens, 1998). Due to the homology 
of its PX domain with SNX1 (Ponting, 1996), it was categorised into the sorting nexin 
family as ‘sorting nexin-3’ (SNX3) (Haft et al., 1998). SNX3 associates with endosomes 
via its PX-domain, which directly interacts with PI3P (Xu et al., 2001; Zhou et al., 2003) 
and SNX3 does not contain a BAR domain (Cullen and Korswagen, 2012).  
SNX3 recruits retromer to early endosomes via a direct interaction (Harterink et al., 
2011). Through the formation of the SNX3-retromer, where SNX3 jointly binds to 
VPS35 and to VPS26, SNX3 acts as a retromer cargo adapter (Strochlic et al., 2007; 
Lucas et al., 2016) (Figure 1.6A). Metazoan SNX3-retromer cargoes include: Wntless 
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(Belenkaya et al., 2008; Franch-Marro et al., 2008; Pan et al., 2008; Yang et al., 2008; 
Harterink et al., 2011; Zhang et al., 2011), transferrin receptor (Xu et al., 2001; Chen et 
al., 2013), DMT1-II (Lucas et al., 2016), polycystin-2 (Feng et al., 2017) and the C. 
elegans bone morphogenic protein type I receptor SMA-6 (Gleason et al., 2014). 
Interestingly, electron microscopy has revealed that the membrane carriers positive for 
SNX3 are vesicular, rather than tubular, and are decorated with clathrin (Harterink et 
al., 2011). Furthermore, at least for the SNX3-retromer-dependent sorting of Wntless, 
the SNX-BAR complex is not required (Harterink et al., 2011; Zhang et al., 2011). The 
question of how SNX3-retromer couples to a membrane deformation complex to 
facilitate Wntless recycling is examined in Chapter 3.  
The Lucas et al. (2016) crystal structure of a SNX3:VPS26A:VPS35 complex bound to 
the DMT1-II recycling signal defined the structural basic of SNX3-retromer cargo 
recognition. The direct association of SNX3 to retromer causes a conformational 
change in VPS26, revealing a binding site at the SNX3:VPS26 interface for cargo with 
a Ø-X-[L/M/V] motif (Ø indicates an aromatic residue) (Lucas et al., 2016) (Table 1.2) . 
This Ø-X-[L/M/V] motif is present in several known retromer cargoes, including 
Wntless, DMT1-II, CIMPR and sortilin; this motif has previously been shown to be 
important for the endosomal retrieval of Wntless and CIMPR (Seaman, 2007; Lucas et 
al., 2016; Varandas et al., 2016).  
 
1.4.3.2 SNX27-retromer 
Another member of the PX-domain containing sorting nexin family is sorting nexin-27 
(SNX27), which also contains a postsynaptic density 95/discs large/zonula occludens-1 
(PDZ)-domain and band 4.1/ezrin/radixin/moesin (FERM)-domain. SNX27 is 
predominantly expressed in the brain and in testes; it was originally identified as an  
upregulated gene following methamphetamine injection in rodents and also in a 
proteomic screen for interactors of 5-hydroxytryptamine type 4 receptors (Kajii et al., 
2003; Joubert et al., 2004). Global unbiased cell-surface proteomics have revealed 
hundreds of cargoes which rely on SNX27 for their endosomal retrieval and recycling to 
the plasma membrane (Steinberg et al., 2013b). Some of the identified cargoes 
include: N-methyl-D-aspartate (NMDA) receptors (Wang et al., 2013), α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (Hussain et al., 2014; 
Loo et al., 2014), the β2-adrenergic receptor (Temkin et al., 2011), the parathyroid 
hormone receptor (Chan et al., 2016), the inwardly rectifying potassium channel 3.3 
(Kir3.3) (Balana et al., 2011) and glucose transporter 1 (GLUT1) (Steinberg et al., 
2013b).  
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The SNX27 PDZ domain recognises cargoes with a type I PDZ binding motif: [S/T]-x-Φ 
(in which Φ represents any hydrophobic residue) (Hung and Sheng, 2002). SNX27 
has been shown to engage PDZ binding motifs with either high or low affinity; high 
affinity binders require the presence of acidic residues located upstream of the PDZ 
binding motif which can be substituted by conserved phosphorylation sites (see 
Table 1.2 for full sorting motifs) (Clairfeuille et al., 2016). Building on this information, 
bioinformatic screening for potential SNX27-depenent cargoes identified over 400 
potential binders of SNX27 with appropriate PDZ binding motifs (Clairfeuille et al., 
2016).  
The SNX27 FERM-domain is thought to bind numerous NPxY or NxxY binding motif-
containing cargoes, with a preference for those which are phosphorylated at position 
‘Y0’ (i.e. the tyrosine at the end of the motif; see Table 1.2) (Ghai et al., 2013). 
Validated SNX27-dependent cargoes with NPxY/NxxY binding motifs include the 
amyloid precursor protein and P-selectin; a peptide array has also suggested that 
various activated (i.e. Y0-phosphorylated) receptor tyrosine kinases are SNX27 cargo 
too (Ghai et al., 2011; Ghai et al., 2013).  
By directly binding to retromer (Steinberg et al., 2013b; Gallon et al., 2014a), SNX27 
acts as a retromer cargo adapter (Burd and Cullen, 2014a). A hydrophobic pocket 
within VPS26 is contacted by Leu67 and Leu74 within the β3-β4 loop of SNX27’s PDZ 
domain, an area distant from the site of PDZ binding motif recognition, explaining 
SNX27’s simultaneous association with retromer and cargo (Gallon et al., 2014a) 
(Figure 1.6D). The formation of the SNX27-retromer allosterically enhances the affinity 
of SNX27 for PDZ binding motifs (Gallon et al., 2014a). SNX27-retromer dependent 
retrieval and recycling is thought to occur on Rab4-positive early endosomes and 
requires the SNX-BAR complex (Section 1.4.2) (Temkin et al., 2011; Steinberg et al., 
2013b). 
 
1.4.4 Spatiotemporal control of retromer  
Retromer does not have any intrinsic membrane-binding ability and relies on 
protein:protein interactions to associate with the cytosolic surface of endosomal 
membranes. As previously outlined (Section 1.4.3.1), retromer associates with early 
endosomes via SNX3 (Harterink et al., 2011; Harrison et al., 2014b; Lucas et al., 
2016). A recent study has suggested a mechanism for the regulation of the ability of 
SNX3 to associate with PI3P: phosphorylation of Ser72 on the PI3P binding site which 
prevents membrane association (Lenoir et al., 2018). How this is regulated is currently 
unclear, but this phosphorylation is thought to extend to other sorting nexins, including 
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SNX1, and may be a general mechanism for controlling the membrane association of 
PX-domain containing proteins (Lenoir et al., 2018). 
In addition, retromer is recruited to maturing endosomes through its interaction with 
Rab7-GTP (Nakada-Tsukui et al., 2005; Rojas et al., 2008). Together with the Rab7 
GAP TBC1D5 (which directly binds to VPS29 of retromer), retromer negatively 
regulates Rab7 activity and localisation; concurrently, by promoting Rab7-GTP 
hydrolysis, retromer initiates a negative feedback loop which promotes retromer 
dissociation from the endosomal membrane (Seaman et al., 2009; Jia et al., 2016; 
Jimenez-Orgaz et al., 2018).  
Due to its profound role in maintaining and modulating transmembrane protein 
localisation, it is likely that the function and activity of retromer is regulated 
transcriptionally and post-translationally. Evidence for the transcriptional control of 
retromer is currently lacking. A phosphorylation-dependent mechanism for modulating 
assembly of Vps35:Vps26:Vps29 into retromer has been described for S. cerevisiae 
Vps26; its relevance for mammalian retromer has not yet been proven (Cui et al., 
2017). Retromer has also been described to undergo Parkin-mediated 
polyubiquitylation, although the functional consequence of this is currently unknown 
(Williams et al., 2018). It is likely that as the molecular details of retromer cargo 
recognition become increasingly understood, research focus will turn towards the 
question of the regulation and modulation of retromer activity.  
 
1.4.5 The WASH complex 
Correct endosomal organisation and function is dependent on the polymerisation of 
branched actin networks (Puthenveedu et al., 2010; Ohashi et al., 2011; Derivery et al., 
2012; Gomez et al., 2012). Branched actin polymerisation is promoted by the actin-
related protein 2/3 (Arp2/3) complex-dependent nucleation of monomeric actin; 
however, without being engaged by nucleation-promoting factor (NPF) proteins, it 
possesses little biochemical activity (Goley and Welch, 2006). On endosomes, the 
principle NPF is WASP and SCAR homologue 1 (WASH1), which incorporates into the 
heteropentameric WASH complex (Derivery et al., 2009; Gomez and Billadeau, 2009; 
Jia et al., 2010).  
The WASH complex is composed of: WASH1, Family with sequence similarity 21 
(FAM21), Strumpellin, Coiled-coil domain containing 53 (CCDC53), and Strumpellin 
and WASH-interacting protein (SWIP). There is no high-resolution structure available of 
the WASH complex, but it is thought to be analogous to another heteropentameric NPF 
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complex, the WASP family verprolin homolog isoforms (WAVE) complex, based on an 
electron microscopy-solved 20 Å structure and immunoprecipitation experiments (Jia et 
al., 2010). 
WASH1 knockout mouse embryonic fibroblasts (MEFs) show a ‘collapsed’ 
endolysosomal network, where endosomes coalesce into the juxta-nuclear region and 
are devoid of filamentous endosomal actin (Gomez et al., 2012). Importantly, this 
phenotype could not be rescued with a WASH mutant devoid of its Arp2/3 complex-
activating domain (Gomez et al., 2012). This ‘collapsed’ endolysosomal phenotype has 
subsequently been reproduced for Strumpellin knockouts in mouse melanocytes 
(Tyrrell et al., 2016). Although elongated endosomal tubules have been reported when 
WASH complex components have been depleted (Derivery et al., 2009; Gomez and 
Billadeau, 2009; Duleh and Welch, 2010), this is not phenocopied in the WASH1 
knockout MEFs or when actin polymerisation or the Arp2/3 complex is suppressed, 
where endosomes become swollen, aggregated and devoid of tubules (Gomez et al., 
2012). It is hypothesised that these contradictory phenotypes may represent two 
distinct roles of the WASH complex (Gautreau et al., 2014). 
There is increasing evidence that some cargo may directly interact with actin to 
facilitate their endosomal sorting. The fusion of an actin-binding domain was able to 
overcome the addition of a ubiquitin degradative signal in a transferrin receptor 
chimeric protein (MacDonald et al., 2018) and replacing the PDZ binding motif of the 
β2-adrenergic receptor (a SNX27-retromer cargo) with an actin binding domain 
permitted functional recycling (Puthenveedu et al., 2010). As actin has a role in 
endosomal recycling, it is therefore not surprising that various cargo, including the 
transferrin receptor (Derivery et al., 2009), CIMPR (Gomez and Billadeau, 2009), the 
β2-adrenergic receptor (Puthenveedu et al., 2010), α5β1 integrin (Zech et al., 2011), T-
cell receptor (Piotrowski et al., 2013), GLUT1 (Lee et al., 2016), LDLR (Bartuzi et al., 
2016) and GLUT2 (Ding et al., 2018) have been shown to require the WASH complex 
for either their endosome-to-plasma membrane or endosome-to-TGN recycling. Many 
of these cargoes also require retromer or retriever for their sorting (see Section 1.4.1 
and Section 1.4.6). 
The WASH complex localises to retromer-positive endosomes, dependent on the 
∼1100 amino acid unstructured and flexible ‘tail’ of FAM21 (Derivery et al., 2009; 
Gomez and Billadeau, 2009). A large portion of the endosomal association of the 
WASH complex is dependent on its direct association with retromer (Harbour et al., 
2012; Jia et al., 2012; McNally et al., 2017). This direct interaction has been shown to 
be dependent on a series of approximately 21 L-F-[D/E]3-10-L-F (so-called ‘LFa’) motifs 
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(Jia et al., 2012). It has been proposed that the binding of multiple retromers by FAM21 
allows the density of endosomal retromer to be sensed, thereby coordinating cargo 
recognition and clustering with the endosomal recruitment of the WASH complex and 
therefore the polymerisation of filamentous actin (Jia et al., 2012; Cullen and Steinberg, 
2018).  
The mechanism of retromer-independent endosomal WASH complex recruitment is 
undetermined. However, FAM21 binds to other endosome-localised proteins, including 
RME-8 (Freeman et al., 2014) and SNX27 (Steinberg et al., 2013b). It has also been 
shown to bind promiscuously to lipids in vitro, including PI3P and PI(3,5)P2 (Derivery et 
al., 2009).  
 
1.4.6 Retromer-independent endosomal retrieval 
In recent years, it has become increasingly clear that retromer, although responsible for 
the retrieval and recycling of hundreds of transmembrane proteins, is not involved in all 
sequence-dependent endosomal cargo sorting (McNally and Cullen, 2018). Hundreds 
of transmembrane proteins have been identified as being dependent on the SNX27-
retromer for their cell-surface localisation (see Section 1.4.3.2) (Steinberg et al., 
2013b). However, there were around 40 transmembrane proteins which were lost from 
the cell surface in a SNX27-dependent but retromer-independent fashion, suggesting 
retromer-independent SNX27 cargo retrieval and recycling (Steinberg et al., 2013b).  
Sorting nexin-17 (SNX17) is another FERM-domain containing (but not PDZ-domain 
containing) sorting nexin (Ghai et al., 2011). SNX17 does not associate with retromer 
(Steinberg et al., 2012). Consistent with this, a global cell-surface proteomic study 
revealed that SNX17 regulates the cell-surface localisation of hundreds of ΦxNPx[F/Y]- 
or ΦxNxx[F/Y]-motif containing cargo (Table 1.2), independently of retromer (McNally 
et al., 2017). SNX17-dependent cargoes include β1-integrin (Bottcher et al., 2012; 
Steinberg et al., 2012), low-density lipoprotein receptor-related protein 1 (LRP1) (van 
Kerkhof et al., 2005) and P-selectin (Florian et al., 2001). Upon perturbation of SNX17, 
these cargoes undergo lysosomal-mediated cargo degradation.  
Further molecular insight into SNX17-dependent cargo retrieval came from the 
discovery that SNX17 requires the evolutionary-conserved, retromer-like, ‘retriever’ 
complex to mediate endosomal cargo retrieval and recycling (McNally et al., 2017). The 
retriever complex is thought to be structurally homologous to retromer, being a 
heterotrimer of VPS29, chromosome 16 open reading frame 62 (C16orf62 but now 
known as VPS35L; predicted to contain HEAT-repeats similar to VPS35) and VPS26C 
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(see Section 1.4.1) (McNally et al., 2017). Interestingly, the copy number (in HeLa 
cells) of C16orf62 and DSCR3 is much lower compared to VPS35 and 
VPS26A/VPS26B (Kulak et al., 2014; McNally and Cullen, 2018).  
The endosomal association of retriever is not dependent on SNX3 or Rab7, but another 
evolutionary conserved, multiprotein endosomal sorting complex: the CCC complex 
(McNally et al., 2017). The CCC complex is composed of coiled-coil domain-containing 
protein 22 (CCDC22), coiled-coil domain-containing protein 93 (CCDC93) and (at least) 
one of ten copper metabolism MURR1 domain (COMMD) proteins (Starokadomskyy et 
al., 2013; Phillips-Krawczak et al., 2015). COMMD proteins are thought to recognise 
cargo (Li et al., 2015). They can also homo- and hetero-dimerize (Burstein et al., 2005), 
suggesting that different COMMD-combinations assembled into the CCC complex may 
enable the recognition of different cargo. For example, COMMD1 has been implicated 
in the retrieval and recycling of ATP7A (Phillips-Krawczak et al., 2015) and LDLR 
(Table 1.2) (Bartuzi et al., 2016), whereas the plasma-membrane retrieval and 
recycling of Notch2 requires a heterodimer of COMMD9:COMMD5/COMMD10 (Li et 
al., 2015). The degree of cross-over between cargo retrieval of the CCC complex and 
retriever is currently unclear. It is also unclear how SNX17:retriever:CCC complex 
couples cargo recognition to membrane deformation.  
To add an extra layer of complication, the endosomal association of the CCC complex 
is dependent on its interaction with the FAM21 subunit of the WASH complex (Phillips-
Krawczak et al., 2015) (see Section 1.4.5). Therefore, retriever is dependent on both 
the CCC and WASH complexes for its endosomal localisation (Figure 1.8) (McNally et 
al., 2017). Perturbation of SNX17, retriever, the CCC complex, or the WASH complex 
results in the lysosomal missorting of β1-integrin (Zech et al., 2011; Steinberg et al., 
2012; McNally et al., 2017). As stated before, a large proportion of the WASH complex 
associated with endosomes requires an interaction with retromer (Harbour et al., 2012; 
Jia et al., 2012). Retromer knockout results in a mild β1-integrin trafficking defect, likely 
due to the loss of the endosomal association of the WASH complex (McNally et al., 
2017).  




Figure 1.8 Retromer-independent endosomal cargo retrieval. 
Retriever, a heterotrimeric complex of VPS35L:VPS26C:VPS29, is recruited to the endosomal 
membrane by its interactions with the CCC complex (CCDC22:CCDC93:COMMD), which is 
recruited to endosomes through its interactions with the WASH complex. It is hypothesised that 
this forms a higher order complex called ‘COMMander’, although experimental evidence for this 
is currently lacking. SNX17 and COMMD proteins are thought to act as cargo adaptors for the 
COMMander complex. Adapted from (Cullen and Steinberg, 2018). 
 
Although the SNX-BAR complex has traditionally been thought of as the membrane 
deformation element to which the cargo-selective retromer couples (see Section 
1.4.2), two recent papers independently described SNX-BAR complex-dependent, 
retromer-independent recognition of the CI-MPR and insulin-like growth factor 1 
receptor (IGF1R), challenging the dogma of the field (Kvainickas et al., 2017a; 
Simonetti et al., 2017). All of the endosomal retrieval complexes are thought to coexist 
on the same retrieval subdomains (McNally et al., 2017; Cullen and Steinberg, 2018) 
(Figure 1.4). A summary of the retrieval complexes is shown in Table 1.3. 
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Table 1.3 Summary of the main endosomal retrieval complexes and how they associate 
with the endosomal membrane.  
 
1.5 Endosomal cargo retrieval and recycling is 
neuroprotective 
As endosomal cargo retrieval and recycling plays such a major role in the maintenance 
and modulation of the cell surface proteome (and of other intracellular compartments), 
it is not surprising that the deletion of various components of this pathway, including 
VPS35, VPS26A (but not VPS26B), FAM21, CCDC53, WASH1, Strumpellin, SNX3, 
COMMD1, COMMD9 and a combination of SNX1 and SNX2, result in embryonic 
lethality in mice (Lee et al., 1992; Schwarz et al., 2002; van de Sluis et al., 2007; Kim et 
al., 2010; Wen et al., 2011; Gomez et al., 2012; Jahic et al., 2015; Li et al., 2015) (the 
lethality of SNX3, FAM21 and CCDC53 knockouts were identified by the International 
Mouse Phenotyping Consortium). Furthermore, dysfunction of many of these 
components have also been implicated in human neurological diseases (Section 
1.5.1). A growing body of evidence also suggest that the enhancement of the best-
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characterised endosomal retrieval complex, retromer, is neuroprotective in a range of 
disease models (Bi et al., 2013; MacLeod et al., 2013; Linhart et al., 2014; Mecozzi et 
al., 2014; Dhungel et al., 2015; Follett et al., 2016; McMillan et al., 2017). 
Why are neurons particularly sensitive to disruptions in the endosomal cargo sorting 
machinery? Their ‘extreme’ morphology and polarisation, with elaborate branched 
dendritic projections and long axonal extensions (of up to 1m in length) Figure 1.9), 
makes the endolysosomal pathway and retrograde transport a logistical challenge (Jin 
et al., 2018). Most degradative lysosomes are located close to the cell body meaning 
that cargoes may have to travel long distances to be degraded (Figure 1.9) (Kulkarni 
and Maday, 2018). Neuronal synaptic and postsynaptic biology, including the synaptic 
vesicle cycle and the modulation of cell-surface transmembrane proteins, is also 
heavily dependent on an efficient endosomal system (Jin et al., 2018). Furthermore, 
neurons are post-mitotic, long-lived and not easily replaced if this system becomes 
dysfunctional (Schreij et al., 2016).  
 
 
Figure 1.9 Neuronal distribution of the endolysosomal pathway 
(A) A cartoon representing the morphology of neuronal cells. The degradative lysosomes are 
distributed in proximity to the soma. (B) The distribution of early, transition and late endosomes, 
as well as degradative lysosomes, in major dendrites. Adapted from (Kulkarni and Maday, 
2018) 
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1.5.1 Associations between endosomal retrieval complexes and 
neurological disorders 
In Alzheimer’s disease (AD), the protein levels of VPS35 and VPS26 of retromer were 
shown to be decreased in the hippocampal tissue of patients with AD (Small et al., 
2005). Depletion of retromer components in human tissue culture or using in vivo 
models results in the pathogenic processing of amyloid precursor protein (APP) into 
amyloid-β (a hallmark of AD pathology) (Small et al., 2005; Muhammad et al., 2008; 
Lane et al., 2010; Vieira et al., 2010; Wen et al., 2011; Bhalla et al., 2012; Fjorback et 
al., 2012; Mecozzi et al., 2014). Conversely, an AD mouse model (which 
overexpresses a variant of APP which causes early-onset AD), displayed reduced 
levels of retromer components (Chu and Pratico, 2017). Mechanistically, retromer has 
been implicated in AD pathology through influencing the processing of the APP: the 
trafficking of APP is dependent on the retromer cargo SorLA (and other VPS10-
containing proteins). The depletion of retromer increases the time APP spends in 
endosomes where it can be processed into amyloid-β (Small and Petsko, 2015). In vivo 
models depleting retromer components displayed Alzheimer’s disease phenotypes, 
such as impaired cognition, synaptic dysfunction and defective long-term potentiation 
(Muhammad et al., 2008; Wen et al., 2011). Non-synonymous de novo variants of 
VPS35 were also identified associated with sporadic early-onset AD (Rovelet-Lecrux et 
al., 2015). Likewise, other endosome-associated proteins including SNX3, SWIP, 
Rab7A and SNX1 have been genetically linked to AD (Vardarajan et al., 2012).  
Rare mutations in various subunits of retromer have been implicated in familial 
Parkinsonism disorders (McMillan et al., 2017). The best characterised and most 
common of these is the autosomal dominant VPS35(p.D620N) mutation, which has 
been identified in both familial and sporadic forms of the disease (Vilarino-Guell et al., 
2011; Zimprich et al., 2011; Ando et al., 2012; Kumar et al., 2012; Lesage et al., 2012; 
Sharma et al., 2012; Sheerin et al., 2012; Chen et al., 2017; McMillan et al., 2017; 
Bentley et al., 2018). This mutation causes a decrease in retromer’s association with 
the WASH complex (McGough et al., 2014b; Zavodszky et al., 2014) and functionally 
has been implicated in perturbing: lysosomal health (Follett et al., 2014; McGough et 
al., 2014b; Zavodszky et al., 2014); mitochondrial health (Tang et al., 2015b; Wang et 
al., 2016b; Wang et al., 2017); synaptic plasticity (Munsie et al., 2014); and dopamine 
transport and signalling (Wang et al., 2016a; Wu et al., 2017; Cataldi et al., 2018). 
Furthermore, in samples of sporadic Parkinson’s disease patients’ substantia nigra 
pars compacta (the brain area which displays prominent dopaminergic neuronal death 
in Parkinson’s disease), the mRNA levels of VPS35 were reduced (MacLeod et al., 
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2013). A more detailed consideration of retromer’s association with Parkinson’s 
disease will be explored in Chapter 4.  
The retromer-associated cargo adapter SNX27 has also been linked to neurological 
disorders. Patients harbouring a homozygous deletion mutation of SNX27 die within 2 
years of birth and exhibit intractable monoclinic epilepsy and psychomotor defects 
(Damseh et al., 2015). In Down’s syndrome, the trisomic chromosome 21 causes the 
overexpression of a negative regulator of SNX27, miR-155, leading to a decreased 
expression of SNX27. Interestingly, synaptic and cognitive phenotypes exhibited in a 
mouse model of Down’s syndrome can be rescued through SNX27 overexpression 
(Wang et al., 2013). Other neurodevelopmental disorders implicated with endosomal 
sorting complexes include: X-linked recessive intellectual disability, which can be 
caused by mutations in CCDC22 (Kolanczyk et al., 2015; Bartuzi et al., 2016); and 
autosomal recessive intellectual disease, which can be caused by a mutation in SWIP 
(Ropers et al., 2011). Various mutations in Strumpellin have also been identified which 
cause hereditary spastic paraplegia (Valdmanis et al., 2007; Bettencourt et al., 2013; 
de Bot et al., 2013; Ishiura et al., 2014; Wang et al., 2014; Ichinose et al., 2016) and 
Ritscher-Schinzel/3C syndrome (Elliott et al., 2013).  
 
1.6 Aims 
Once transmembrane protein cargoes enter the endosomal network, a fundamental 
fate decision occurs: cargoes are either sorted for degradation or they undergo retrieval 
and recycling. The process of endosomal retrieval and recycling has been highlighted 
by its association with several neurological diseases (Section 1.5.1). Our 
understanding of the process of retrieval and recycling has greatly improved in recent 
years and we now understand retromer, retriever, the WASH complex, the CCC 
complex and the SNX-BAR complex to be fundamental orchestrators, together with 
their various interactors (Figure 1.4) (Cullen and Steinberg, 2018). The general aim of 
my thesis was to dissect key molecular and functional interactions of the best 
characterised of these complexes: retromer. 
Global and unbiased proteomic studies have increasingly mapped the interactors of 
retromer (Section 1.4.1) and the retromer cargo adaptors SNX3 (Section 1.4.3.1) and 
SNX27 (Section 1.4.3.2). Notably, a detailed understanding of the mechanism by 
which some of these interactions occur and their functional significance is lacking.  
In Chapter 3, I will describe research aimed at defining the residues in SNX3 which 
allow the formation of the SNX3-retromer. Through a collaboration with the Rik 
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Korswagen lab, I aimed to identify the importance of the physical association between 
SNX3 and retromer in the formation of Wnt morphogenetic gradients. In addition, I 
provide new insight into the fundamental question of how SNX3-retromer couples to a 
membrane deformation complex in order to couple cargo enrichment with membrane 
carrier formation.  
In Chapter 4, I examine retromer’s role in the pathogenesis of familial Parkinson’s 
disease. The most common mutation in retromer which causes Parkinson’s disease, 
VPS35(p.D620N), has set a precedent that disease-causing mutations in retromer may 
affect its molecular interactions. Taking forward this precedent, I describe whether 
other Parkinsonism-associated retromer mutations affect its interactome. 
Lastly, in Chapter 5, I aim to increase our understanding of one of the more enigmatic 
of the retromer interactions: the retromer-WASH complex association. Both retromer 
and the WASH complex are fundamental players in endosomal biology and much has 
been inferred from their interaction. However, much of this speculation is not based 
upon experimental evidence. I will describe research that has defined the retromer 
residues which are critical for this interaction and aim to elucidate its functional 
importance.  
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2.1.1 List of suppliers 
Abcam, Cambridge, UK. AbD Serotec, Raleigh, NC, USA. Adobe Systems, 
Uxbridge, UK. Amersham, Little Chalfont, UK. Apollo Scientific, Denton, UK. BD 
Biosciences, San Jose, CA, USA. Beckman Coulter, High Wycombe, UK. Bio-
Rad, Hemel Hempstead, UK. Calbiochem, San Diego, CA, USA. Cell Signaling 
Technology (CST), Beverley, MA, USA. Corning, Corning, NY, USA. Covance, 
Princeton, NJ, USA. Dharmacon, Lafeyette, CO, USA. Elga Labwater, High 
Wycombe, UK. Eppendorf, Hamburg, Germany. Eurofins MWG Operon, 
Ebersberg, Germany. GE Healthcare, Piscataway, NJ, USA. Hamamatsu 
Photonics, Hamamatsu, Japan. Improvision, Coventry, UK. Jackson 
ImmunoResearch, West Grove, PA, USA. Leica Microsystems, Milton Keynes, 
UK. Life Technologies, Carlsbad, CA, USA. Lonza, Basel, Switzerland. 
Microsoft, Redmond, WA, USA. Millipore, Watford, UK. Molecular Devices, 
Sunnydale, CA, USA. Molecular Probes, Cambridge, UK. New England Biolabs, 
Hitchin, UK. Novagen, Madison, WI, USA Olympus Microscopes, London, UK. 
PerkinElmer Life Sciences, Waltham, MA, USA. Pierce, Rockford, IL, USA. 
Promega, Southampton, UK. Qiagen, Crawley, UK. Roche Applied Science, 
Lewes, UK. Santa Cruz Biotechnology, CA, USA. Sigma-Aldrich (UK), Poole, 
UK. Solent Scientific, Segensworth, UK. Stratagene, La Jolla, CA, USA. 
ThermoScientific UK. 
 
2.1.2 Sterilised water 
All water used in the preparation of reagents or in experiments was sterilised using a 
PURELAB Option system (Elga Labwater). Nuclease-free water was purchased from 
Promega (cat. # P1193). 
 
2.1.3 Cell lines used in this study 
HEK 293: a human embryonic kidney cell line, immortalised by transformation with 
sheared human adenovirus type 5 DNA and stably transfected with the large T antigen 
of SV40 (Graham et al., 1977). This cell line was used for transient transfections and 
biochemical GFP/RFP trap experiments.  
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hTERT-RPE-1: a human retinal pigment epithelial cell line immortalised through stable 
transfection of human telomerase reverse transcriptase (hTERT) (Bodnar et al., 1998). 
This cell line was used in stable transductions and transient transfections for confocal 
imaging.  
HeLa: human cervical adenocarcinoma cell line (Scherer et al., 1953). This cell line 
was used in stable transduction and transient transfections for confocal imaging.  
 
2.1.4 Reagents for cell culture  
Media for culturing HEK 293, HeLa and RPE-1 cells: Dulbecco’s Modified Eagle’s 
Medium (DMEM) with 4.5 g L-1 glucose/L, L-glutamine, NaHCO3 and pyridoxine 
(Sigma, cat. # D5796), supplemented with 10% (v/v) foetal bovine serum (Sigma, cat. # 
F7524). Cells were grown without antibiotics.  
Media for cell line transfection: OptiMEM® reduced serum media with GlutaMAX™ 
supplement (ThermoScientific, Gibco, cat. # 51985034) for transfecting siRNA 
oligonucleotides; OptiMEM® reduced serum media (ThermoScientific, Gibco, cat. # 
31985062) for transfecting plasmid DNA.  
For washing cells: cell culture-grade phosphate buffered saline (PBS) with 170 mM 
NaCl, 1 mM Na2HPO4, 3 mM KCl, 1.8 mM KH2PO4, pH 7.4. (Lonza, cat. # 17-516F). 
For detaching cells from tissue culture plate: trypsin-EDTA solution, with 0.2 g/L EDTA, 
0.5 g/L porcine trypsin in Hank’s balance salt solution (Sigma, cat. # T3924). 
Inhibitors used: VPS34-IN1 (C₂₁H₂₄ClN₇O), a VPS34 inhibitor (Calbiochem®, cat. # 
532628). Bafilomycin A1 (C35H58O9), a lysosomal acidification inhibitor (Sigma, cat. #  
B1793). 
For culturing cell lines for a SILAC experiment: Dulbecco’s Modified Eagle’s Medium 
(DMEM) with 1000mg/L D-glucose, L-glutamine, and sodium bicarbonate, without 
arginine, leucine, lysine, sodium pyruvate, and phenol red (Sigma, cat. # D9443), 
supplemented with 10% (v/v) dialysed foetal bovine serum (Sigma, cat. # F0392). This 
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Table 2.1 SILAC amino acids 
SILAC amino acids 
 
Composition Source Catalogue 
number 
R0 (light arginine) L-arginine 
monohydrochloride 
Sigma A6969 












2.1.5 Bacterial cell strains 
XL-Blue competent E. coli, genotype: recA1, endA1, gyrA96, thi-1, hsdR17, supE44, 
relA1 lac [F’ proAB lacIq Z∆M15 Tn10(Tetr)] were purchased from Stratagene (cat. # 
200236). Used in the transformation of constructs generated by restriction enzyme 
digestion followed by ligation. 
XL10-Gold ultracompetent E. coli, genotype: TetrD(mcrA)183, D(mcrCB-hsdSMR-
mrr)173, endA1, supE44, thi-1, recA1, gyrA96, relA1, lac were purchased from 
Stratagene (cat. # 200314). Used in the transformation of constructs generated by site-
directed mutagenesis.  
 
2.1.6 Bacterial growth media and antibiotics  
Luria-Bertani (LB) media (10 g NaCl, 10 g Tryptone, 5 g yeast extract in 1 L sterilised 
water). Purchased from Sigma (cat. # L3022).  
Super Optimal broth with Catabolite repression (SOC) media (20 g Tryptone, 5 g yeast 
extract in 1 L sterilised water). Purchased from Sigma (cat. # S1797). 
LB agar (20 g agar, 10 g NaCl, 10 g Tryptone, 5 g yeast extract in 1 L sterilised water). 
Purchased from Sigma (cat. #L2897). 
Ampicillin: Working concentration 100 µg ml-1 (aq). Purchased from Sigma (cat. # 
A9518) in salt form. 
Chapter 2: Materials and Methods 
41 
 
Kanamycin: Working concentration 50 µg ml-1 (aq). Purchased from Sigma (cat. # 
B5264) in salt form. 
 
2.1.7 Buffers and solutions 
Phosphate buffered saline (PBS): PBS tablets (Oxoid™, cat. # BR0014G) were 
dissolved in laboratory grade purified water (1 tablet per 100 ml).  
Lysis buffer: PBS, 5 mM ethylenediaminetetraacetic acid (EDTA), 1% (v/v) Triton X-100 
(Sigma, cat. # T8787) and 1x complete protease inhibitor (Roche, cat. 04693124001).  
GFP/RFP nanotrap buffer: 20 mM Tris/HCl, pH 7.4, 0.5% (v/v) Igepal (NP-40) (Sigma, 
cat. # I8896) and 1x complete protease inhibitor (Roche, cat. 04693124001). 
Sample buffer: NuPAGE SDS sample buffer (4x) (ThermoScientific, Invitrogen cat. # 
NP0007) supplemented with 2.5% β-mercaptoethanol (Sigma, cat. # M6250). 
 
2.1.8 Plasmid vectors 
pEGFP-C1, pEGFP-N1, pmCherry-C1 were purchased from Clontech and used for 
transient transfection of mammalian cells.  
pcDNA3.1 was purchased from Invitrogen and used for the transient transfection of 
mammalian cells.   
pXLG3 was derived from pHR9SINSEW (Demaison et al., 2002) and modified by Dr 
Florian Steinberg. pMDG2 (VSV-G lentivirus envelope plasmid) was derived from (Ory 
et al., 1996). pCMV_R8.91 (lentivirus packaging construct) was derived from (Zufferey 
et al., 1997). These plasmids were used for the generation of lentiviral particles.  
Other plasmids used in this study are listed in Table 2.2. 
 
Table 2.2 List of plasmids used in this study 
Plasmid name Vector type Origin 
GFP-SNX3 pEGFP-C1 from the lab 
GFP-SNX3 (p. 9,10 RR-
AA) 
pEGFP-C1 SDM of GFP-SNX3 
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GFP-SNX3 (p.Δ22-28) pEGFP-C1 SDM of GFP-SNX3 
GFP-SNX3 (p EID-TIR) pEGFP-C1 SDM of GFP-SNX3 
GFP-SNX3 (p. E50K) pEGFP-C1 SDM of GFP-SNX3 
GFP-SNX3 (p. E75A) pEGFP-C1 SDM of GFP-SNX3 
GFP-SNX3 (p. ESK(84-
86)NAG) 
pEGFP-C1 SDM of GFP-SNX3 
GFP-SNX3 (p.Δ99-110) pEGFP-C1 SDM of GFP-SNX3 
GFP-SNX3 (p. Y154A) pEGFP-C1 SDM of GFP-SNX3 
GFP-SNX3 (p. P156A) pEGFP-C1 SDM of GFP-SNX3 
GFP-SNX3 (p. R160A) pEGFP-C1 SDM of GFP-SNX3 
GFP-SNX3 (p.Y22A) pEGFP-C1 SDM of GFP-SNX3 
GFP-SNX11 pEGFP-C1 from the lab 
GFP-SNX12 pEGFP-C1 from the lab 
GFP-SNX1 pEGFP-C1 from the lab 
GFP-MON2 pcDNA3.1 cloned by Dr Ian McGough 
MON2-GFP pEGFP-N1 cloned by Dr Ian McGough 
MON2-flag pcDNA3.1 cloned by Dr Ian McGough 
DOPEY2-GFP pEGFP-N1 cloned by Dr Ian McGough 
Flag-DOPEY2 pcDNA3.1 cloned by Dr Ian McGough 
ATP9A-HA pcDNA3.1 cloned by Dr Ian McGough 
HA-Wntless-HA pIRESneo3 a gift from Dr Katherine Varandas 
HA-Wntless-HA pXLG3 cloned by PCR 
GFP-VPS26A pEGFP-C1 from the lab 
GFP-VPS26A (p.K93E) pEGFP-C1 SDM of GFP-VPS26A 
GFP-VPS26A (p.M112V) pEGFP-C1 SDM of GFP-VPS26A 
GFP-VPS26A (p.K297X) pEGFP-C1 SDM of GFP-VPS26A 
GFP-VPS26A pXLG3 from the lab 
GFP-VPS26A (p.K93E) pXLG3 subcloning 
GFP-VPS26A (p.M112v) pXLG3 subcloning 
GFP-VPS26A (p.K297X) pXLG3 subcloning 
GFP-VPS35 pEGFP-C1 from the lab 
GFP-VPS35 pXLG3 from the lab 
VPS35-GFP pEGFP-C1 cloned by PCR 
VPS35-GFP pXLG3 subcloning 
VPS35 (p.R32S)-GFP pEGFP-C1 SDM of VPS35-GFP 
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VPS35 (p.R32S)-GFP pXLG3 subcloning 
VPS35 (p.G51S)-GFP pEGFP-C1 SDM of VPS35-GFP 
VPS35 (p.G51S)-GFP pXLG3 subcloning 
mCherry-SNX3 pmCherry-C1 from the lab 
mCherry-Rab7 (p.Q67L) pmCherry-C1 from the lab 
GFP-FAM21 (1-220) pEGFP-C1 from the lab 
GFP-FAM21 (Δ1-220) pEGFP-C1 from the lab 
VPS35 (p.D620N)-GFP pEGFP-N1 SDM of VPS35-GFP 
VPS35 (p.K552H)-GFP pEGFP-N1 SDM of VPS35-GFP 
VPS35 (p.K559Q)-GFP pEGFP-N1 SDM of VPS35-GFP 
VPS35 (p.K573N)-GFP pEGFP-N1 SDM of VPS35-GFP 
VPS35 (p.R650E)-GFP pEGFP-N1 SDM of VPS35-GFP 
VPS35 (p.K659E)-GFP pEGFP-N1 SDM of VPS35-GFP 
VPS35 (p.K663E)-GFP pEGFP-N1 SDM of VPS35-GFP 
VPS35 (p.K694E)-GFP pEGFP-N1 SDM of VPS35-GFP 
VPS35 (p.R695E)-GFP pEGFP-N1 SDM of VPS35-GFP 
VPS35 (p.K701E)-GFP pEGFP-N1 SDM of VPS35-GFP 
VPS35 (p.K705E)-GFP pEGFP-N1 SDM of VPS35-GFP 
VPS35 (p.K552H, K555N, 
K556L)-GFP 
pEGFP-N1 SDM of VPS35-GFP 
VPS35 (p.K555N, K556L, 
K559Q)-GFP 
pEGFP-N1 SDM of VPS35-GFP 
VPS35 (p.K555E, K556E, 
K559E)-GFP 
pEGFP-N1 SDM of VPS35-GFP 
VPS35 (p.D620N)-GFP pXLG3 subcloning 
VPS35 (p.K559Q)-GFP pXLG3 subcloning 
VPS35 (p.K555N, K556L, 
K559Q)-GFP 
pXLG3 subcloning 
VPS35 (p.K555E, K556E, 
K559E)-GFP 
pXLG3 subcloning 
BFP-Rab5(p.Q79L) BFP-C1 from the lab 
SDM indicates ‘site-directed mutagenesis’.  




The PCR primers used to amplify genes or to create site directed mutations in 
contructs are listed in Table 2.2. The primers used for RT-qPCR are listed in Table 2.4. 
The siRNA duplexes used for knockdowns are listed in Table 2.5.  
 
Table 2.3 List of DNA oligonucleotides used for cloning 
Primer name Sequence, 5’-3’ 
SNX3 SDM (9,10 RR-AA) F 
 
accgtggctgacaccgcggcgctgatcaccaagcc 
SNX3 SDM (9,10 RR-AA) R 
 
ggcttggtgatcagcgccgcggtgtcagccacggt 
SNX3 SDM (∆22-28) F 
 
gaacctgaatgacgccctcgagatcgatgtga 
SNX3 SDM (∆22-28) R 
 
tcacatcgatctcgagggcgtcattcaggttc 








SNX3 SDM (E50K) F 
 
gccgcttcaccacttacaaaatcagggtcaagaca 
SNX3 SDM (E50K) R 
 
tgtcttgaccctgattttgtaagtggtgaagcggc 








SNX3 SDM (∆99-110) F 
 
gggaaagcgtttttgcgtcaggatgacaattttattgaggaa 
SNX3 SDM (∆99-110) R 
 
ttcctcaataaaattgtcatcctgacgcaaaaacgctttccc 
SNX3 SDM (Y154A) F 
 
ttttacaagatgaaataatagataaaagcgctactccatctaaaataagacatgcctgag 
SNX3 SDM (Y154A) R 
 
ctcaggcatgtcttattttagatggagtagcgcttttatctattatttcatcttgtaaaa 
SNX3 SDM (P156A) F gaaataatagataaaagctatactgcatctaaaataagacatgcctgag 




SNX3 SDM (P156A) R 
 
ctcaggcatgtcttattttagatgcagtatagcttttatctattatttc 
SNX3 SDM (R160A) F 
 
ataatagataaaagctatactccatctaaaatagcacatgcctgaggatcca 
SNX3 SDM (R160A) R 
 
tggatcctcaggcatgtgctattttagatggagtatagcttttatctattat 
VPS26A SDM (K93E) F 
 
gttctccaggtaaggctagttcctccactaggtttacaaattcatga 
VPS26A SDM (K93E) R 
 
tcatgaatttgtaaacctagtggaggaactagccttacctggagaac 
VPS26A SDM (M112V) F 
 
gactcagagcagaagttatgattttgaatttgtgcaagttgaaaagcc 
VPS26A SDM (M112V) R 
 
ggcttttcaacttgcacaaattcaaaatcataacttctgctctgagtc 
VPS26A SDM (K297X) F 
 
gaagtccggagttcactaagcatattagaagcatgttttag 
VPS26A SDM (K297X) R 
 
ctaaaacatgcttctaatatgcttagtgaactccggacttc 
VPS35 SDM (D620N) F 
 
gtatgaagatgaaatcagcaattccaaagcacagctagc 
VPS35 SDM (D620N) R 
 
gctagctgtgctttggaattgctgatttcatcttcatac 
VPS35 SDM (K515S) F 
 
gatttccaccagctccaaaatggcttcgtgctgtgttcaaaatcaa 




VPS35 SDM (K552H) F 
 
aatcttctggcatttcttttcccaatggtcatccactttagaattctcttt 
VPS35 SDM (K552H) R 
 
aaagagaattctaaagtggatgaccattgggaaaagaaatgccagaagatt 
VPS35 SDM (K559Q) F 
 
ggtgggcaaatgaaaaaatctgctggcatttcttttcccattt 
VPS35 SDM (K559Q) R 
 
aaatgggaaaagaaatgccagcagattttttcatttgcccacc 
VPS35 SDM (K573N) F 
 
ctgccagctctgcattgatcaaagcactgatagt 
VPS35 SDM (K573N) R 
 
actatcagtgctttgatcaatgcagagctggcag 
VPS35 SDM (R650E) F 
 
gcaagggcacactgagtctccagaggttcatgattctc 
VPS35 SDM (R650E) R 
 
gagaatcatgaacctctggagactcagtgtgcccttgc 
VPS35 SDM (K659E) F gatcaggtttctttagaagctcggatgcagcaagggcacac 




VPS35 SDM (K659E) R 
 
gtgtgcccttgctgcatccgagcttctaaagaaacctgatc 
VPS35 SDM (K663E) F 
 
gctcggccctgatcaggctcctttagaagtttggatgcagc 
VPS35 SDM (K663E) R 
 
gctgcatccaaacttctaaaggagcctgatcagggccgagc 
VPS35 SDM (K694E) F 
 
actccattaccctctcgcctccgtgaagctc 
VPS35 SDM (K694E) R 
 
gagcttcacggaggcgagagggtaatggagt 
VPS35 SDM (R695E) F 
 
tttaggcactccattacctccttgcctccgtgaagctc 
VPS35 SDM (R695E) R 
 
gagcttcacggaggcaaggaggtaatggagtgcctaaa 
VPS35 SDM (K701E) F 
 
gcaagagggtaatggagtgcctagagaaagctctaaaaatagcaaatca 
VPS35 SDM (K701E) R 
 
tgatttgctatttttagagctttctctaggcactccattaccctcttgc 
VPS35 SDM (K705E) F 
 
ggtccatgcactgatttgctatctctagagctttttttaggcactcc 
VPS35 SDM (K705E) R 
 
ggagtgcctaaaaaaagctctagagatagcaaatcagtgcatggacc 
VPS35 SDM (K552H, 
K555N, K556L) F 
 
tggtgggcaaatgaaaaaatcttctggcataaattttcccaatggtcatccactttagaattctctttatatcg 
VPS35 SDM (K552H, 
K555N, K556L) R 
 
cgatataaagagaattctaaagtggatgaccattgggaaaatttatgccagaagattttttcatttgcccacca 
VPS35 SDM (K555N, 
K556L, K559Q) F 
 
ctggtgggcaaatgaaaaaatctgctggcataaattttcccatttgtcatccactttagaattct 
VPS35 SDM (K555N, 











VPS35-GFP primer (Spe1) F ataagaactagtcgccaccatgcctaca 






Abbreviations: SDM (site directed mutagenesis), F (forward/sense primer), R 
(reverse/antisense primer). 
 
Table 2.4 List of primers for RT-qPCR 
Primer name Sequence, 5’-3’ 
β-actin left agagctacgagctgcctgac 
β-actin right cgtggatgccacaggact 
ATP9A left gcctcaccaagatcctctttgg 
ATP9A right ggttcacgcgcaaactaatggg 
 
Table 2.5 siRNA duplexes used for knockdowns  

















MON2 caugcagauaauguauccagcuatt Eurofins MWG operon 
SNX3 aacaagggcuggagcaguyyatt Eurofins MWG operon 
DOPEY2 uuggcaaacucaacaaggcucuutt Eurofins MWG operon 
VPS35 guuguuaugugcuuagua; 
aaauaccacuugacacuua 
Eurofins MWG operon 
SNX1 aagaacaagaccaagagccac Eurofins MWG operon 
SNX2 aaguccaucaucuccagaacc Eurofins MWG operon 








VPS26A gcuagaacaccaaggaauu Eurofins MWG operon 
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Unknown (cat. # l-029678-01) GE Healthcare 
Oligonucleotides were modified with a 3’dTdT overhang.  
 
2.1.10 Antibodies 
The primary antibodies used in this study are listed in Table 2.6 and the secondary 
antibodies are listed in Table 2.7.  
 
Table 2.6 Primary antibodies 
Primary antibody Species Dilution Supplier Catalogue number 
GFP Mouse 1:2000 (IB) 
1:1000 (IF) 
Roche 11814460001 
VPS35 Rabbit 1:2000 (IB) Abcam Ab157220 
VPS35 Rabbit 1:200 (IF) Abcam Ab97545 
VPS35 Goat 1:200 (IF) Abcam Ab10099 
VPS26A Rabbit 1:1000 (IB) Abcam Ab137447 
VPS26A Rabbit 1:200 (IF) Abcam Ab23892 
VPS29 Rabbit 1:1000 (IB) Abcam Ab98929 
SNX27 Mouse 1:500 (IB) Abcam Ab77799 
SNX3 Rabbit 1:500 (IB) 
1:100 (IF) 
Proteintech 10772-1-AP 
FAM21 Rabbit 1:1000 (IB) 
1:500 (IF) 
Gift from Billideau N/A 
Strumpellin Rabbit 1:500 (IB) Santa Cruz Sc-87442 
WASH1 Rabbit 1:1000 (IB) 
1:500 (IF) 
Gift from Billideau N/A 
SWIP Rabbit 1:1000 (IB) Proteintech S1101-1-AP 
CDC53 Rabbit 1:1000 (IB) Temecula ABT69 
Ankrd50 Rabbit 1:1000 (IB) Abcam Ab108219 
mTOR Rabbit 1:1000 (IB) Cell signalling 2983P 
ATM Rabbit 1:500 (IB) Abcam Ab32420 
MON2 Rabbit 1:500 (IB) Gift from Wantanabe N/A 
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DOPEY1 Rabbit 1:500 (IB) Abcam Ab95458 
DOPEY2 Rabbit  1:500 (IB) Santa Cruz Sc-83241 
HA Mouse 1:2000 (IB) 
1:1000 (IF) 
Proteintech 66006-1-1g 
Tubulin Mouse 1:2000 (IB) Sigma T9026 
β-actin Mouse 1:2000 (IB) Sigma A1978 
GAPDH Rabbit 1:2000 (IB) sigma G9545 
GCN1 Rabbit 1:1000 (IB) Abcam Ab86139 
EEA1 Mouse 1:200 (IF) BD transduction 
laboratories 
610456 
EEA1 Goat 1:200 (IF) Santa Cruz Sc-6415 
LAMP1 Rabbit 1:400 (IF) Abcam Ab24170 




Rab7 Rabbit 1:1000 (IB) Cell Signalling 93675 





SNX2 Mouse 1:1000 (IB) BD transduction 
laboratories 
611308 
SNX5 Rabbit 1:1000 (IB) Proteintech 17918-1-AP 
SNX6 Mouse 1:1000 (IB) Santa cruz S6324 
mCherry Rabbit 1:1000 (IB) Abcam Ab167453 
GLUT1 Rabbit 1:1000 (IB) 
1:150 (IF) 
Abcam Ab115730 
TGN46 Sheep 1:400 (IF) BioRad AHP500GT 
Hrs/Hrs-2 Mouse 1:200 (IF) Enzo ALX-804-382-C050 
Abbreviations: IB (immunoblot), IF (immunofluorescence), N/A (not applicable) 
 
Table 2.7 Secondary antibodies 
Secondary antibody Species Dilution Supplier  
Alexa 488 anti-mouse 
IgG 
Donkey IF 1:400 Molecular Probes  
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Alexa 568 anti-mouse 
IgG 
Donkey IF 1:400 Molecular Probes  
Alexa 647 anti-mouse 
IgG 
Donkey IF 1:400 Molecular Probes  
Alexa 488 anti-rabbit 
IgG 
Donkey IF 1:400 Molecular Probes  
Alexa 568 anti-rabbit 
IgG 
Donkey IF 1:400 Molecular Probes  
Alexa 647 anti-rabbit 
IgG 
Donkey IF 1:400 Molecular Probes  
Alexa 488 anti- goat 
IgG 
Donkey IF 1:400 Molecular Probes  
Alexa 488 anti- goat 
IgG 
Donkey IF 1:400 Molecular Probes  
Alexa 488 anti- goat 
IgG 
Donkey IF 1:400 Molecular Probes  
Alexa 800 anti-rabbit 
IgG 
Donkey IB 1:20000 Life Technologies  
Alexa 680 anti-mouse 
IgG 
Donkey IB 1:20000 Life Technologies  
Abbreviations: IB (immunoblot), IF (immunofluorescence). 
  





2.2.1 Bacterial cell culture 
 
2.2.1.1 Bacterial colony growth 
Bacterial colonies were grown through the inoculation of a 9 cm LB-agar (15 g Agar, 5 
g NaCl, 10 g Tryptome, 5 g yeast extract in 1L H20, pH 7.0 (aq), Sigma) plates 
containing the appropriate antibiotics. An ethanol sterilised spreader was used for 
inoculations under sterile conditions (flame). The plates were left for 16-20 hours at 
37°C for colony growth to occur. Colonies were then picked under sterile conditions 
and grown in liquid cultures.  
 
2.2.1.2 Transformation of competent E. coli 
5-50 ng of DNA were mixed with 30 µl of thawed chemically competent E. coli in a 1.5 
ml Eppendorf tube. The tubes were incubated on ice for 30 minutes prior to heat shock 
at 42°C for 45 seconds. 200 µl of SOC media (20 g Tryptone, 5 g yeast extract, 0.5 g 
NaCl, 20 mM glucose in 1 L H20, Sigma) was added following a 2 minute incubation on 
ice. The tube was then incubated for 1 hour at 37°C with shaking at 180 rpm. 100 µl of 
the sample was then used to inoculate agar plates containing the appropriate antibiotic 
for colony growth and incubated for 12-16 hours at 37°C. 
 
2.2.1.3 Bacterial liquid cultures 
Bacterial liquid cultures were grown in suspension in LB broth (10 g NaCl, 10 g 
Tryptome, 5 g yeast extract in 1L H20, pH 7.0 (aq), Sigma) in appropriate antibiotics for 
16-20 hours at 37°C, with shaking at 180 rpm. For small scale DNA purification 
(minipreps), cultures were grown in 5 ml of LB broth in a 20 ml universal tube. For large 
scale DNA purification (maxipreps), cultures were grown in 500 ml of LB broth in a 1 L 
conical flask.  
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2.2.2 Molecular biology methods 
 
2.2.2.1 Small scale purification of plasmid DNA (Miniprep) 
The ‘QIAprep Spin Miniprep Kit’ (Qiagen, cat. # 27106) was used for the small-scale 
purifications of plasmid DNA from liquid cultures. Purifications were performed 
according to the manufacturer’s instructions and at room temperature. 4 ml of liquid 
bacterial culture were pelleted in centrifuge tubes at 6,800 x g for 3 min at room 
temperature. The pellets were resuspended in 250 µl P1 buffer (50 mM Tris-Cl, 10 mM 
EDTA, 100 µg ml-1 RNase, pH 8.0 (aq)) before mixing with 250 µl of P2 buffer (200 mM 
NaOH, 1 % (w/v) SDS (aq)) through inversion to lyse the cells. 350 µl of N3 buffer 
(contents not disclosed) was then added and thoroughly mixed to neutralise the 
solution before centrifugation at 17,900 x g for 10 minutes; this step took place within 5 
minutes of the addition of the P2 buffer. The supernatants were then added to a 
QIAprep spin column before a 1 minute centrifugation step at 16,000 x g. The flow 
through was discarded. The QIAprep spin column was then washed with 500 µl of PB 
buffer (contents not disclosed) and then subsequently with 750 µl of PE buffer 
(contents not disclosed, contains 80 % (v/v) ethanol). Residual wash buffer was then 
removed with a further centrifugation step at 16,000 x g for 1 minute. 50 µl of RNAse 
free water was then incubated onto the column for 1 minute before the DNA was eluted 
through centrifugation at 16,000 x g for 1 minute. The DNA samples were then stored 
at -20°C. 
 
2.2.2.2 Large-scale purification of DNA (Maxiprep) 
The ‘HiSpeed Plasmid Maxi Kit’ (Qiagen cat. # 12662) was used for large-scale 
purification of plasmid DNA from liquid cultures (buffer contents undisclosed by the 
manufacturer). 500 ml of bacterial liquid culture was pelleted through centrifugation at 
4,000 x g for 10 minutes at 4°C and resuspended in 10 ml of Buffer P1. The bacterial 
suspension was then lysed through the addition of 10 ml Buffer P2, thoroughly mixed 
and incubated for 5 minutes at room temperature. 10 ml of Buffer P3 was then added 
to neutralise the solution before the lysate was poured into a QIAfilter Cartridge and 
incubated at room temperature for 10 minutes. A plunger was then inserted into the 
QIAfilter Cartridge to filter the cell lysate into a HiSpeed Tip which had been 
equilibrated with Buffer QBT. The HiSpeed Tip was then washed with 60 ml of Buffer 
QC following the lysate entering. The DNA was then eluted using Buffer QF and 
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precipitated through the addition of 10.5 ml isopropanol, mixed and incubated at room 
temperature 5 minutes. The Buffer QF/isopropanol mixture was then placed into a 
syringe and filtered through a QIAprecipitator. The sample was then washed with 70% 
ethanol and dried. 1ml of DNAase-free water was then used to elute the DNA into a 1.5 
ml Eppendorf tube. The DNA samples were then stored at 20°C 
 
2.2.2.3 Nucleic acid quantification 
Purified DNA and RNA concentrations were determined through absorbance 
measurements from a ND-1000 NanoDrop spectrophotometer.  
 
2.2.2.4 DNA sequencing  
DNA samples, 50-100 ng/μl, were sent to Eurofins MWG Operon, who performed all 
DNA sequencing reactions.  
 
2.2.2.5 Polymerase Chain Reaction (PCR) for gene amplification 
To amplify a gene of interest from a purified plasmid, the following reaction mix was 
prepared:  
 
Step Temperature  Time  
Initial denaturation 98°C 30 seconds 
35 cycles of: Denaturation 
                     Annealing 






30 seconds /kb 
Final extension  72°C 2-10 minutes ** 
Hold 4°C Until stopped 
*value dependent of Tm of primers; **dependent on length of DNA 
Once completed, the PCR products were stored at -4°C. 
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2.2.2.6 Polymerase Chain Reaction (PCR) Site-Directed mutagenesis (SDM) 
To introduce mutation(s) in a target construct, primers containing complementary DNA 
as well as specific nucleotide changes were designed using the Agilent QuikChange® 
Primer design tool (https://www.agilent.com/store/primerDesignProgram.jsp). 
The following mix was prepared in a PCR tube: 
Component Amount 
Pfu buffer (+MgSO4) 5 μl 
PCR enhancer 5 μl 
10 mM dNTPs 0.5 μl 
10 μM sense primer 0.75 μl 
10 μM antisense primer 0.75 μl 
Template DNA Up to 50 ng 
Pfu polymerase** 1 μl 
Nuclease-free water To 50 μl (final volume) 
*Pfu DNA polymerase (Thermo Scientific, cat. # EP0501). 
The PCR mixture was then transferred to a T100 Thermal Cycler machine (Bio-Rad) 
and the following programme was performed: 
Step Temperature  Time 
Initial denaturation 95°C 30 seconds 
18 cycles of: Denaturation 
                     Annealing 






1 minute per kb 
Final extension  72°C 10 minutes 
Hold 4°C Until stopped 
 
Following the PCR reaction, the methylated DNA, i.e. non-mutated template DNA, was 
digested using 1 μl of the restriction enzyme Dpn1 (New England Biolabs, cat. # 
R0176) per 30 μl of PCR products and incubated at 37°C for 1 hour. The sample was 
then transformed into XL10-Gold ultracompetent E. coli. 
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2.2.2.7 RNA extraction and quantitative-reverse transcriptase PCR 
The RNeasy kit (Qiagen, cat. # 74134) was used to extract cellular RNA. Cells in a 
confluent 6-well tray were washed twice in ice-cold PBS. Using a cell scraper, cells 
were lysed with 350 μl of ice-cold RLT buffer (contents undisclosed), supplemented 
with 1% (v/v) β-mercaptoethanol, and transferred to an ice-cold Eppendorf tube. 350 μl 
of 70% ethanol was added to the lysate before transferring to a RNeasy column. 
Following centrifugation at 8000 x g for 15 seconds, the flow through was discarded. 
Three wash steps were performed (including centrifugation at 8000 x g for 60 seconds 
and the discarding of the flow through), once with 700 μl RW1 buffer and twice with 
500 μl RPE buffer. The RNA was eluted using 30 μl of RNase-free water and stored at 
-80°C.  
For q-RT PCR analysis, to analyse gene expression following RNAi-mediated 
suppression, a SuperScript III Platinum SYBR Green One-Step qRT-PCR kit 
(Invitrogen, cat. # 11736059) was utilised. Each primer reaction was performed in 
triplicate. The sense and antisense q-RT PCR primers (100 μM stock) were diluted with 
RNase-free water to 0.1 μM.  
For each well required, the following mix was prepared in an RNase-free Eppendorf 
(added in the order of H20, RNA, 2x SYBR® Mix, SuperScript III Reverse 
Transcriptase):  
 
 RNA sample 2x SYBR® Mix SuperScript III RT RNase-free water 
1 well sample 0.1 μg 10 μl 0.4 μl To 16 μl (total volume 
1 well blank 0 μg  10 μl 0.4 μl To 16 μl (total volume 
 
Following thorough mixing, 16 μl of the mix was added to each well, followed by 4 μl of 
each primer. The plate was then centrifuged at 2000 x g for 4 minutes. Thermo cycling 
was performed in an Opticon2 system (MJ Research) using the following programme: 
Step Temperature  Time 
cDNA synthesis 50°C 3 minutes 
Initial denaturation 95°C 5 minutes 




Final extension 40°C 1 minutes 
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Hold 4°C Until stopped 
 
The fluorescence threshold was set manually. The Cycle threshold (CT) value (the 
number of cycles required to cross the threshold) was calculated by the Opticon2 
software. The change in gene expression was determined through: x=2-ΔΔCT (ΔCT = 
difference in CT values between gene of interest and the control gene [β-actin]; ΔΔCT = 
difference between ΔCT of the experimental sample [targeting siRNA] and the control 
sample [non-targeting siRNA]).  
 
2.2.2.8 DNA analysis with agarose gel electrophoresis 
To analyse the size of PCR products and restriction digests, the DNA samples were 
loaded onto a 1% agarose gel for electrophoresis. Agarose gels were made by mixing 
the required w/v mass of agarose with tris-acetate-EDTA (TAE) buffer (20 mM EDTA, 
0.8 M Tris-acetate, pH 7.8). The solution was heated in a conical flask using a 
microwave until the agarose was dissolved, left to cool for 2 minutes and added to a 
casting tank which contained ethidium bromide (6 μl of 10mg/ml stock per 100 ml of the 
agarose-TAE mixture). A comb was inserted into the buffer. Once set, the comb was 
removed and the gel was transferred to a gel running tank and submerged in TAE 
buffer. The DNA samples were mixed with 6x gel loading due (NEB, cat. # B7024) and 
loaded onto the gel with a 2-log DNA ladder (NEB, cat. # N3200) alongside, before a 
voltage of 100 V was applied for an appropriate time. The DNA was visualised using 
the ChemiDoc system (Bio-Rad) through UV light. DNA bands could be excised from 
the gel and then purified immediately. 
 
2.2.2.9 Purification of PCR and restriction digest products  
PCR or restriction digest products to be used in subsequent reactions were purified 
using the GFX PCR DNA and Gel Band purification kit (GE Healthcare, cat. # 28-9034-
70). The buffer contents of the kit are not disclosed by the manufacturer.  
For DNA purification from agarose gels, the DNA band was excised from the gel using 
a clean scalpel blade and transferred to an Eppendorf. 10 μl of Capture buffer was 
added for each 10 mg of agarose gel excised and incubated at 60°C. Once the 
agarose gel had dissolved, the mixture was transferred to a GFX MicroSpin Column, 
centrifuged at 16,000 x g and the flow through discarded. The column was washed 
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twice in 500 μl Wash buffer with 1 minute 16,000 x g centrifugation steps to discard any 
flow through. An appropriate volume of nuclease-free water was then incubated with 
the column for 1 minute and the DNA was eluted into a clean Eppendorf through a 1 
minute 16,000 x g centrifugation step. The purified DNA could then be stored at -20°C.  
If the DNA was being purified from a solution, the same protocol was carried out with 
two modifications: 500 μl of Capture buffer was added, which was not heated at 60°C.  
 
2.2.2.10 Restriction enzyme digestion 
Restriction digestions, from either plasmid vectors or PCR products, were performed 
using high-fidelity restriction enzymes from New England Biolabs. The following 
mixtures were prepared: 
Component Amount (plasmid vector) Amount (PCR product) 
DNA 1 μg 43 μl 
Compatible NEB buffer (10x) 1 μl 5 μl 
Restriction enzyme 1 1 μl 1 μl 
Restriction enzyme 2 1 μl 1 μl 
Nuclease-free water To 10 μl (final volume) N/A 
 




Digested PCR products and the digested vector were mixed in an insert/vector molar 
ratio of 3:1 and the following mix was prepared in a PCR tube: 
Component Volume  
Purified digested vector DNA Variable 
Purified digested insert DNA Variable 
T4 DNA ligase* 1 μl 
10x T4 ligase buffer 1.5 μl 
Nuclease-free water To 15 μl (final volume) 
*T4 DNA ligase (ThermoScientific, cat. # EL0014).  
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The ligation mixture was incubated at room temperature for 1 hour. 2 μl of ligation 
mixture was used to transform XL-Blue competent E. coli. 
 
2.2.3 Mammalian cell culture 
 
2.2.3.1 Culturing mammalian cells  
Human cell lines were cultured in humidified incubators at a constant temperature of 
37°C with 5% CO2. All cell-based experiments, including passaging, seeding, 
transfections, transductions and RNAi-based suppressions were performed in sterile 
class II vertical laminar flow cabinets (Holten Laminair, Thermo Fisher). All disposable 
materials used for cell based experiments were purchased as sterile items. Non-
disposable materials were sterilised using 70% ethanol before use. Glass coverslips 
used for the seeding of cells for imaging were flame sterilised using 100% ethanol.  
 
2.2.3.2 Passaging mammalian cells 
Tissue-cultured cell lines were regularly passaged to prevent the cell density 
(confluency) becoming too high. DMEM was removed through aspiration before the 
cells were washed in sterile PBS. The cells were then incubated in Tryspin-EDTA 
solution for 5 minutes at 37°C to detach them from the plate. With the addition of 
DMEM, the cell suspension was centrifuged at 3000 x g for 2 minutes in sterile tubes to 
pellet the cells. The supernatant was then removed before the cells were resuspended 
in 1 ml of DMEM. An appropriate proportion of the cells were then seeded into a cell 
culture dish containing an appropriate volume of growth media.  
 
2.2.3.3 HA antibody uptake (Wntless) assay 
RPE-1 cells stably expressing HA-Wntless-HA were plated onto coverslips to achieve 
appropriate confluency for the following day. Cells were then placed on ice and washed 
in ice-cold PBS and labelled with α-HA antibodies (Roche 11867423001) diluted in ice-
cold PBS (1:1000) for 30 minutes on ice. The cells were then washed with room 
temperature PBS. Cells for the 0 minute time point were immediately fixed using 4% 
paraformaldehyde. For the other time points, 37°C DMEM was added to the cells to 
induce trafficking and were placed in a 37°C incubator for set time points. Following 
Chapter 2: Materials and Methods 
59 
 
completion of each time point, the cells were washed in PBS and fixed in 4% 
paraformaldehyde.  
 
2.2.3.4 Transfection of DNA using PEI  
The PEI (polyethlenimine) method of transfection was used for HEK293 cells for 
GFP/RFP trap experiments or the production of lentivirus. Cells were grown in tissue 
culture dishes to a confluency of 80-90%. For 15 cm dishes, 5 ml (2.5 ml for a 10 cm 
dish) of OptiMEM was aliquoted into 2 separate sterile tubes. 15 μg (or 10 μg for a 10 
cm dish) of DNA was added to one of these tubes and left to incubate for 5 minutes. To 
the second tube, 4.5 μl (or 3 μl for a 10 cm dish) of PEI was added and thoroughly 
mixed with the OptiMEM through vortexing, and filter sterilised using a 0.2 μm filter. 
The two Opti-MEM containing mixtures were then mixed and incubated at room 
temperature for 20 minutes.  
The HEK 29T cells were then washed twice in sterile PBS before being incubated with 
the OptiMEM/DNA/PEI mixture for 4 hours at 37°C. The OptiMEM was then removed 
and exchanged for normal serum-containing DMEM and incubated for 48 hours at 
37°C prior to experimental use.  
 
2.2.3.5 Transfection of DNA using FuGENE  
The FuGENE transfection protocol was used for RPE-1 cells or HeLa cells for 
subsequent confocal imaging experiments. Cells were seeded onto coverslips in a 12-
well tray at a density of 3.5 x 104 per well and left for 16 hours. For each well, 1 μg of 
DNA and 3 μl of FuGENE 6 (Promega, cat. # E2691) were added to 100 μl of Opti-
MEM in a sterile 1.5 ml Eppendorf. The mixture was then mixed through pipetting and 
left to incubate at room temperature for 20 minutes. The mixture was then added drop-
wise to the well. Cells were then incubated at 37°C for 24 hours before fixation.  
 
2.2.3.6 Transfection of siRNA using DharmaFECT 
DharmaFECT (Dharmacon, cat. # T-2001) was used to transfect siRNA to knockdown 
genes. All knockdown experiments involved the transfection of siRNA twice in order to 
achieve adequate levels of gene suppression. The transfections were performed on 
cells, at approximately 80% confluency, adhered to 6-well plates. 200 μl of OptiMEM 
Chapter 2: Materials and Methods 
60 
 
was aliquoted into two different sterile Eppendorf tubes. 3 μl of siRNA (20 μM) was 
diluted in one of the tubes and 6 μl of DharmaFECT was diluted in the other. Following 
a 5 minute incubation at room temperature, the contents of the two tubes were mixed 
and a further room temperature incubation was performed for 20 minutes. The mixture 
was then added dropwise to cells in a 6-well plate. The cells were then left at 37°C until 
the next day, when they were split to be approximately 80% confluent the day after, 
when a second transfection (as already described) was completed. The cells were then 
incubated for a further 48 hours before subsequent protocols.  
 
2.2.3.7 Lentiviral particle preparation  
Genes of interest were packaged into lentiviral particles which could then be harvested 
and used to transduce cells. 40 μg of pXLG3 vector containing the gene of interest, 10 
μg of pMDG2 envelope plasmid and 30 μg of pCMV_R8.91 packing construct were 
transfected into HEK293T cells in a 15 cm cell culture plate using the PEI method of 
transfection. The virus was left to proliferate for 3 days, in which time viral particles 
accumulated in the media. The media was pipetted into sterile tubes and centrifuged 
for 10 minutes at 4000 x g. The supernatants were then filtered through 0.45 μm filters 
before being aliquoted into 1.5 ml cryovials and stored at -80°C.  
 
2.2.3.8 Transduction of cells using lentivirus 
Viral transduction allows the creation of cells stably expressing a gene of interest. In a 
12-well tray, 79,000 cells (RPE-1s) were seeded per well. A quantity of virus was then 
added to each well (the viral supernatants were titrated and supplemented with DMEM 
to give a final volume of 1 ml per well) before being incubated for 2 days at 37°C.  
 
2.2.4 GFP- or RFP-nanotrap immunoprecipitations 
Cells were transfected or transduced to express GFP-tagged or mCherry-tagged 
proteins and were grown to full confluency in a cell culture dish and washed twice in 
ice-cold PBS. Cells were lysed in GFP/RFP nanotrap buffer and the lysate was cleared 
by centrifugation at 13,000 x g at 4°C for 10 minutes. The resulting supernatant was 
incubated with 20 μl of GFP-nanotrap (Chromotek, cat. # gta-20) or RFP-nanotrap 
(Chromotek, cat. # rta-20) beads in a 1.5 ml microcentrifuge tube and incubated at 4°C 
on a rocker for 1 hour. Following incubation with the lysates, the beads were 
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centrifuged at 2000 x g for 10 seconds at 4°C and washed by resuspension in 
GFP/RFP nanotrap buffer. This washing process was repeated three times. The beads 
were then resuspended in 2x sample buffer, heated at 95°C for 5 minutes, and 
resolved using SDS-PAGE and immunoblotting.  
 
2.2.5 Protein biochemistry 
 
2.2.5.1 Cell lysis and sample preparation 
When ready for lysis, cell culture dishes were placed on ice before being washed twice 
in ice-cold PBS. An appropriate amount of lysis buffer (approximately 100 μl for a 12-
well tray, 150 μl for a 6-well tray) was added to the cells before a cell scraper was used 
to expose the cells to the lysis buffer. The lysed cells were transferred into 1.5 ml 
microcentrifuge tubes and centrifuged at 13,000 x g for 10 minutes at 4°C. The 
supernatant was added to an ice-cold microcentrifuge tube and mixed with 4x sample 
buffer supplemented with 2.5% (v/v) β-mercaptoethanol. The samples were then 
heated to 95°C for 5 minutes and resolved using SDS-PAGE and immunoblotting. 
 
2.2.5.2 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) 
Proteins were resolved by SDS-PAGE using the NuPAGE® gel electrophoresis system 
by Invitrogen/Life Technologies. 500 ml of NuPAGE® MOPS running buffer (Invitrogen, 
cat. # NP0001) was added to the gel tank. Samples and the precision plus all blue 
standard (Bio-Rad, cat. #1610373) were loaded into the wells of a NuPAGE® 4-12% 
gradient Bris-Tris precast gels (Invitrogen, cat. # NP0322BOX). 150 V was applied to 
the system until the dye front had migrated to the required degree.  
 
2.2.5.3 Transfer of proteins onto a membrane 
The resolved proteins were subsequently transferred onto a polyvinylidene 
difluoride (PVDF) membrane (Immobilon-FL, pore size 0.45 um, Millipore, cat. # 
IPFL00010) using the Bio-Rad Mini Trans-Blot Electrophoretic Transfer cell (cat. # 170-
3930). The membrane was soaked in methanol for 30 seconds. The components of the 
cassette (PVDF membrane, 2 foam pads, and 2 pieces of Whatman 3 mm filter blotting 
paper) were then soaked in transfer buffer (25 mM tris, 192 mM glycine, 10% 
methanol) before assembly. The gel and membrane were then sandwiched between 
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the foam pads and filter paper and braced into a blotting cassette and placed in a mini-
Trans Blot Cell (Biorad) electrophoretic transfer cell and submerged in transfer buffer. 




Following protein transfer onto the PVDF membrane, the membrane was removed from 
the transfer cassette and a blocking step proceeded in order to prevent unspecific 
antibody binding to the membrane. The membrane was incubated for 1 hour at room 
temperature in 5% (w/v) milk powder in TBS 0.1% (v/v) Tween-20 (TBST) on a rocker. 
The membrane was then incubated with the primary antibody, diluted in 2% (w/v) 
Bovine Serum Albumin (BSA) in PBS, overnight at 4°C.  
The membrane was then washed 3 times in TBST for 10 minutes each. The membrane 
was then incubated with fluorophore-conjugated secondary antibodies, diluted in 5% 
(w/v) powdered milk in TBST, for 1 hour at room temperature in darkness. Following 
secondary antibody incubation, the membrane was washed 3 times for 10 minutes, 
twice in TBST and then once in TBST supplemented with 0.1% (w/v) sodium dodecyl 




2.2.6.1 Stable isotope labelling of amino acids in culture (SILAC)-based 
proteomics 
SILAC was used in this study to identify a protein of interest’s interactors through mass 
spectrometry, an ‘interactome’, and to compare this interactome with a mutant form of 
the same protein, therefore distinguishing any changes in the interactome caused by 
the mutation.  
This was accomplished by the differential incorporation of labelled essential amino 
acids. Cells were grown in culture media deficient in the amino acids arginine and 
lysine, supplemented with arginine and lysine with heavy isotopes of hydrogen, carbon 
and nitrogen (2H, 13C and 15N). This media was also supplemented with dialysed FBS 
(to avoid any growth factors with ‘normal’ amino acids).  
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Cells could be labelled with the following amino acids: R0K0 (light media), R6K4 
(medium media) and R10K8 (heavy media). In the medium media, cells are labelled 
with lysine residues containing four heavy isotopes, making the lysine residues 4 Da 
heavier (hence the ‘K4’ label) compared to lysine residues in the light media (referred 
to as ‘K0’). In the heavy media, the arginine residues contain ten heavy isotopes, 
making them 10 Da heavier (hence the R10) compared to arginine residues in the light 
media (R0) and 4 Da heavier compared to arginine residues in the medium media (R6).  
In this study, the three conditions (labelled with either light, medium or heavy media) 
were: GFP-only, GFP chimera with a protein of interest, and a GFP chimera with a 
mutant protein of interest. To sufficiently label and incorporate the isotope-labelled 
amino acids within the cellular proteome, the cells were cultured for at least 6 
doublings. The cells were then subjected to a GFP-trap experiment according to 
Section 2.2.4. Following the washing steps, all the GFP-trap beads were combined 
and combined with sample buffer and heated to 95°C and the sample was run on an 
SDS-PAGE gel and stained with SimplyBlue SafeStain (Invitrogen, cat. # LC6060). 
Stained gels were then given to the proteomics facility in the Faculty of Life Sciences at 
the University of Bristol to carry out Nano-LC Mass Spectrometry analysis using an 
Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific). 
 
2.2.6.2 Tandem mass tagging (TMT) labelling and High pH reversed-phase 
chromatography 
TMT-based proteomics was used in this study in a similar experimental design to the 
SILAC-based proteomics: comparison of a protein of interest’s interactors through 
mass spectrometry to generate an ‘interactome’ and its comparison with the 
interactome of a mutant form of the same protein. A GFP-trap experiment was carried 
out and following the wash steps, the GFP-trap beads were sent to the proteomics 
facility in the Faculty of Life Sciences at the University of Bristol to carry out TMT 
labelling.  
Samples were digested with trypsin (2.5 µg trypsin; 37°C, overnight), labelled with 
Tandem Mass Tag (TMT) ten plex reagents according to the manufacturer’s protocol 
(Thermo Fisher Scientific, Loughborough, LE11 5RG, UK) and the labelled samples 
pooled. The pooled sample was then evaporated to dryness, resuspended in 5% formic 
acid and then desalted using a SepPak cartridge according to the manufacturer’s 
instructions (Waters, Milford, Massachusetts, USA).  Eluate from the SepPak cartridge 
was again evaporated to dryness and resuspended in buffer A (20 mM ammonium 
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hydroxide, pH 10) prior to fractionation by high pH reversed-phase chromatography 
using an Ultimate 3000 liquid chromatography system (Thermo Scientific). In brief, the 
sample was loaded onto an XBridge BEH C18 Column (130Å, 3.5 µm, 2.1 mm X 150 
mm, Waters, UK) in buffer A and peptides eluted with an increasing gradient of buffer B 
(20 mM Ammonium Hydroxide in acetonitrile, pH 10) from 0-95% over 60 minutes.  The 
resulting fractions were evaporated to dryness and resuspended in 1% formic acid prior 
to analysis by nano-LC MSMS using an Orbitrap Fusion Tribrid mass spectrometer 
(Thermo Scientific). 
  
2.2.6.3 Nano-LC Mass Spectrometry 
High pH RP fractions were further fractionated using an Ultimate 3000 nano-LC system 
in line with an Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific). In brief, 
peptides in 1% (v/v) formic acid were injected onto an Acclaim PepMap C18 nano-trap 
column (Thermo Scientific). After washing with 0.5% (v/v) acetonitrile 0.1% (v/v) formic 
acid peptides were resolved on a 250 mm × 75 μm Acclaim PepMap C18 reverse 
phase analytical column (Thermo Scientific) over a 150 minute organic gradient, using 
7 gradient segments (1-6% solvent B over 1 minute, 6-15% B over 58 minute, 15-32% 
B over 58 minutes, 32-40%B over 5 minutes, 40-90%B over 1minutes, held at 90%B 
for 6 minutes and then reduced to 1%B over 1 minute) with a flow rate of 300 nl 
min−1.  Solvent A was 0.1% formic acid and Solvent B was aqueous 80% acetonitrile in 
0.1% formic acid. Peptides were ionized by nano-electrospray ionization at 2.0kV using 
a stainless steel emitter with an internal diameter of 30 μm (Thermo Scientific) and a 
capillary temperature of 275°C. 
All spectra were acquired using an Orbitrap Fusion Tribrid mass spectrometer 
controlled by Xcalibur 2.0 software (Thermo Scientific) and operated in data-dependent 
acquisition mode using an SPS-MS3 workflow. FTMS1 spectra were collected at a 
resolution of 120 000, with an automatic gain control (AGC) target of 200 000 and a 
max injection time of 50 ms. Precursors were filtered with an intensity threshold of 
5000, according to charge state (to include charge states 2-7) and with monoisotopic 
precursor selection. Previously interrogated precursors were excluded using a dynamic 
window (60s +/-10 ppm). The MS2 precursors were isolated with a quadrupole mass 
filter set to a width of 1.2m/z. ITMS2 spectra were collected with an AGC target of 10 
000, max injection time of 70ms and CID collision energy of 35%. 
For FTMS3 analysis, the Orbitrap was operated at 50 000 resolution with an AGC 
target of 50 000 and a max injection time of 105 ms. Precursors were fragmented by 
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high energy collision dissociation (HCD) at a normalised collision energy of 60% to 
ensure maximal TMT reporter ion yield.  Synchronous Precursor Selection (SPS) was 
enabled to include up to 5 MS2 fragment ions in the FTMS3 scan. 
The raw data files were then processed and quantified using Proteome Discoverer 
software v2.1 (Thermo Scientific) and searched against the UniProt Human database 
(downloaded 14-09-17: 140000 sequences) using the SEQUEST algorithm. Peptide 
precursor mass tolerance was set at 10 ppm, and MS/MS tolerance was set at 0.6 
Da. Search criteria included oxidation of methionine (+15.9949) as a variable 
modification and carbamidomethylation of cysteine (+57.0214) and the addition of the 
TMT mass tag (+229.163) to peptide N-termini and lysine as fixed modifications. 
Searches were performed with full tryptic digestion and a maximum of 2 missed 
cleavages were allowed.  The reverse database search option was enabled and the 




2.2.7.1 Fixing and permeabilising cells for immunofluorescence-based imaging 
Cells were seeded onto sterile 13 mm glass coverslips. Once at an appropriate 
confluency, the DMEM was removed through aspiration and then washed twice in PBS. 
The cells were then incubated with 4% (w/v) paraformaldehyde (Pierce, 16% 
Formaldehyde, cat. # 28906, diluted in PBS) for 20 minutes at room temperature. The 
PFA was then removed before three further PBS washes.  
The PBS was removed before incubating the fixed cells with 0.1% (v/w) Triton X-100 
(Sigma, cat. # T8787) in PBS for 5 minutes at room temperature to permeabilise the 
cells. The cells were then washed three times in PBS. For LAMP1 staining, 0.1% (w/v) 
Saponin in PBS replaced Triton X as a cell permeabiliser.   
 
2.2.7.2 Staining fixed cells for immunofluorescence  
Following permeabilization of cells, the PBS was replaced with 1% (w/v) BSA in PBS 
and incubated for 15 minutes at room temperature to block non-specific antibody 
binding. Primary antibodies were diluted in 1% (w/v) BSA in PBS and were aliquoted 
into 60 μl spots onto Parafilm. Coverslips were placed cell-side down onto the 
antibody-containing spots and incubated for 1 hour at room temperature (in darkness if 
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the cells had expressed GFP-tagged proteins). The coverslips were then washed 3 
times in PBS before being placed onto 60 μl spots of Alexafluor-conjugated secondary 
antibodies diluted in 1% (w/v) BSA in PBS containing 4′,6-Diamidino-2-phenylindole 
dihydrochloride (DAPI) (0.5 μg per ml) for 1 hour at room temperature in darkness. The 
coverslips were then washed a further 3 times in PBS before being dried and mounted 
cell-side down onto Fluoromount-G (Invitrogen, cat. # 00-4958-02) on glass slides. The 
Fluoromount-G was left to dry for at least 4 hours at room temperature in darkness.  
 
2.2.7.3 Confocal microscopes 
Microscopy images were collected using a confocal laser-scanning microscope (SP5 
AOBS; Leica Microsystems) attached to an inverted epifluorescence microscope 
(DMI6000; Thermo Fisher Scientific). A 63x CX PL APO lambda blue UV oil-immersion 
lens was used to take all images. Leica Application Suite AF software (version 
2.7.3.9723) was used to acquire the images.  
 
2.2.8 Software 
Colocalisation analysis was performed using Volocity 6.3 Software (PerkinElmer). 
Pearson’s correlation coefficient (PCC), which measures the correlation in the variation 
between two channels) and Overlap coefficient (measuring the degree to which the 
corresponding channel overlaps with the other channel) were measured using 
automatic thresholding using the Costes method (Costes et al., 2004).   
 
Protein fluorescent band intensity from Western blots were measured using an 
Odyssey Fc imaging system from LI-COR. 
 
Statistical analyses were performed using GraphPad Prism 7 software (La Jolla, CA). 
All quantified Western blot and colocalisation analysis data were the result of at least 3 
independent experiments. 
 
3D-modelling of protein structures were performed using UCSF Chimera (version 
1.13).  
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3.1.1 The intracellular trafficking of Wnt morphogens depend on their 
association with Wntless 
Wnt proteins are a family of secreted glycoproteins which act as morphogens (Langton 
et al., 2016). Wnts are synthesised in and secreted from ‘Wnt-producing’ cells and 
activate Wnt signalling in ‘Wnt-receiving’ cells. This can initiate several downstream 
signal transduction pathways, including canonical signalling, where target gene 
expression is regulated, and the non-canonical planar cell polarity pathway (Sokol, 
2015). Not only is it essential for stem and progenitor cell proliferation and 
differentiation during embryonic development and adult tissue homeostasis (Steinhart 
and Angers, 2018), but aberrant Wnt signalling has been implicated in a variety of 
diseases, including various cancers (Zhan et al., 2017), neurodegenerative disorders 
(Libro et al., 2016) and osteoporosis (Baron and Kneissel, 2013).  
Wnts associate with an intracellular chaperone called ‘Wntless’, which mediates their 
intracellular transport from the endoplasmic reticulum to the cell surface (Banziger et 
al., 2006; Bartscherer et al., 2006; Goodman et al., 2006). Once synthesised in the ER, 
Wnts are lipidated, which facilitates their binding to Wntless (Herr and Basler, 2012). 
The Wnt:Wntless complex is then transported to the Golgi before the Wnts are 
secreted. There is controversy in the literature regarding the mechanism of Wnt 
secretion: whether the Wnt:Wntless complex is trafficked straight from the Golgi to the 
cell surface or from the Golgi to an endosomal compartment before arriving at the cell 
surface; it is also unclear whether the Wnt:Wntless complex dissociates in the acidic 
endosomal environment or once at the cell surface (Langton et al., 2016). How the 
Wnts reach the Wnt-receiving cells is also uncertain, models include: their 
incorporation into exosomes or lipoprotein particles, and direct cell:cell transfers 
(Langton et al., 2016).  
After the Wnt morphogen dissociates from Wntless, the unbound Wntless is 
endocytosed through an AP-2-dependent mechanism (Pan et al., 2008; Port et al., 
2008; Yang et al., 2008; Gasnereau et al., 2011). Once delivered to the endosomes, 
retromer (Coudreuse et al., 2006; Prasad and Clark, 2006; Franch-Marro et al., 2008; 
Pan et al., 2008; Yang et al., 2008) and sorting nexin-3 (SNX3) (Harterink et al., 2011; 
Zhang et al., 2011) (see Section 1.4.3.1) mediate the endosomal retrieval of Wntless 
to the Golgi, preventing its lysosomal degradation. SNX3 and retromer directly interact 
(Harterink et al., 2011; Zhang et al., 2011; Vardarajan et al., 2012; Harrison et al., 
2014b), but whether or not this physical interaction is required for the sorting of Wntless 
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(and other cargo) back to the Golgi is unknown. Once retrieved and subsequently 
recycled to the Golgi, Wntless is retrogradely transported back to the ER through a 
COPI-mediated mechanism, where it undergoes further cycles of Wnt trafficking (Yu et 
al., 2014). The functional consequence of blocking the endosomal retrieval of Wntless 
is defective Wnt signalling, as the decrease in whole-cell quantities of Wntless perturbs 
the trafficking and therefore the secretion of Wnt morphogens (Belenkaya et al., 2008; 
Franch-Marro et al., 2008; Pan et al., 2008; Yang et al., 2008; Harterink et al., 2011; 
Zhang et al., 2011). 
Intriguingly, the endosomal retrieval of Wntless has been shown to be independent of 
the classical retromer membrane remodelling complex: the SNX-BAR complex 
composed of SNX1/2 and SNX5/SNX6/SNX32 (Harterink et al., 2011; Zhang et al., 
2011). This has been shown in the context of D. melanogaster, C. elegans and in vitro 
human cell culture (Harterink et al., 2011; Zhang et al., 2011). One study reported that 
SNX1 suppression increased Wntless colocalisation with lysosomes (Shi et al., 2009), 
but their analyses were limited to intensity measurements from immunofluorescence 
data and did include a biochemical or functional assessment. Without associating with 
the SNX-BAR complex, how the SNX3-retromer couples Wntless cargo recognition 
with membrane deformation and carrier formation is unclear. 
 
3.1.2 Aims 
In this chapter I aim to progress our molecular understanding of the SNX3-retromer 
mediated endosomal sorting of the Wnt chaperone, Wntless. To explore whether the 
physical interaction between VPS35 and SNX3 is necessary for Wntless sorting, I 
sought to identify SNX3 mutants unable to bind to retromer. The functional 
consequences of perturbing this interaction was then explored in vivo through a 
collaboration with the Korswagen lab. To identify how the SNX3-retromer coordinates 
Wntless enrichment with endosomal membrane deformation and carrier formation, I 
sought to investigate two proteins enriched in the SNX3 interactome: MON2 and 
DOPEY2. The S. cerevisiae homologues of these proteins form a complex with the 
putative aminophospholipid translocase, Neo1p, which is proposed to generate 
membrane curvature and to be involved in membrane trafficking within the endosomal 
network (Barbosa et al., 2010).   
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3.2.1 Identification of the SNX3:VPS35 binding surface 
To investigate the functional importance of the SNX3 interaction with the retromer 
complex, I first sought to identify residues in SNX3 critical for its association with the 
core retromer component: VPS35. To establish candidate binding-residues in SNX3, I 
performed a bioinformatics sequence alignment. SNX3 and its paralogue, SNX12, can 
immunoprecipitate VPS35 (Pons et al., 2012); SNX11, a closely related sorting nexin, 
cannot (Figure 3.1A). I aligned the sequences of the VPS35-binding sorting nexins 
(SNX3 and SNX12) with the non-VPS35 binder (SNX11) to identify residues conserved 
between SNX3 and SNX12, but not conserved in SNX11 (Figure 3.1B). From this, I 
identified several residues that may be critical for VPS35 association. I therefore 
generated several mutant GFP-SNX3 constructs through site directed mutagenesis 
(Figure 3.1B).  
 
Figure 3.1 Bioinformatic analysis to identify residues in SNX3 important for 
VPS35 binding. 
(A) SNX3 and SNX12 but not SNX11 can bind to VPS35. HEK293T cells were transfected with 
GFP-tagged SNX3, SNX12 and SNX11 constructs and subjected to a GFP-trap before immuno-
blotting for VPS35. (B) Sequence alignment comparing the retromer associating SNX3 and 
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SNX12 with the non-retromer binding SNX11. H. sapiens, D. melanogaster and C. elegans 
SNX3 homologues were aligned against H. sapiens SNX12 and SNX11. SNX3 residues 
identified as candidates for VPS35 association are marked on the alignment. 
 
 
Figure 3.2 Immunoprecipitation screen identify GFP-SNX3 constructs with 
perturbed VPS35 binding.  
(A-B) HEK293T cells were transfected with the indicated GFP-SNX3 constructs and subjected 
to a GFP-trap before immuno-blotting for VPS35. HEK293T cells were transfected with the 
indicated GFP-SNX3 constructs and subjected to a GFP-trap immunoprecipitation. The 
immuno-precipitates were then immuno-blotted for VPS35. (C) Quantifications show the mean 
of 3 independent experiments ± s.e.m. of the relative binding to VPS35 of the various GFP-
SNX3 constructs relative to wild-type GFP-SNX3. Data were analysed using a one-way ANOVA 
followed by a Dunnett’s test, comparing the various GFP-SNX3 constructs to the wild-type; ** P 
≤ 0.01. 
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To screen for mutations which perturb SNX3’s association with VPS35, I transiently 
transfected HEK293T cells with the GFP-SNX3 constructs. I then performed GFP-
nanotrap immuno-precipitations and immuno-blotted for VPS35 (Figure 3.2A). When 
the immuno-precipitated VPS35 was quantified over 3 independent experiments, 
several of these SNX3 mutations were revealed to diminish VPS35 binding (Figure 
3.2C). Building on the drastic loss of VPS35 association in the ∆22-28 mutation, I 
generated a single point mutation, Y22A, which also caused perturbed VPS35 
association (Figure 3.2B). To show that this loss of VPS35 association was not due to 
a loss of endosomal association, I transiently transfected the mutant GFP-SNX3 
constructs into HeLa cells. All GFP-SNX3 variants colocalised on endosomal puncta 
positive for VPS35 (Figure 3.3).  
 
 
Figure 3.3 GFP-SNX3 constructs retain their endosomal association. 
HeLa cells were transfected with the indicated GFP-SNX3 constructs and were stained for 
endogenous VPS35 before being imaged on a confocal microscope. Scale bars indicate 23 μm. 
 
Chapter 3: SNX3-retromer requires an evolutionary conserved MON2:DOPEY2:ATP9A 
complex to mediate Wntless sorting and Wnt secretion 
73 
 
I then identified the spatial distribution of the SNX3 residues important for VPS35 
binding using a model of the NMR-solved SNX3 solution structure (Overduin et al., 
2015) (Figure 3.4). This revealed a potential binding surface consisting of the N- and 
C-termini of SNX3, as well as the anti-parallel β-sheet, which may be essential for 
VPS35 association. It should be noted that the N- and C-termini of SNX3 are thought to 
be intrinsically disordered (Overduin et al., 2015).   
 
Figure 3.4 Model showing the identified residues in SNX3 important for the 
binding of VPS35. 
Model of the NMR-resolved SNX3 structure from Overduin et al., 2015. The residues which, 
when mutated, caused a loss of association between SNX3 and VPS35 are shown in green. 
The residues which, when mutated, did not cause a dramatic loss of VPS35 associated are 
shown in blue. Note that the N- and C-termini of SNX3 are intrinsically disordered. 
 
3.2.2 Heat repeat-domain containing SNX3-interactors associate 
independently of VPS35 
Several proteins in the SNX3 interactome, including VPS35, contain a similar tertiary 
structure composed of a series of HEAT (Huntingtin, elongation factor 3, protein 
phosphatase 2A and TOR1) repeat domains (McGough et al., 2018). This raised the 
possibility that these interactors may bind to SNX3 through the same mechanism as 
VPS35. I therefore utilised the SNX3 variants which have severely perturbed VPS35 
association and determined whether other HEAT-repeat containing SNX3-interactors 
could bind. Following transient transfection, into HEK293T cells, of GFP, GFP-SNX3 or 
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one of two mutant GFP-SNX3 variants (9,10 RR-AA and R160A) with perturbed VPS35 
association, I performed a GFP-nanotrap experiment. I subsequently immuno-blotted 
for various HEAT repeat containing SNX3 interactors (MON2, GCN1, mTOR and ATM) 
(Figure 3.5A). Although VPS35 and VPS26A of the retromer complex consistently lost 
association with the mutant GFP-SNX3 variants, the other interactors did not (Figure 
3.5B). The mechanism of VPS35 association to SNX3 is therefore independent from 
other HEAT repeat domain-containing interactors.  
 
Figure 3.5 SNX3 can bind to various HEAT-repeat domain-containing proteins 
independently of its ability to bind to the retromer complex.  
(A) HEK293T cells were transfected with the indicated GFP-SNX3 construct and subjected to a 
GFP trap. The immuno-precipitate was resolved using SDS-PAGE before immuno-blotting for 
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the indicated antibodies. (B) Quantification of the GFP-SNX3 constructs’ ability to bind to 
VPS35, MON2, GCN1, mTOR and ATM. The binding is shown relative to the wild-type GFP-
SNX3 construct. Data were analysed using a one-way ANOVA with a post-hoc Dunnetts test, 
comparing the mutant constructs to the wild-type; **** p ≥ 0.0001.. 
 
3.2.3 The association between VPS35 and SNX3 is required for the 
secretion of Wnt morphogens in C. elegans 
Having established point mutations in SNX3 which perturb VPS35 association, I wished 
to determine the functional importance of this interaction. The best characterised 
function of SNX3-retromer is the trafficking of Wntless, a Wnt chaperone (Banziger et 
al., 2006). Whether the physical interaction between SNX3 and VPS35 is required for 
Wntless retrieval, or whether these proteins act separately or sequentially, has never 
been explored.  
 
 
Figure 3.6 The SNX3:VPS35 interaction is necessary for Wnt secretion and 
morphogenic gradient formation. 
(A) Schematic representation of the migration of the QL neuroblast descendants (QL.d) and the 
dependency of this migration on Wnt signalling. In wild type, the QL.d migrate to positions in the 
posterior part of the animal. In the absence of Wnt signalling, the QL.d migrate in the opposite, 
anterior, direction. (B) C. elegans CRISPR knock-in of snx-3(p.Y22A), which cannot bind to vps-
35, causes a failure of the posterior migration of the QL neuroblast descendants. The 
percentage of C. elegans with an anterior migration of the QL.d are shown ± standard deviation. 
Significance was determined using a Student’s t-test. *** p < 0.0001. Data from Dr Marco Betist. 
 
To translate my in vitro biochemical data into an in vivo setting, I turned to a 
collaboration with the Rik Korswagen lab, who use C. elegans as a model to study Wnt 
signalling. In C. elegans, the EGL-20 (a Wnt homologue)-dependent migration of the 
QL neuroblast descendants (QL.d) is a well characterised assay for studying of Wnt 
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signalling defects (Maloof et al., 1999; Pan et al., 2008; Yang et al., 2008; Harterink et 
al., 2011). In wild-type C. elegans, the QL.d will migrate posteriorly. In a genetic context 
where EGL-20 cannot be secreted, such as in a snx-3 or vps-35 null C. elegans, or 
when there is a loss of EGL-20 signalling, the QL.d will migrate anteriorly (Figure 
3.6A). Building on my cell-culture based analysis of human SNX3 variants with 
perturbed VPS35 binding (Figure 3.2), Dr Marco Betist generated C. elegans with 
CRISPR-mediated knock-in of snx-3(p.Y22A) and examined the migration of QL.d in 
these worms. The snx-3(p.Y22A) knock-in C. elegans had a 81 ± 4.7 % penetrant QL.d 
migration defect (n = 202) (Figure 3.6B). This compares with snx-3 null C. elegans 
which have a fully penetrant QL.d migration defect and wild-type C. elegans which do 
not have a QL.d migration defect. This is the first evidence that the physical interaction 
between vps-35 and snx-3, and therefore assembly of the SNX3-retromer complex, is 
required for Wnt secretion and Wnt signalling. 
 
Figure 3.7 MON2, DOPEY1, DOPEY2 and ATP9A associate biochemically. 
(A-F) HEK293T cells were transfected with the indicated construct and subjected to a GFP-trap. 
The immuno-lysates were then resolved using SDS-PAGE and immuno-blotted for the indicated 
antibodies. A, D, E and F were performed by Dr Ian McGough. 
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3.2.4 SNX3, but not SNX1, associates with MON2  
The SNX3-retromer retrieval of Wntless is independent from the classic retromer-
associated remodelling complex (the SNX-BAR complex) (Harterink et al., 2011; Zhang 
et al., 2011). One major interest in the generation of the SNX3 interactome was to 
identify potential membrane remodelling proteins. Two SNX3 interactome hits, MON2 
and DOPEY2, have been shown in S. cerevisiae to interact with a putative 
phospholipid translocase, implicated in membrane remodelling (Hua and Graham, 
2003; Wicky et al., 2004; Singer-Kruger et al., 2008; Barbosa et al., 2010). Dr Ian 
McGough therefore set up a GFP-trap immuno-precipitation experiment to compare the 
binding of MON2 to GFP-SNX3 and a member of SNX-BAR complex, GFP-SNX1 
(Figure 3.7A). As well as binding to the known SNX3-interactor, VPS26, SNX3 could 
immunoprecipitate endogenous MON2. The immunoprecipitation of MON2 was specific 
to SNX3 and therefore shows heterogeneity between SNX3-retromer and SNX-BAR-
retromer. 
 
3.2.5 MON2 and DOPEY2 share some features of their S. cerevisiae 
homologues 
Very little is known about mammalian MON2 and DOPEY1/DOPEY2; however, there is 
some genetic and biochemical data from their yeast homologues. Mon2p and Dop1p 
(S. cerevisiae homologues of MON2 and DOPEY1/DOPEY2 respectively) have been 
shown to genetically and biochemically associate with each other (Efe et al., 2005; 
Gillingham et al., 2006; Barbosa et al., 2010). It is unknown whether their mammalian 
homologues do the same. To test this, I transfected GFP-tagged constructs into 
HEK293T cells followed by a GFP-trap experiment. GFP-MON2 could immuno-
precipitate endogenous DOPEY1 and DOPEY2 (Figure 3.7B) and GFP-DOPEY2 
could immuno-precipitate endogenous MON2 and endogenous DOPEY1 (Figure 
3.7C). The formation of a complex between MON2 and DOPEY1/DOPEY2 therefore 
seems to be conserved from yeast to humans.  
Another feature of the S. cerevisiae proteins Mon2p and Dop1p, is their ability to form 
homomeric complexes, i.e. Mon2p can bind to Mon2p, and Dop1p can bind to Dop1p 
(Barbosa et al., 2010). To test whether this has been conserved in their mammalian 
homologues, Dr Ian McGough transiently transfected HEK293T cells and performed 
GFP-trap experiments. MON2-GFP could pull down Flag-tagged MON2 (Figure 3.7D) 
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and DOPEY2-GFP could pull-down Flag-tagged DOPEY2 (Figure 3.7E). The 
divergence of Dop1p into the two human paralogues, DOPEY1 and DOPEY2, has not 
changed the ability of these proteins to associate with one another, as GFP-trap of 
DOPEY2-GFP could pull down endogenous DOPEY1 (Figure 3.7C). The self-
association properties of Mon2p and Dop1p are therefore conserved from yeast to 
humans. 
 
Figure 3.8 ATP9A localises to the TGN and SNX3-retromer positive endosomes.  
(A) HeLa cells were transfected with ATP9A-HA and stained for HA and endogenous TGN46. 
Cells were imaged on a confocal microscope. Scale bar indicates 19 µm. (B) HeLa cells were 
transfected with ATP9A-HA and stained for HA and endogenous SNX3 and VPS35. Cells were 
imaged on a confocal microscope. Scale bar indicates 19 µm. 
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Mon2p and Dop1p interact genetically and biochemically with Neo1p, a putative 
aminophospholipid translocase (flippase) (Hua and Graham, 2003; Wicky et al., 2004; 
Singer-Kruger et al., 2008; Barbosa et al., 2010). Neo1p has two homologues in 
humans: ATP9A and ATP9B. ATP9A localises to the TGN and endosomal network 
whereas ATP9B localizes just to the TGN (Takatsu et al., 2011; Tanaka et al., 2016). 
To test whether ATP9A (the endosome-localised paralogue) could bind to the MON2-
DOPEY1/2 complex, Dr Ian McGough co-expressed DOPEY2-GFP and ATP9A-HA (an 
endogenous ATP9A antibody could not be validated) in HEK293T cells and performed 
a GFP-trap experiment. ATP9A-HA and endogenous MON2 could be pulled down by 
DOPEY2-GFP (Figure 3.7F). The formation of a Mon2p:Dop1p:Neo1p complex 
therefore seems to be conserved from yeast to humans.  
 
3.2.6 The MON2:DOPEY:ATP9A complex co-localise with SNX3-retromer 
and Wntless 
To examine the localisation of MON2, DOPEY2 and ATP9A in cells, I turned to 
confocal microscopy. Following the transient transfection of ATP9A-HA into HeLa cells, 
I observed that ATP9A localised to the TGN-marker TGN46 (Figure 3.8A) and to 
endogenous SNX3-retromer positive puncta (Figure 3.8B). Dr Ian McGough also found 
extensive co-localisation of co-expressed ATP9A-HA, DOPEY2-GFP and MON2-Flag 
when transfected into HeLa cells (Figure 3.9A).  
Together, the biochemical and imaging-based data raise the possibility that MON2, 
DOPEY2 and ATP9A may support SNX3-retromer-mediated cargo-retrieval. We 
therefore tested whether the SNX3-retromer cargo protein Wntless co-localised with 
ATP9A and SNX3. To this end, Dr Ian McGough transiently expressed ATP9A-HA and 
Wntless-mCherry and stained for endogenous SNX3 in HeLa cells (Figure 3.9B). 
ATP9A co-localises with Wntless and SNX3-enriched endosomes. SNX3-retromer 
dependent retrieval of Wntless therefore seems to be taking place on endosomes 
enriched for ATP9A.  
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Figure 3.9 ATP9A colocalises with MON2, DOPEY2 and Wntless. 
(A) Hela cells were transfected with ATP9A-HA, DOPEY2-GFP and MON2-Flag and imaged on 
a confocal microscope. Data from Dr Ian McGough. (B) Hela cells were transfected with 
ATP9A-HA and Wntless(WLS)-mCherry and stained for endogenous SNX3. Cells were imaged 
on a confocal microscope. Scale bars represents 10 μm. Data from Dr Ian McGough. 
 
3.2.7 Establishment of an in vitro cell culture-based system to study 
Wntless retrieval 
MON2, DOPEY1/2 and ATP9A associate biochemically and co-localise in cells with 
SNX3 and Wntless. These data raise the intriguing possibility that the 
MON2:DOPEY1/2:ATP9A complex may aid the retrieval of Wntless from the 
endosomes to the TGN. I therefore wanted to perform functional biochemistry 
experiments to test whether this is the case. To do this, I decided to create a cell-line  
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Figure 3.10 Validation of the HA-WLS construct. 
(A) Schematic of the HA-WLS (HA-Wntless) construct. (B) RPE-1 cells, transduced with various 
titres of lentivirus to express HA-WLS, were lysed and immuno-blotted for the indicated 
antibodies. RPE-1 cells, transduced with HA-WLS, were stained for HA and endogenous: (C) 
TGN46 and (D) VPS35. Cells were imaged on a confocal microscope; the scale bar indicates 
11 µm. (E) RPE-1 cells were transduced with HA-WLS. The HA-tag was then chased from the 
cell surface to the TGN. The cells were fixed at the indicated time points following incubation 
with an α-HA primary antibody to label cell-surface localised HA-WLS. Cells were imaged on a 
confocal microscope; the scale bar indicates 11 µm. 
 
stably expressing a Wntless construct. I utilised a Wntless construct, recently published 
by the Von Zastrow lab (Varandas et al., 2016), in which the ER localisation signal is 
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masked using an HA-tag to optimise trafficking of the complex through the endosomal 
system (HA-WLS) (Figure 3.10A). 
To produce a stable population of HA-Wntless in a cell line, I cloned HA-Wntless into 
the XLG3 lentiviral vector and produced lentivirus. I then transduced RPE-1 cells to 
express HA-Wntless with various titres of lentivirus and tested the expression of HA-
Wntless using western blotting (Figure 3.10B). I selected the 250 µl titre as it gave a 
strong signal by western blotting and showed extensive co-localisation between the 
TGN marker TGN46 (Figure 3.10C) and VPS35-positive endosomes (Figure 3.10D).  
At the cell surface, Wntless is endocytosed into the endosomes through an AP-2 and 
clathrin-dependant mechanism (Port et al., 2008; Yang et al., 2008; Gasnereau et al., 
2011) and then retrieved to the Golgi via SNX3-retromer (Belenkaya et al., 2008; 
Franch-Marro et al., 2008; Pan et al., 2008; Yang et al., 2008; Harterink et al., 2011; 
Zhang et al., 2011). I therefore tested the functionality of the HA-Wntless construct’s 
cell surface to Golgi trafficking. By labelling the cell surface with primary antibodies 
raised against the HA-tag, which bind to the HA-Wntless at the cell surface, I could 
follow the internalisation of the HA-Wntless. Consistent with functional HA-Wntless 
cycling between the Golgi and the cell surface, the cell-surface labelled HA-Wntless 
could be chased to the TGN after a 60-minute time point (Figure 3.10E).  
The endosome-to-Golgi retrieval of Wntless away from lysosomal degradation (and 
therefore the whole-cell proteins levels of Wntless) is dependent on SNX3-retromer but 
not the SNX-BAR complex (Harterink et al., 2011; Zhang et al., 2011). To further 
validate the HA-Wntless expressing RPE-1 line, I examined whether the whole-cell 
protein levels of HA-Wntless is dependent on the SNX3-retromer, rather than the SNX-
BAR-retromer or the SNX27-retromer (Figure 3.11A). The whole-cell level of HA-
Wntless was significantly decreased following the suppression of VPS35 or SNX3 but 
not following SNX1/SNX2 or SNX27 suppression (Figure 3.11B). To examine whether 
the decrease in HA-Wntless levels were due to lysosomal degradation, I treated the 
cells with Bafilomycin A1, a lysosomal acidification inhibitor (Yoshimori et al., 1991), for 
16 hours prior to cell lysis (Figure 3.11C). Bafilomycin A1 treatment rescued the whole-
cell levels of HA-Wntless following SNX3 or retromer suppression (Figure 3.11D). 
Furthermore, when HA-Wntless was transfected into VPS35-knockout HeLa cells, it co-
localised with the late endosomal/ lysosomal marker LAMP1; however, when 
transfected into VPS35-knockout HeLa cells rescued with VPS35-GFP, its localisation 
was reminiscent of the TGN and endosomes (Figure 3.11E) which is similar to its 
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Figure 3.11 HA-WLS whole-cell levels are dependent on SNX3-retromer-mediated 
retrieval away from lysosomal degradation. 
(A) RPE-1 cells, transduced with HA-Wntless(WLS), were suppressed with siRNA targeting the 
indicated protein(s). Cells were lysed, the lysates resolved using SDS-PAGE and immuno-
blotted using the indicated antibodies. (B and D) The intensities of the fluorescent HA-WLS 
bands were quantified using a Licor Odyssey scanner. Data were normalised to the non-
targeting control (with DMSO in D). Data shows the mean of 3 independent experiments ± 
s.e.m. Significance was determined by a one-way ANOVA with a post-hoc Dunnett’s test 
comparing experimental conditions to the control knock-down. (C) Following suppression with 
non-targeting siRNA, VPS35 siRNA or SNX3 siRNA, RPE-1 cells, stably expressing HA-WLS, 
were treated with 100nM Bafilomycin or DMSO for 16 hours prior to cell lysis. The lysates were 
then resolved using SDS-PAGE and immuno-blotted with the indicated antibodies. (E) VPS35 
knockout HeLa cells, supplied from Dr Florian Steinberg, were transduced with VPS35-GFP and 
transfected with HA-WLS. Once adhered onto coverslips, the cells were fixed with 4% 
paraformaldehyde and immuno-stained for HA, and endogenous LAMP1. Cells were imaged 
using a confocal microscope. The scale bar indicates 33 µm. 
 
normal distribution (Figure 3.10C-D). These data validate this in vitro cell culture-based 
system as a tool to study the endosomal-TGN retrieval of Wntless. 
 
3.2.8 The retrieval of HA-Wntless is dependent on MON2 and ATP9A 
Having validated the in vitro cell culture-based system to examine Wntless retrieval, I 
then examined whether MON2, DOPEY1/2 and ATP9A have a role in the retrieval of 
Wntless. I firstly examined whether MON2, DOPEY1, DOPEY2 or DOPEY1+DOPEY2 
suppression would phenocopy VPS35 suppression in terms of decreasing the whole-
cell levels of HA-Wntless (Figure 3.12A). Although MON2 suppression caused a 
similar decrease in HA-Wntless levels as VPS35 suppression, knocking down 
DOPEY1, DOPEY2 or a combination of DOPEY1 and DOPEY2 did not (Figure 3.12B). 
I then examined whether the decrease in HA-Wntless levels following MON2 
suppression was due to lysosomal degradation (Figure 3.12C). Inhibiting lysosomal 
acidification through Bafilomycin A1 increased the levels of HA-Wntless following 
MON2 knockdown compared to the DMSO-treated control, suggesting that the 
decrease in HA-Wntless levels following MON2 suppression is due to lysosomal 
degradation (Figure 3.12D). 
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Figure 3.12 Inhibition of MON2 or ATP9A, but not DOPEY1/DOPEY2, cause the 
whole-cell level decrease of HA-WLS due to lysosomal degradation. 
(A) RPE-1 cells, transduced with HA-Wntless(WLS), were suppressed with siRNA targeting the 
indicated protein(s). Cells were lysed, the lysates resolved using SDS-PAGE and immuno-
blotted using the indicated antibodies. (B, D and G) The intensities of the fluorescent HA-WLS 
bands were quantified using a Licor Odyssey scanner. Data were first normalised to GAPDH 
before normalisation to the non-targeting control (with DMSO in D and G). Data is a mean from 
3 (or 5 in G) individual experiments ± s.e.m. Significance was determined by a one-way ANOVA 
with a post-hoc Dunnett’s test comparing experimental conditions to the control knock-down; *p 
≤ 0.05; **p ≤ 0.01. (C and E) Following suppression with the indicated siRNAs, RPE-1 cells, 
stably expressing HA-WLS, were treated with 100nM Bafilomycin or DMSO for 16 hours prior to 
cell lysis. The lysates were then resolved using SDS-PAGE and immuno-blotted with the 
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indicated antibodies. (F) Knock-down of ATP9A was confirmed through RT-qPCR. Significance 
was determined using a student’s t-test. Error bars indicate standard error; **** p ≤ 0.0001. 
 
I then examined the role of ATP9A in Wntless recycling via RNAi-mediated 
suppression (Figure 3.12E). As no endogenous antibody for ATP9A could be verified, I 
used qRT-PCR to confirm an 80% suppression of ATP9A (Figure 3.12F). ATP9A 
suppression phenocopies VPS35 suppression in terms of the decrease in the whole-
cell levels of HA-Wntless (Figure 3.12G). Furthermore, the inhibition of lysosomal 
acidification increased the levels of HA-Wntless compared to the DMSO-treated control 
(Figure 3.12G). The levels of HA-Wntless are therefore dependent on MON2 and 
ATP9A proteins, but not DOPEY1/2, in this in vitro cell culture system.  
 
Figure 3.13 Inhibition of vps-35, mon-2 or pad-1 (DOPEY orthologue) causes a 
whole-cell level decrease of MIG-14 (Wntless) and its colocalisation with late 
endosomes/lysosomes in C. elegans L1 larvae. 
(A) C. elegans, endogenously expressing MIG-14::GFP (huSi2), were treated with RNAi 
targeting vps-35, mon-2, pad-1 or non-targeting RNAi. The proteins were then resolved on an 
SDS-PAGE gel and immunoblotted for GFP or tubulin. (B) C. elegans L1 larvae were treated 
with the indicated RNAi and immuno-stained for MIG-14::GFP and the late endosomal and 
lysosomal marker LMP-1::mCherry. Arrows indicate colocalisation. The tail area is shown; 
anterior is left and dorsal is up. Images were taken on a confocal microscope and the scale bar 
is 10 µm. Data in this figure was collected by Dr Reinoud de Groot.  
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3.2.9 RNAi of mon-2 and pad-1 cause a loss of mig-14 levels and an EGL-
20 secretion defect in C. elegans  
Having presented biochemical evidence in a mammalian cell culture-based system that 
Wntless retrieval is dependent on MON2, but not DOPEY1/DOPEY2, we wanted to 
translate these finding into an in vivo setting. We therefore returned to the C. elegans 
model to study Wnt signalling in vivo (all further C. elegans experiments were 
performed by Dr Reinoud de Groot). C. elegans were systemically fed dsRNA to 
suppress the orthologues of VPS35, MON2 and DOPEY1/DOPEY2 (vps-35, mon-2 
and pad-1 respectively). Systemic knockdown of these proteins caused a decrease in 
the total levels of GFP-fused MIG-14 (the C. elegans orthologue of Wntless), as shown 
through immunoblotting for GFP (Figure 3.13A). Furthermore, suppressing vps-35, 
mon-2 or pad-1 caused MIG-14 to co-localise with the late endosomal/lysosomal 
marker LMP-1 (Figure 3.13B). These data show that mon-2 and pad-1 are required for 
the maintenance of MIG-14 levels in vivo. This contrasts with the mammalian 
orthologues of pad-1 (DOPEY1/2), which, at least in my in vitro model of Wntless 
retrieval, does not cause a decrease in HA-Wntless levels at the level of suppression I 
achieved using siRNA (Figure 3.12A).  
 
Figure 3.14 Inhibition of vps-35, mon-2 or pad-1 (DOPEY orthologue) causes a 
loss of the EGL-20 (Wnt) gradient and a perturbation of the posterior migration of 
QL neuroblast decedents. 
(A) C. elegans L1 larvae were treated with RNAi targeting vps-35, mon-2, pad-1 or non-
targeting RNAi were immuno-stained for EGL-20::protA. The EGL-20 producing cells are 
indicated with a solid line and the punctate gradient that is formed by EGL-20::protA is indicated 
with a dashed line. Anterior is left and dorsal is up. Images were obtained on a confocal 
microscope; scale bar is 10 µm. (B) Systemic knock-down of mon-2 or pad-1 interferes with the 
EGL-20/Wnt dependent posterior migration of the QL neuroblast descendants (QL.d) in a vps-
29(tm1320) sensitized genetic background. The percentage of animals with anteriorly displaced 
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QL.d is shown (data are presented as mean +/- SD and include results from 4 experiments, with 
n≥25 per experiment) *p=1.158 x 10-6 for vps-35 RNAi, *p=1.44 x 10-5 for mon-2 RNAi and 
*p=0.0024 for pad-1 RNAi (Student’s t-test). Data in this figure was collected by Dr Reinoud de 
Groot.  
 
During C. elegans development, EGL-20 (a Wnt orthologue) is secreted in the posterior 
of the worm from Wnt secreting cells; this secretion forms a morphogenic gradient 
along the worm (Figure 3.14A) (Maloof et al., 1999). Suppressing vps-35 prevented 
EGL-20 secretion from the Wnt secreting cells and caused a loss of the EGL-20 
gradient (Figure 3.14A). Mon-2 and pad-1 suppression phenocopied vps-35 
suppression in terms of the EGL-20 secretion defect (Figure 3.14A). The secretion of 
MIG-14 is therefore dependent on mon-2 and pad-1 in vivo. 
During C. elegans development, the QL. neuroblast descendants (QL.d) migrate 
towards the posterior of the worm, due to signalling cascades initiated by EGL-20 
(Figure 3.6A); this contrasts with the QR. neuroblast descendants, which do not 
encounter EGL-20 and migrate anteriorly (Lorenowicz et al., 2014). Reinoud de Groot 
took advantage of this EGL-20-dependent posterior migration of the QL.ds as an assay 
for Wnt secretion deficits. As QL.d migration is relatively insensitive to EGL-20 and the 
suppressions of mon-2 and pad-1 are only partial, a sensitised background (vps-29 
mutant) was used to assay the effects of mon-2 and pad-1 suppression. Vps-35, mon-2 
and pad-1 suppression caused a significant increase in the anterior migration of the 
QL.ds (Figure 3.14B). These data show that that vps-35, mon-2 and pad-1 are 
necessary for EGL-20 secretion and the EGL-20-dependant posterior migration of the 
QL. neuroblast descendants.   
 
3.2.10 Tat-5 flippase activity is necessary for the EGL-20-dependent 
posterior migration of the QL. neuroblast descendants in C. elegans 
The suppression of tat-5 (the C. elegans ATP9A orthologue) in vivo is lethal (Wehman 
et al., 2011). To suppress tat-5 in C. elegans, the RNAi against tat-5 was expressed 
using a MIG-14 promoter (to suppress tat-5 only in the Wnt secreting cells). This 
method of suppression causes a poorer knock-down of the protein of interest 
compared to systemic feeding of dsRNA (personal communication from Professor Rik 
Korswagen), as shown by the lower penetrance of the QL.d anterior-migration 
phenotype when vps-35 suppressed using this method (Figure 3.15A) compared to 
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systemic feeding of dsRNA targeting vps-35 (Figure 3.14B). Expression of the RNAi 
targeting tat-5 using the MIG-14 promotor resulted in an increase in the anterior 
migration of the QL.d, similar to what is seen with vps-35 suppression using the same 
method (Figure 3.15B).  
The C. elegans data presented so far indicate that mon-2, pad-1 or tat-5 suppression 
phenocopy vps-35 suppression in terms of their effect on the migration of QL.d. I have 
not yet presented any data which would indicate that the flippase activity of ATP9A/tat-
5 is important for Wntless/MIG-14 retrieval and Wnt/EGL-20 secretion. The ability of 
aminophospholipids to flip lipids is dependent on the activity of the protein’s ATPase 
cycle (Lenoir et al., 2009). A yeast Drs2(p.E342Q) mutation blocks its ATPase cycle at 
the E2P conformation and inhibits phospholipid translocation across the lipid bilayer 
(Lenoir et al., 2009; Zhou and Graham, 2009). Dr Reinoud de Groot created a 
construct which would express the equivalent mutation (Figure 3.15C), tat-5(E246Q), 
and overexpressed it under a heatshock promotor. This resulted in the increase in the 
QL.d migration defect (Figure 3.15D). These data indicate that the ATPase-cycle and 
therefore the flippase activity of tat-5 is important for Wnt secretion in vivo.  
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Figure 3.15 Suppressing tat-5 (ATP9A homologue), or inhibiting the ATPase 
activity of tat-5, perturbs the posterior migration of the QL neuroblast 
descendants in L1 larvae.  
Tissue specific RNAi of vps-35 (Ai) or tat-5 (Aii) in Wnt producing cells (Pmig-14::tat-5 RNAi) in 
a C. elegans vps-29(tm1320) sensitized mutant background. The percentage of animals with 
anteriorly displaced QL.d is shown (data are presented as mean +/- SD and include results from 
7 experiments, n≥24 per experiment) *p=0.013 (Student’s t-test). (Bi) Sequence alignment of 
Drs2p with Neo1p homologues highlighting the conserved catalytic glutamic acid residue 
essential for ATPase activity. (Bii) Overexpression of catalytically inactive TAT-5(E246Q) in a 
vps-29(tm1320) sensitized mutant background. The percentage of animals with anteriorly 
displaced QL.d is shown (data are presented as mean +/- SD and include results from 3 
experiments, n≥30 per experiment) *p=0.0089 (Student’s t-test). Data in this figure was 
collected by Dr Reinoud de Groot.   
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3.3.1 The SNX3-retromer binding interface 
Previous work indicated that SNX3 associates with the retromer complex through the 
direct association with VPS35 (Harterink et al., 2011; Zhang et al., 2011; Vardarajan et 
al., 2012; Harrison et al., 2014b). To extend these findings, I undertook a biochemical 
screen, informed through a bioinformatic sequence alignment of similar PX-only sorting 
nexins, to identify candidate residues within SNX3 which may be important for retromer 
association. This approach identified several mutations of highly evolutionary-
conserved residues within the termini of SNX3, as well as its anti-parallel β-sheet, 
which abrogate SNX3-retromer association, informing the mechanism of this 
association (Figure 3.4).  
Following my identification of the critical SNX3 residues essential for retromer 
association, a crystal structure of SNX3 bound to a VPS26/VPS35 interface was 
published (Lucas et al., 2016). This structure revealed that SNX3 directly associates 
not only with VPS35, but also to VPS26A; this induces a conformational change in 
VPS26A revealing a cargo-binding pocket (see section 1.4.1.2.1) (Tabuchi et al., 2010; 
Lucas et al., 2016). Most of the residues I identified to be critical for retromer binding, 
when highlighted in the Lucas et al., (2016) structure, were located on the SNX3-
retromer interface, therefore validating my results (Figure 3.16). However, the Lucas et 
al., (2016) crystal structure reveals no interaction between the C-terminus of SNX3 and 
retromer. This contrasts with my findings, which identified that the C-terminal SNX3 
residues mutations, Y154A and P156A, causes a partial loss of VPS35 association and 
most strikingly, R160A, which severely perturbs retromer binding (Figure 3.2). The 
Lucas et al., (2016) crystal structure utilises a non-canonical SNX3 isoform lacking the 
final 3 amino acids (K158, I159 and R160). It may be the case that a crystal structure 
formed using full-length SNX3 may bind to retromer in a different conformation, with 
both termini of SNX3 engaging with retromer. Although the crystal structure indicates 
that the C-terminus of SNX3 is not essential for retromer binding in the in vitro 
crystallisation conditions, the perturbation of GFP-SNX3(p.R160A) binding to VPS35 
(Figure 3.2) suggests that, in vivo, the C-terminus of SNX3 may be critical in stabilising 
the SNX3-retromer interaction. Furthermore, a recently published solution structure of 
full-length SNX3 has identified that its C-terminus is structured (interfacing with the α1, 
α3, and α4 helices of SNX3), facing away from the PI3P binding site with the N-
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terminus; the authors hypothesise that the termini form a binding platform for 
interactions with the retromer complex (Lenoir et al., 2018).  
 
Figure 3.16 Modelling of the residues identified in SNX3 which causes a 
perturbation in VPS35 binding onto the SNX3:VPS35:VPS26A crystal structure 
Model of the SNX3 (yellow):VPS35 (red):VPS26A (blue) crystal structure from Lucas et al., 
2016. The residues which, when mutated, caused a loss of association between SNX3 and 
VPS35 are shown in yellow. The residues which, when mutated, did not cause a dramatic loss 
of VPS35 associated are shown in cyan. For clarity, a spherical representation of the 
highlighted residues is shown on the ribbon backbone. 
 
The Lucas et al., (2016) structure revealed that the SNX3 binding to the 
VPS35/VPS26A interface induces a conformational change in VPS26A which opens-up 
a binding site for cargoes which contain a binding site for ØX(L/M/V) motifs (where Ø is 
an aromatic residue). The divalent iron transporter, DMT1-II, is the only cargo with 
structural evidence to prove this. However, several retromer cargoes, including 
Wntless, contain this motif, making it a probable mechanism for its binding (Lucas et 
al., 2016).  
Both SNX3 and the retromer complex have previously been shown to be essential for 
the endosomal sorting of the Wnt chaperone, Wntless, and therefore Wnt secretion 
(Belenkaya et al., 2008; Franch-Marro et al., 2008; Pan et al., 2008; Yang et al., 2008; 
Harterink et al., 2011; Zhang et al., 2011). However, due to the lack of structural 
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information of how SNX3 associates with retromer, it had never been established 
whether the direct association between SNX3 and retromer is required for the 
endosomal sorting of Wntless. Here, data I gathered through a biochemical, site-
directed mutagenesis screen, which identified specific SNX3 residues required for 
VPS35 association (Figure 3.2), could be translated into an in vivo C. elegans setting 
through the CRISPR knock-in of SNX3(p.Y22A), which uncouples SNX3 from the 
retromer complex. Animals with SNX3(p.Y22A) exhibited a Wnt secretion defect, with 
the QL.d migrating in the anterior, rather than the posterior, direction (Figure 3.6). 
These data reveal the necessity of the interaction between SNX3 and retromer for the 
endosomal sorting of Wntless and the maintenance of Wnt secretion. As it is probable 
that cargo bind to SNX3-retromer through the same binding mechanism (Lucas et al., 
2016), the functional insight gained through uncoupling the SNX3-retromer interaction 
in the context of Wntless trafficking may also be relevant for other SNX3-retromer 
cargoes, such as DMT1-II and the Transferrin receptor (Tabuchi et al., 2010; Chen et 
al., 2013; Lucas et al., 2016).  
The SNX3 interactome contain several proteins (such as VPS35, ATM kinase, GCN1 
and mTOR) which have a similar tertiary structure: HEAT-repeat domains (Hierro et al., 
2007; Knutson, 2010; Lau et al., 2016; Rakesh et al., 2017). It was therefore tempting 
to speculate that they all associate with SNX3 through the same mechanism. However, 
when I examined the ability of SNX3 variants unable to associate with VPS35, to bind 
to the other interactors, there was no difference in the binding (Figure 3.5). This 
establishes that even though these other interactors have a similar tertiary structure to 
VPS35, that they do not associate using the same mechanism. The Lucas et al., (2016) 
SNX3-retromer crystal structure, which revealed that SNX3 associates with the 
VPS26A retromer subunit, which has an arrestin-like structure (Gallon et al., 2014b), as 
well as to VPS35, is consistent with the SNX3-retromer interaction being unique.  
 
3.3.2 The role of aminophospholipid translocases in membrane traffic 
Protein trafficking has received extensive research attention, but the trafficking of lipids 
is less well understood. The subcellular lipid organisation within cells is maintained 
through mechanisms which concentrate specific lipid species within specific organelles, 
and between the lipid bilayers within these organelles (Santos and Preta, 2018). 
Although there is rapid lipid lateral mobility within a membrane bilayer, the spontaneous 
translocation (or flip-flop) of lipids between one leaflet to another, due to the polar head 
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group crossing the hydrophobic membrane, faces high energetic barriers (Singer and 
Nicolson, 1972). The translocation of phospholipids is therefore coordinated via 3 
protein families: scramblases, flippases and floppases (Figure 3.17). Most 
phospholipid synthesis occurs in the ER (Bell et al., 1981; Blom et al., 2011). To 
maintain this lipid bilayer, some phospholipids must be redistributed, or flipped, onto 
the other leaflet. The ER membrane contains scramblases, which, in an energy-
independent fashion, non-specifically redistributes the lipids across the bilayer. The 
identities of these ER-localised scramblases have remained elusive, but recent results, 
largely through studies on Opsin, suggest that GPCRs may be responsible (Menon et 
al., 2011; Goren et al., 2014); the evidence for this comes from in vitro reconstitution 
experiments, not in cells. Many cellular lipid bilayers tend to be asymmetric in their lipid 
composition; this is best characterised in the plasma membrane, where sphingomyelin 
and phosphatidylcholine are enriched in the extracellular leaflet, while 
phosphatidylethanolamine and phosphatidylserine are enriched to the cytosolic leaflet 
(Ingolfsson et al., 2014).  
 
Figure 3.17 Flippases, floppases and scramblases mediate phospholipid 
transfers across the lipid bilayer. 
A schematic depicting the protein families which mediate the transfer of phospholipids across 
lipid bilayers. Flippases use ATP hydrolysis to transfer phospholipids from the 
extracellular/luminal leaflet to the cytosolic leaflet. Floppases use ATP hydrolysis to transfer 
phospholipids from the cytosolic leaflet to the extracellular/luminal leaflet. Scramblases transfer 
phospholipids across the lipid bilayer in an energy-independent fashion. 
 
This differential and asymmetric distribution of lipids creates unique membrane 
properties which can dynamically be exploited for numerous cellular applications. For 
example, exposure of phosphatidylserine on the outer plasma membrane lipid leaflet, 
mediated through a scramblase, serves as a trigger of apoptosis (Fadok et al., 2001). 
The active redistribution of lipids from one side of a leaflet to another induces 
membrane bending, which can be a trigger for vesicular budding in the endocytic and 
secretory pathways (Farge et al., 1999; Muthusamy et al., 2009; Takada et al., 2018). 
The deformation of membranes through cytosolic coat proteins (Section 1.1.1) is the 
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best-characterised mechanism for the generation of transport vesicles, but accessory 
proteins such as flippases are thought to aid the generation of membrane curvature 
(Shin et al., 2012; Takada et al., 2018). Not only are lipids, such as sterols and 
sphingolipids, segregated during the formation of secretory vesicles (Klemm et al., 
2009; Deng et al., 2016), the action of flippases have been implicated in the formation 
of extracellular vesicles (Wehman et al., 2011), exocytic vesicles (Gall et al., 2002) and 
endocytic carriers (Pomorski et al., 2003).  
Flippases (also known as P4 ATPases and aminophospholipid translocases) mediate 
the ATP-dependent translocation of aminophospholipids, such as phosphatidylserine 
and phosphatidylethanolamine, from the extracellular (or luminal) leaflet of the lipid 
bilayer, to the cytosolic leaflet (Figure 3.17). In S. cerevisiae, there are 5 members of 
the flippase family: Drs2p, Dnf3p, Dnf1p, Dnf2p and Neo1p. The only essential gene in 
this family is NEO1 (Hua et al., 2002), but the best characterised is Drs2p, which is 
involved in the flipping of (predominantly) phosphatidylserine in the TGN compartment 
(Natarajan et al., 2004; Chen et al., 2006). C. elegans have 6 and humans have 14 P4-
ATPases (Table 3.1). Unlike cation transporter members of the P-ATPase family, 
which have a conserved acidic residues in their transmembrane segments, 
aminophospholipid translocases have a highly conserved lysine residue critical for their 
function (Coleman et al., 2012). Reconstitution assays have demonstrated the activity 
of several flippases (Coleman et al., 2009; Zhou and Graham, 2009; Takatsu et al., 
2014; Yabas et al., 2016) but many of the others have phenotypes consistent with a 
role in flipping lipids.  
Table 5.1 VPS35-GFP variants created through site-directed mutagenesis 
P4-ATPases, class S. cerevisiae C. elegans H. sapiens 
1a DRS2 tat-1 ATP8A1, ATP8A2 
1b N/A tat-2 ATPB1, ATPB2, ATPB3, ATPB4 
2 NEO1 tat-5, tat-6 ATP9A, ATP9B 
3 DNF1, DNF2 N/A N/A 
4 DNF3 N/A N/A 
5 N/A tat-3, tat-4 ATP10A, ATP10B, ATP10D 
6 N/A N/A ATP11A, ATP11B, ATP11C 
Table 3.1 P4-ATPases in S. cerevisiae, C. elegans and H. sapiens 
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3.3.3 The role of MON2/DOPEY/ATP9A in Wntless recycling and Wnt 
secretion 
The SNX3-retromer-mediated retrieval of Wntless is independent from the SNX-BAR 
complex, the classical membrane deformation complex associated with retromer-
mediated retrieval and recycling (Harterink et al., 2011; Zhang et al., 2011). The 
generation of the SNX3 interactome revealed candidate proteins for the SNX3-
retromer-associated membrane-remodelling complex: MON2 and DOPEY2, which in S. 
cerevisiae, interact with the putative phospholipid translocase: neo1p (Hua and 
Graham, 2003; Wicky et al., 2004; Singer-Kruger et al., 2008; Barbosa et al., 2010). 
Some members of the MON2/DOPEY2/ATP9A complex and the retromer complex (or 
associated endosomal proteins) and have previously been linked together in the 
regulation of β-catenin asymmetry during C. elegans stem cell divisions (Kanamori et 
al., 2008), the regulation of  extracellular vesicle budding in C. elegans (Beer et al., 
2018) and cargo recycling in S. cerevisiae (Dalton et al., 2017). Furthermore, ATP9A 
has been linked to the endosomal recycling of GLUT1 and transferrin (Tanaka et al., 
2016).  
MON2 has been implicated in promoting cargo sorting (Avaro et al., 2002; Bonangelino 
et al., 2002; Efe et al., 2005; Gillingham et al., 2006) and reported to be required for 
correct Gag localisation during HIV-1 infection of mammalian cells (Tomita et al., 
2011). The Sec7-like domain of MON2 resulted in it being proposed as a GEF for Arl1 
(Wicky et al., 2004), but this was subsequently shown to be incorrect (Mahajan et al., 
2013). Little is known about mammalian DOPEY1/2 beyond associations with Down’s 
syndrome, Alzheimer’s disease and breast cancer (Rachidi et al., 2009; Swaminathan 
et al., 2012; Lend et al., 2015). In C. elegans it is an essential gene required for 
embryonic patterning (Guipponi et al., 2000).  
Here, I have further characterised human MON2 and DOPEY1/2 proteins and have 
established that they share many features of their yeast homologues (Mon2p and 
Dop1p respectively). This includes self-association properties (i.e. MON2 interacts with 
MON2 and DOPEY2 interacts with DOPEY2) (Barbosa et al., 2010), their association 
with each other (i.e. MON2 interacts with DOPEY2) (Gillingham et al., 2006) and the 
formation of a complex with the human equivalent of the putative phospholipid 
translocase neo1p: ATP9A (Barbosa et al., 2010) (Figure 3.7B-F). I have also 
presented evidence that this putative flippase complex of MON2, DOPEY1/2 and 
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ATP9A can associate with SNX3-retromer (Figure 3.7A), although whether this is a 
direct interaction or not will need further investigation.  
In vivo, RNAi of the C. elegans homologues of MON2, DOPEY1/2 and ATP9A (mon-2, 
pad-1 and tat-5 respectively) all cause a Wnt-secretion phenotype, phenocopying the 
RNAi of vps-35 (Figure 3.14B and Figure 3.15A-B). In my in vitro model of Wntless 
retrieval, the knock-down of MON2 or ATP9A phenocopy that of SNX3 or retromer in 
terms of the decrease in whole-cell levels of HA-Wntless (Figure 3.12A-B). However, 
DOPEY1/2 knock-down did not recapitulate this phenotype (Figure 3.12A-B). This 
suggests that in the human cell culture model, either the levels of suppression I 
achieved during siRNA-treatment were insufficient, the DOPEY proteins are not 
needed for Wntless retrieval, or that there is another factor in human cells that is 
redundant for these proteins. Performing a bioinformatic BLAST search on the SNX3 
interactome did not reveal any other homologous interactors to DOPEY1/2. In the 
mammalian context, the role of DOPEY1 and DOPEY2 is therefore unclear. There is 
some evidence in C. elegans that mon-2 and pad-1 may have some differing functions, 
with tat-5/pad-1 maintaining PE asymmetry at the cell surface, and tat-5/mon-2 
regulating endosomal trafficking (Beer et al., 2018). It is therefore possible that 
mammalian MON2 and DOPEY1/2 could have functions that relate together as well as 
separately in this pathway. 
It is interesting to note that in both yeast and humans, Mon2p and MON2 respectively, 
can associate with and influence the localisation of the GGA (Golgi-localising, γ-adaptin 
ear domain homology, ARF-binding protein) adaptors via the GGA VHS domain 
(Singer-Kruger et al., 2008). As GGA adaptors have previously been linked to 
endosomal cargo recycling (Zhao and Keen, 2008; Parachoniak et al., 2011; Ratcliffe 
et al., 2016; Toh et al., 2018), it is tempting to link this interaction to the clathrin 
decoration of SNX3-positive transport carriers enriched with Wntless (Harterink et al., 
2011). Future studies will need to investigate the importance of this connection for 
SNX3-retromer mediated cargo retrieval.  
The data I have presented here are consistent with a model (Figure 3.18) in which the 
tat-5/mon-2/pad-1 and MON2/ATP9A (the role of mammalian DOPEY1/2 remains 
unclear) complexes couple with SNX3-retromer to combine Wntless cargo enrichment 
with endosomal membrane deformation and initial membrane bending and carrier 
formation. Membrane deformation, induced via the ATPase-dependent flippase activity 
of ATP9A, causes the enrichment of phospholipids in the cytosolic leaflet of the 
endosomal membrane, increasing its surface area compared to the luminal leaflet, 
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inducing bending into the cytosol. The oligomeric properties of MON2/DOPEY have 
previously been proposed to promote and stabilise membrane deformation by forming 
a meshwork, concentrating the flippase action of ATP9A in a diffusion-restricted 
membrane microdomain (Barbosa et al., 2010). The alteration of the membrane 
properties through the concentration of specific phospholipids species such as 
phosphatidylethanolamine may also promote the recruitment of accessory proteins to 
support membrane deformation and initial membrane bending, promoting carrier 
formation. This is the case in S. cerevisiae, where endosomal recycling is supported by 
the Drs2p-mediated flipping of phosphatidylserine to recruit the ARFGAP Gcs1 (Xu et 
al., 2013) and in mammalian cells, where EHD1 is recruited to recycling endosomes by 
the flippase ATP8A1 (Lee et al., 2015). The interaction between MON2 and GGA 
adapters (Singer-Kruger et al., 2008) may also be required for the observed clathrin-
decoration of SNX3-positive vesicles (Harterink et al., 2011). Future studies will be 
required to test various aspects of this model.  
 
Figure 3.18 Working model of the coordination of SNX3-retromer with the 
MON2:DOPEY1/2:ATP9A complex. 
SNX3-retromer enriches cargoes such as Wntless on the endosomal membrane. In tandem, 
SNX3 can (directly or indirectly) couple to the MON2:DOPEY1/2:ATP9A complex. ATP9A 
causes the translocation of aminophospholipids, such as phosphatidylethanolamine, from the 
luminal leaflet to the cytosolic leaflet of the lipid bilayer, inducing initial membrane bending and 
the formation of cargo-enriched nascent carriers. SNX3-positive carriers are clathrin-decorated, 
possibly induced by the MON2 interaction with GGA adaptors.  
 
3.3.4 Phopholipid flippase activity of ATP9A 
The class II members of the P4 ATPase family include Neo1p in S. cerevisiae, tat-5 in 
C. elegans and ATP9A/B in H. sapiens. Neo1p and tat-5 are the only members of the 
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aminophospholipid translocase family to be essential for survival and cannot be 
compensated for by overexpression of others (Hua et al., 2002; Lyssenko et al., 2008). 
It has not been possible, due to technical issues, to biochemically reconstitute and 
conclusively show that Neo1p/tat-5/ATP9A/ATP9B flip lipids across a membrane 
(Takar et al., 2016). Whether or not flippase activity is reconstituted is a significant 
question. This is due to their activity being implicated in protein trafficking pathways, 
which may raise the question of whether the phenotypes exhibited are caused by 
perturbed trafficking of other proteins, such as an uncharacterised lipid transporter. The 
class II flippases are distinct from others in that they do not associate with a Cdc50 
family member (Saito et al., 2004; Takatsu et al., 2011), which are required for the 
flippase activity of other flippases such as Drs2p, (Lenoir et al., 2009). The purification 
of 10-pass transmembrane spanning proteins, with potentially critical (and undefined) 
accessory proteins, and the reconstitution of the lipid-flipping activity in 
proteoliposomes, is not trivial. 
Disruption of neo1p, tat-5 and ATP9A all lead to phenotypes indicative of their role in 
phospholipid flipping (Wehman et al., 2011; Ansari et al., 2015; Takar et al., 2016; 
Tanaka et al., 2016; Wu et al., 2016; Dalton et al., 2017; Beer et al., 2018). Their lipid 
substrate has not been conclusively shown, but their disruption leads to the cell surface 
exposure of phosphatidylethanolamine, making it the most likely candidate (Wehman et 
al., 2011; Takar et al., 2016; Wu et al., 2016; Beer et al., 2018). A mutation in Neo1p, 
Neo1p(D503N), which blocks the ATPase cycle at the E1 stage, fails to complement 
the neo1∆ yeast strain (Takar et al., 2016), showing that the ATPase activity and 
therefore its putative flippase activity, is required for S. cerevisiae viability. The drs2∆ (a 
proven flippase) yeast strain displays growth deficits, which can be suppressed through 
overexpression of Neo1p, but not through the overexpression of Neo1p(D503N); 
Neo1p overexpression also suppresses the loss of PE and PS asymmetry in drs2∆ 
cells (Takar et al., 2016). Further evidence has be seen in C. elegans, where 
catalytically inactive tat-5(E246Q) failed to rescue the tat-5 mutant embryonic lethality 
phenotype (Wehman et al., 2011) and tat-5(E246Q) overexpression led to a Wnt 
secretion defect (Figure 3.15D). These data are entirely consistent with Neo1p/tat-
5/ATP9A/B acting as flippases. However, it will be necessary for future studies to 
demonstrate the biochemical reconstitution of the flippase activity.  
























4.1.1 Mutations in the retromer complex are associated with Parkinsonism 
disorders 
Parkinson’s disease (PD) is the second most common neurodegenerative disorder. In 
males over 40, the incidence rate is 61.21 per 100,000 person-years; for females over 
40, the incidence rate is 37.55 per 100,000 person-years (Hirsch et al., 2016). The 
most recognised symptoms of PD are the motor dysfunctions, which include 
bradykinesia (slow movements), extrapyramidal rigidity (muscle stiffness), gait 
disturbance, postural instability (loss of balance) and tremors (Williams and Litvan, 
2013). Non-motor systems include: impaired olfaction; cardiovascular, gastrointestinal 
and urinary abnormalities; and sleep disorders (Ferrer et al., 2011). The predominant 
pathology of PD is the progressive degeneration of dopaminergic neurons in the 
substantia nigra pars compacta (SNpc) which contain protein aggregates called Lewy 
bodies, enriched with α-synuclein (Dickson, 2012). It is now recognised that 
Parkinson’s disease fits within a broader class of Parkinsonism disorders. Examples of 
other Parkinsonism disorders include: progressive supranuclear palsy, multiple system 
atrophy, and dementia with Parkinson’s disease (Williams and Litvan, 2013). 
PD is a multifactorial disease with a variety of risk factors including environmental and 
genetic, with age being the most dominant. The majority of cases are sporadic while 
<10% have a familial aetiology, where a specific disease-causing mutation is passed 
onto the next generation (Thomas and Beal, 2007). However, several PD disease-
causing mutations sporadically form in patients with no family history; this may be 
explained by incomplete penetrance, early death of relatives before symptoms develop 
or inaccurate medical records (Zhang et al., 2018). Proteins which are associated with 
familial PD highlight the molecular pathways involved in disease progression; these 
include: defects in autophagy, mitophagy, lysosomal health, synaptic transmission and 
endosomal recycling (Lin and Farrer, 2014). A greater understanding of rare familial 
mutations may assist in our understanding of disease pathogenesis.  
The retromer complex (composed of a VPS35:VPS26A/B:VPS29 heterotrimer) 
(Section 1.4.1), when dysfunctional, is implicated in several neurological diseases, 
including PD (Section 1.5.1). The mRNA levels of the retromer complex components 
VPS35 and VPS26 were reduced in samples of sporadic PD patients’ SNpc (MacLeod 
et al., 2013). However, it was originally implicated in familial PD when an autosomal 
dominant missense mutation in the retromer complex, VPS35(p.D620N), was identified 
in multiple family members in several ethnicities (Vilarino-Guell et al., 2011; Zimprich et 




al., 2011). More incidences of this mutation have been reported worldwide (Vilarino-
Guell et al., 2011; Zimprich et al., 2011; Ando et al., 2012; Kumar et al., 2012; Lesage 
et al., 2012; Sharma et al., 2012; Sheerin et al., 2012; Chen et al., 2017; McMillan et 
al., 2017; Bentley et al., 2018). It is currently thought to cause 1.3% of familial 
Parkinson’s disease cases and 0.3% of sporadic Parkinson’s disease, with symptoms 
similar to sporadic PD (Mohan and Mellick, 2017). Many other rarer mutations in the 
retromer complex have been identified to be associated with Parkinsonism disorders 
(Table 4.1), but most are yet to be characterised. 
Biochemically, the VPS35(p.D620N) variant does not affect the assembly of the 
retromer heterotrimer, but reduces association (by approximately 50%) with the WASH 
complex (McGough et al., 2014b; Zavodszky et al., 2014). Functionally, it has been 
reported to perturb CIMPR, ATG9 and LAMP2a trafficking, impacting lysosomal health, 
autophagy and chaperone-mediated autophagy (Follett et al., 2014; McGough et al., 
2014b; Zavodszky et al., 2014; Tang et al., 2015a). These trafficking deficits are 
thought to partly explain the increased α-synuclein aggregates reported in cells and 
animal models (Miura et al., 2014; Dhungel et al., 2015; Tang et al., 2015a; Tang et al., 
2015b).  
VPS35(p.D620N) has also been implicated in perturbed endosome-to-plasma 
membrane trafficking. VPS35(p.D620N) has been reported to cause defects in the cell 
surface localisation of GLUT1 (Zavodszky et al., 2014), dopamine receptor-D1 (Wang 
et al., 2016a), the dopamine transporter (Wu et al., 2017; Cataldi et al., 2018) and 
AMPA receptors (Munsie et al., 2014). Impaired trafficking of these proteins is thought 
to contribute to the perturbed dopaminergic neurotransmission in the striatum of 
VPS35(p.D620N) knock-in mice (Ishizu et al., 2016), and the impaired excitatory 
neurotransmission in rat cortical neurons (carrying the mutation) and induced 
pluripotent stem cells (from human p.D620N carriers) differentiated into dopaminergic 
neuronal-like cells (Munsie et al., 2014). Furthermore, VPS35(p.D620N) has been 
reported to impair the trafficking of the mitochondrial fission regulator DLP1 and 
increase mitochondrial fragmentation and dysfunction (Wang et al., 2016b).  
 















Frequency of 1.3% (familial 
PD) and 0.3% (sporadic PD) 
No 51.4 PD Various* (Mohan and Mellick, 2017) 
L774M 2 Yes 62 PD (Sharma et al., 2012) 
M607V 1 No 76 PD (Verstraeten et al., 2012) 
H599R 1 No 54 PD (Verstraeten et al., 2012) 
I560T 1 Yes 68 PD (Verstraeten et al., 2012) 
R524W 1 No 37 PD (Zimprich et al., 2011) 
P316S 2 Yes 53 PD (Vilarino-Guell et al., 2011; Nuytemans et al., 2013) 
I241M 1 No 72 PD (Zimprich et al., 2011) 
M57I 1 No 62 PD (Zimprich et al., 2011) 
G51S 2 Yes 60.5 DPD/PD (Sharma et al., 2012; Gustavsson et al., 2015) 
R32S 1 No Unknown PD (Bandres-Ciga et al., 2016) 
VPS26A K297X 1 No 70 PDP (Gustavsson et al., 2015) 
M112V 1 No 51 PSP (Gustavsson et al., 2015) 
K93E 2 No 57 MSA/PD (Shannon et al., 2014; Gustavsson et al., 2015) 
R127H 1 Yes 70 DPD (Gustavsson et al., 2015) 
N308D 1 Yes 73 PSP (Gustavsson et al., 2015) 
VPS29 N72H 1 Yes 70 PD (Shannon et al., 2014) 
 
Table 4.1 Mutations in the retromer complex linked to Parkinsonism disorders 
AA= amino acid; AAO= age-at-onset; PD= Parkinson’s disease; DPD = dementia with Parkinson’s disease; PSP= progressive supranuclear palsy; MSA= 
multiple system atrophy. *(Vilarino-Guell et al., 2011; Zimprich et al., 2011; Ando et al., 2012; Kumar et al., 2012; Lesage et al., 2012; Sharma et al., 2012; 
Sheerin et al., 2012; Chen et al., 2017; McMillan et al., 2017; Bentley et al., 2018). Table adapted from (McMillan et al., 2017). 





In this chapter, I sought to characterise several other Parkinsonism-associated 
retromer complex mutations. I focused on several mutations in VPS26A 
[VPS26A(p.K93E), VPS26A(p.M112V) and VPS26A(p.K297X)] and mutations in the 
amino-terminus of VPS35 [VPS35(p.R32S) and VPS35(p.G51S)]. To this end, I 
analysed the retromer variants’ localisation, ability to assemble into the retromer 
heterotrimer and whether the mutations impacted the interactome of retromer.  






4.2.1 Initial bioinformatic analysis of the VPS26A Parkinsonism-linked 
mutations 
Genome Wide Association Studies (GWAS) have identified several Parkinsonism-
linked mutations in the retromer subunit VPS26A (Gustavsson et al., 2015). Among 
them are VPS26A(p.K93E), VPS26A(p.M112V) and VPS26A(p.K297X) (‘X’ denotes a 
premature stop codon) (Gustavsson et al., 2015). To identify the conservation across 
species of the residues linked with the Parkinsonism disorders, I performed a sequence 
alignment of various homologues of human VPS26A and its paralogue VPS26B 
(Figure 4.1). The K93 residue is largely conserved through the compared species – the 
biggest divergence identified was in C. elegans, where the lysine residue has diverged 
into the similar basic amino acid, arginine (Figure 4.1). The M112 residue is not well 
conserved through evolution, or within the VPS26 human paralogues (Figure 4.1). The 
K297 residue is completely conserved between the aligned VPS26A homologues and 
VPS26B; however, some of the residues following the K297 residue, which are all lost 
in the K297X truncation, are not well conserved (Figure 4.1).   
VPS26A has an arrestin-like fold – antiparallel β-strands forming paired β-sandwich 
subdomains – which binds to the β-hairpin in the SNX27 PDZ domain (Gallon et al., 
2014a). To gain structural insight into the Parkinsonism-linked mutations, I analysed 
their location on the 3-dimentional VPS26A structure using the coordinates of the 
VPS26A:SNX27 crystal structure (Gallon et al., 2014a) (Figure 4.2). The K93 and 
M112 residues of VPS26A are both exposed in a similar region of VPS26A, on one of 
the β-sandwich subdomains (Figure 4.2). These are in close proximity to the SNX27 
binding site, but no direct contacts are formed (Gallon et al., 2014a). The residues 
following K297 are on the opposite β-sandwich subdomains, again in proximity to, but 
not directly interacting with SNX27 (Figure 4.2).  
 









Figure 4.1 Bioinformatic alignment of VPS26 homologues and human 
paralogues. 
Sequences of H. sapiens, M. musculus, D. melanogaster and C. elegans VPS26 homologues 
were aligned using ESPript 3.0 online software (Robert and Gouet, 2014). Secondary structural 
information was modelled in using the VPS26A crystal structure as a reference (Gallon et al., 
2014). The Parkinsonism-associated mutations (K93E, M112V and K297X) are indicated with 
blue arrows. 
 
Figure 4.2 Model showing the location of the Parkinsonism-associated VPS26A 
mutations.  
Modelling the VPS26A residues which have been associated with Parkinsonism-linked 
disorders (K93E, M112V and K297X) onto the structure of SNX27 bound to VPS26A (Gallon et 
al., 2014). VPS26A (blue), SNX27 (green). Modelling was performed using UCSF Chimera 
software. 
 
Figure 4.3 Lentivirally transduced GFP-VPS26A constructs are expressed at near 
endogenous levels. 
RPE-1 cells, lentivirally transduced with the indicated GFP-VPS26A construct, were lysed. The 
lysates were resolved using SDS-PAGE and immuno-blotted for the indicated antibodies. 




4.2.2 Creation of stably expressing GFP-VPS26A RPE-1 cell lines 
To experimentally investigate the VPS26A Parkinsonism-associated mutations, I used 
site directed mutagenesis to introduce the ‘K93E’, ‘M112V’ and ‘K297X’ mutations into 
GFP-VPS26A XLG3 lentiviral constructs, which I then packaged into lentivirus. 
Lentiviral-mediated transduction of RPE-1 cells allowed the expression of the GFP-
VPS26A variants at similar whole-cell protein levels compared to the endogenous 
VPS26A (Figure 4.3). When the GFP-VPS26A variants were expressed, the whole-cell 
levels of endogenous VPS26A (at 37kDa on the immunoblot) were reduced (Figure 
4.3), presumably due to the outcompeting of the endogenous VPS26A for assembly 
into the stable retromer complex, causing the proteasomal-mediated degradation of the 
unbound VPS26 subunit. I created a number of cell lines which stably expressed GFP-
VPS26A, GFP-VPS26A(p.K93E), GFP-VPS26A(p.M112V) and GFP-
VPS26A(p.K297X), all at similar levels of expression with little endogenous VPS26A 
remaining in the cells (Figure 4.3). When immunoblotting for the GFP-
VPS26A(p.K297X), there was no band when blotting against VPS26A as the epitope of 
the monoclonal anti-VPS26A antibody is at the C-terminus of VPS26A, which is lost in 
this truncation (Figure 4.3). I therefore used anti-GFP primary antibodies to visualise 
GFP-VPS26A(p.K297X) (Figure 4.3). GFP-VPS26A(p.K297X) also has a lower 
molecular weight compared to GFP-VPS26A wild-type due to the truncation mutation 
(Figure 4.3).  
 
4.2.3 The VPS26A variants retain the ability to form the retromer complex 
I then tested the GFP-VPS26A variants for their ability to localise to retromer-positive 
endosomes. All the GFP-VPS26A variants had a similar punctate localisation positive 
for VPS35 (Figure 4.4A). Colocalisation analysis between the variants of GFP-
VPS26A with endogenous VPS35 revealed no significant differences in the Pearson’s 
colocalisation coefficient (PCC) or Overlap Coefficient (OC) (Figure 4.4B). This is 
consistent with the Parkinsonism-linked variants retaining the ability to localise to 
endosomes and form the retromer complex. To extend this biochemically, Dr Kirsty 
McMillan transfected HEK293T cells with the various GFP-VPS26A variants and 
performed a GFP-trap immunoprecipitation experiment (Figure 4.5A). No significant 
differences were found between the ability of the wild-type GFP-VPS26A and the 
Parkinsonism-linked GFP-VPS26A variants to associate with the other retromer 
components (Figure 4.5B). Therefore, neither K93E, M112V or K297X mutations in 
VPS26A perturb retromer complex assembly.  









Figure 4.4 The Parkinsonism-associated VPS26A mutations do not affect 
colocalisation with VPS35. 
(A) RPE-1 cells, stably expressing the indicated GFP-VPS26A constructs, were fixed with 4% 
paraformaldehyde, stained for endogenous VPS35 and imaged on a confocal microscope. 
Scale bar indicates 11 µm. (B) Graph showing the quantified Pearson’s colocalisation 
coefficient (PCC) and Overlap coefficient (OC) from 3 independent experiments (at least 25 
cells were quantified per experiment). Error bars indicate standard error; data were analysed 
using a one-way ANOVA and a Dunnett’s post-hoc test comparing the mutant constructs to the 
wild-type VPS26A-GFP construct. 
 
 
Figure 4.5 The VPS26A Parkinsonism-associated mutations do not perturb 
assembly of the retromer complex. 
(A) HEK293T cells were transfected with the indicated GFP-VPS26A construct before 
subjecting the cells to a GFP-trap. The immuno-precipitates were then resolved using SDS-
PAGE and immunoblotted using the indicated antibodies. (B) Quantification of the VPS26A 
constructs’ relative biding to VPS35 and VPS29 from at least 3 independent experiments; error 
bars indicate s.e.m. Florescent bands were quantified using a Licor Odyssey scanner. 
Significance was determined through a one-way ANOVA followed by a Dunnett’s post-hoc test. 
Data collected by Dr Kirsty McMillan. 













Figure 4.6 The VPS26A Parkinsonism-associated mutations do not change the 
localisation of the GFP-VPS26A constructs in relation to early or late 
endosomes. 
RPE-1 cells, stably transduced with the indicated GFP-VPS26A constructs, were fixed with 4% 
paraformaldehyde and immuno-stained for endogenous (A) LAMP1 and (C) LAMP1. Cells were 
imaged on a confocal microscope. The scale bar indicates 11 µm. (B and D) Quantification of 
the pearson’s colocalisation coefficient (PCC) and the overlap coefficient (OC) over 3 
independent experiments, with at least 25 cells quantified per experiment. Error bars indicate 
standard error. Significance was determined using a one-way ANOVA followed by a post-hoc 
Dunnett’s test, comparing the mutant constructs to wild-type VPS26A-GFP. 
 
4.2.4 The Parkinsonism-linked mutations do not perturb GFP-VPS26A 
localisation with the WASH complex, EEA1 or LAMP1 
I then sought to analyse the localisation of the GFP-VPS26A variants with further 
endosomal markers. The stably transduced RPE-1 GFP-VPS26A lines were fixed and 
stained with the late endosomal/lysosomal marker, LAMP1 (Figure 4.6A) and the early 
endosomal marker, EEA1 (Figure 4.6C). No significant differences in colocalisation 
were detected within the GFP-VPS26A variants and LAMP1 (Figure 4.6 B) or EEA1 
(Figure 4.6D). I also analysed the colocalisation of the GFP-VPS26A variants with a 
known interactor of the retromer complex: FAM21 (Figure 4.7A); no significant 
differences within the GFP-VPS26A variants and endogenous FAM21 were detected 
(Figure 4.7B).  
 
4.2.5 SILAC-based proteomics reveal changes in the interactome of 
VPS26A(p.K297X) 
As the assembly and localisation of the retromer complex were not perturbed in the 
GFP-tagged VPS26A variants, I sought to use unbiased proteomics to determine 
whether the K93E, M112V or K297X mutations affect the interactome of VPS26A. In 
collaboration with Dr Kirsty McMillan, I used GFP-trap immunoprecipitation coupled 
with quantitative stable isotope labelling with amino acids in cell culture (SILAC)-based 
proteomics to directly compare the interactome of the wild-type and mutant GFP-
VPS26A variants. I took advantage of the RPE-1 lines which were lentivirally 
transduced with near endogenous levels of GFP-VPS26A (Figure 4.3). The RPE-1 line 
stably expressing GFP-VPS26A wild-type was grown in lysine- and arginine-deficient 
SILAC media, supplemented with ‘light’ isotopes of lysine and arginine (K0, R0). The 
GFP-VPS26A(p.K93E), GFP-VPS26A(p.M112V) or GFP-VPS26A(p.K297X) RPE-1 
lines were supplemented with ‘medium’ isotopes of arginine and lysine (K4, R6). 
Following 8 doublings in the respective SILAC media (to ensure sufficient incorporation  





Figure 4.7 The VPS26A Parkinsonism-associated mutations do not change the 
localisation of the GFP-VPS26A constructs in relation to the retromer-interacting 
FAM21. 




RPE-1 cells, stably transduced with the indicated GFP-VPS26A constructs, were fixed with 4% 
paraformaldehyde and immuno-stained for endogenous (A) FAM21. Cells were imaged on a 
confocal microscope. The scale bar indicates 9 µm (B) Quantification of the pearson’s 
colocalisation coefficient (PCC) and the overlap coefficient (OC) over 3 independent 
experiments, with at least 25 cells quantified per experiment. Error bars indicate standard error. 
Significance was determined using a one-way ANOVA followed by a post-hoc Dunnett’s test, 
comparing the mutant constructs to wild-type VPS26A-GFP. 
 
of the new amino acids) the cells were lysed and immunoprecipitated using GFP-trap 
nanobeads. In each experiment, i.e. GFP-VPS26A(wild-type) vs GFP-
VPS26A(mutant), the beads were combined and resolved using SDS-PAGE before 
being subjected to liquid chromatography-tandem mass spectrometry (LC-MS/MS) 
identification. Three independent experiments were performed for each of the 
mutations.  
 
Figure 4.8 SILAC-based proteomics reveals the interactome of the Parkinsonism-
linked GFP-VPS26A constructs  
RPE-1 cells stably expressing GFP-only, wild-type GFP-VPS26 and Parkinsonism-linked GFP-
VPS26A were grown in SILAC medium supplemented with light (R0 K0), medium (R6 K4) 
heavy (R10 K8) amino acids respectively for 8 doublings. The cells were then lysed and 
subjected to GFP-trap. The co-immunoprecipitated proteins were resolved using SDS-PAGE 
and identified using mass spectrometry. The relative enrichment of co-immunoprecipitated 
proteins of the Parkinsonism-linked VPS26A constructs compared to wild-type VPS26A is 
indicated in the graph. Data is an average of 3 independent experiments and collected in 
collaboration with Dr Kirsty McMillan.    
 




There were no drastic changes in the interactome of the GFP-VPS26A compared to 
the VPS26A(p.K93E) or VPS26A(p.M112V) (Figure 4.8). However, there were several 
changes in the interactome of VPS26A compared to VPS26A(p.K297X). Most 
strikingly, the K297X truncation caused a 100-fold loss in binding with SNX27 (Figure 
4.8). There was also an 8-fold increase in DENND4C binding and an 11-fold increase 
in PKD2 binding (Figure 4.8). The mass spectrometry data indicated that 
VPS26A(p.K297X) had an enhanced binding to ABTB2, ALDH3A2 and TUBβ4B; 
however, immunoprecipitation experiments failed to validate their interactions with 
VPS26A(p.K297X) (Dr Kirsty McMillan, unpublished).  
 
Figure 4.9 The VPS26A(p.K297X) mutation abrogates binding to SNX27 and 
enhances binding to DENND4C and PKD2.  
(A-B) HEK293T cells were transfected with the indicated GFP-VPS26A construct and subjected 
to a GFP trap experiment. The immuno-precipitates were then resolved using SDS-PAGE and 
immuno-blotted with the indicated antibodies. (C) Relative binding of the VPS26A constructs 




compared to wild-type VPS26A. The intensities of the fluorescent bands were quantified using a 
Licor Odyssey scanner over 3 independent experiments. Error bars indicate standard error; 
data analysed using a one-way ANOVA followed by a Dunnett’s post hoc test; * P ≤ 0.05; ** P ≤ 
0.01. Data in this figure was collected by Dr Kirsty McMillan and Dr Frances Tilley.  
 
Dr Kirsty McMillan confirmed that the introduction of ‘K297X’ perturbed SNX27 
association through GFP-trap immunoprecipitations of the GFP-VPS26A constructs 
(Figure 4.9A and Figure 4.9C). The gain of DENND4C and PKD2 associations were 
confirmed by Dr Frances Tilley, also through a GFP-trap immunoprecipitation (Figure 
4.9B and Figure 4.9C).  
 
 




Figure 4.10 The binding of VPS26A(p.K297X) is severely perturbed SNX27.  
(A) Recombinantly expressed GST-SNX27 PDZ domain and His-tagged human VPS26A 
constructs were purified via the GST-tag. The purified proteins were resolved on an SDS-PAGE 
and detected by Coomassie staining (top) or Western blotting using anti-His antibody (bottom). 
(B) Isothermal Titration Calorimetry (ITC) was used to calculate the binding affinity of the Kir3.3 
peptide to the SNX27-binding domain alone, or in the presence of wild-type or mutant VPS26A 
(green). The raw data is shown at the top and the integrated and normalised data is shown at 
the bottom. (C) Table of the binding affinities of the Kir3.3 peptide (PPESESKV) to the SNX27 
PDZ domain alone, or in the presence of VPS26A constructs. (D) Structural modelling of 
VPS26A (gold ribbon) complexed to SNX27 (blue ribbon) from Gallon et al., 2014. The 
Parkinsonism-associated mutations are indicated, as is the site of the Kir3.3 (yellow sticks) 
interaction (modelled based on the SNX27-Kir3.3 structure from Balana et al., 2011). Data in 
this figure was collected by Dr Thomas Clairefeuille. 
 
The severe reduction of association between VPS26A(p.K297X) and SNX27 was 
further confirmed by Dr Thomas Clairefeuille through direct binding assays. The 
VPS26A variants were purified from E. coli and incubated with GST-tagged SNX27 
PDZ domain. Immunoprecipitating the GST-SNX27 PDZ could pull-down VPS26A, 
VPS26A(p.K93E) and VPS26A(p.M112V) but not VPS26A(p.K297X) (Figure 4.10A). 
Dr Thomas Clairefeuille then used isothermal titration calorimetry to measure the 
binding affinity of the tail of the SNX27-dependent cargo, Kir3.3 (including its PDZ 
ligand) (Balana et al., 2011), to the SNX27 PDZ domain. On its own, the SNX27 PDZ 
domain has a low affinity for Kir3.3 (a Kd of 15 ± 2 µM) (Figure 4.10B-C). When 
VPS26, VPS26A(p.K93E) or VPS26A(p.M112V) was added with the SNX27 PDZ 
domain, the formation of SNX27-retromer allosterically increased its affinity for Kir3.3 
(Kds of 0.84 ± 0.05 µM, 1.05 ± 0.01 µM and 1.21 ± 0.01 µM respectively) (Figure 
4.10B-C). However, when VPS26A(p.K297X) was added with the SNX27 PDZ domain, 
the affinity was not enhanced (a Kd of 21 ± 5 µM) (Figure 4.10B-C). Therefore, 
VPS26A(p.K297X) fails to form the SNX27-retromer and the allosteric enhancement of 
Kir3.3 affinity did not occur. 
 
4.2.6 VPS26A(p.K297X) fails to retrieve the SNX27-depedent cargo, 
GLUT1, away from lysosomal degradation 
Having established that the VPS26A K297X mutation perturbs SNX27 binding and the 
formation of the SNX27-retromer, Dr Kirsty McMillan examined the trafficking of the 
well-characterised SNX27-dependent cargo, GLUT1 (Steinberg et al., 2013b). The 
steady-state localisation of GLUT1 is at the cell surface; RNAi against VPS26A and 
VPS26B in HeLa cells caused GLUT1 to be rerouted to the lysosomes and colocalise 
with LAMP1 (Gallon et al., 2014a) (Figure 4.11A). When siRNA-resistant GFP-
VPS26A  





Figure 4.11 VPS26A(p.K297X) missorts the SNX27-dependent cargo GLUT1. 




(A) RPE-1 cells transfected with GFP were suppressed with non-targeting or VPS26A and 
VPS26B siRNA. Cells were fixed using 4% paraformaldehyde and immuno-stained for 
endogenous LAMP1 and GLUT1. The cells were imaged on a confocal microscope. The scale 
bar indicates 10 μm. (B) RPE-1 cells, suppressed for VPS26A and VPS26B, stably expressing 
the indicated siRNA-resistant VPS26A-GFP constructs, were fixed with 4% paraformaldehyde. 
The cells were then immuno-stained with LAMP1 and GLUT1. The scale bar indicates 10 μm. 
(C) The Pearson’s colocalisation coefficient and Overlap coefficient were quantified over 3 
independent experiments. Error bars indicated standard error and data were analysed using a 
one-way ANOVA followed by a Dunnett’s post hoc test; * P ≤ 0.05; ** P ≤ 0.01. Data from this 
figure was collected by Dr Kirsty McMillan. 
 
was transfected into the HeLa cells under VPS26A/B suppression, GLUT1 retained its 
localisation at the cell surface, as did transfection of siRNA-resistant GFP-
VPS26A(p.K93E) or GFP-VPS26A(p.M112V) (Figure 4.11B-C). However, when Dr 
Kirsty McMillan transfected GFP-VPS26A(p.K297X), GLUT1 colocalised with the late 
endosomal/lysosomal marker LAMP1 (Figure 4.11B-C). 
 
 
Figure 4.12 Bioinformatic alignment of VPS35 homologues, highlighting the N-
terminal Parkinson’s disease associated mutations. 
Sequence alignment of the first 60 amino acids of VPS35 between H. sapiens, M. musculus, D. 
melanogaster, C. elegans and S. cerevisiae homologues. The positions of the R32S and G51S 
Parkinsonism-linked mutations are highlighted in blue.   
 
4.2.7 Initial bioinformatic analysis of the VPS35 N-terminal Parkinsonism-
linked mutations 
VPS35 is the most commonly mutated protein in the retromer complex associated with 
Parkinsonism disorders (McMillan et al., 2017). The most common mutation in the 
retromer complex is VPS35(p.D620N) (McMillan et al., 2017). There have also been 
several other, much rarer mutations in VPS35, which have not been proven to be 
causative. Two mutations, clustering around the N-terminus of VPS35, have been 
linked to Parkinsonism disorders: VPS35(p.R32S) and VPS35(p.G51S). This region of 
VPS35 is known to bind to VPS26, SNX3 and Rab7 (Shi et al., 2006; Rojas et al., 
2008; Harrison et al., 2014a). To determine the degree of conservation of these 
residues across species, I aligned various VPS35 homologues (Figure 4.12). R32 is 




highly conserved in all species compared except D. melanogaster and G51 is 
conserved except for in C. elegans and S. cerevisiae (Figure 4.12). 
 
Figure 4.13 The VPS35-GFP construct is more endosomal compared to the GFP-
VPS35 construct.  
(A) RPE-1 cells were lentivirally transduced with the indicated GFP-tagged VPS35 construct. 
The cells were lysed, the lysate resolved by SDS-PAGE and immunoblotted for the indicated 
antibodies. (B) RPE-1 cells, transduced with VPS35-GFP or GFP-VPS35, were fixed using 4% 
paraformaldehyde and immuno-stained with EEA1. The cells were imaged on a confocal 
microscope. The scale bars indicate 11 µm. 
 
4.2.8 Generation of C-terminal VPS35-GFP construct 
Since the Parkinsonism linked mutations VPS35(p.R32S) and VPS35(p.G51S) are 
located at the N-terminus of VPS35, I created a C-terminal VPS35-GFP construct. To 




compare the newly created VPS35-GFP chimera to GFP-VPS35, I cloned both 
constructs into XLG3 lentiviral vectors, packaged them into lentivirus and transduced 
RPE-1 cells. This resulted in stable RPE-1 lines which expressed either GFP-VPS35 or 
VPS35-GFP, both at similar levels and near to the endogenous level of expression 
(Figure 4.13A). As seen in the transduction of GFP-VPS26A (Figure 4.3), expressing 
GFP-tagged VPS35 caused the whole cell levels of the endogenous protein to 
decrease (Figure 4.13A). Immunofluorescence analysis of the GFP-VPS35 and 
VPS35-GFP stable RPE-1 lines revealed that the GFP-VPS35 chimera had a more 
cytosolic localisation compared to the VPS35-GFP chimera (Figure 4.13B).  
 
Figure 4.14 The C-terminal GFP tag enhances binding to the WASH complex and 
does not perturb retromer complex assembly.  
(A) HEK293T cells were transfected with the indicated GFP-tagged construct and subjected to a 
GFP-trap. The immuno-precipitates were resolved using SDS-PAGE and immuno-blotted using 
the indicated antibodies. (B) Quantification of the relative binding between VPS35-GFP and the 
indicated proteins relative to the binding of GFP-VPS35. Quantification is representative of 3 
experiments; significance was determined using a student’s t-test; error bars indicate s.e.m.; * P 
≤ 0.05. 
 




I then compared the ability of the two VPS35 chimeras to assemble into the retromer 
complex and to bind to known retromer interactors (Figure 4.14A). Importantly, the 
retromer complex could still form (Figure 4.14). Surprisingly, there was a trend towards 
increased WASH1 association and a significant increase in FAM21 association in the 
C-terminally tagged VPS35 construct compared to the N-terminally tagged VPS35 
construct (Figure 4.14). There was also a significant increase in association with 
Ankrd50 (Figure 4.14), a WASH complex-associated protein (McGough et al., 2014a). 
As the C-terminus of VPS35 has been implicated in WASH-complex binding (Helfer et 
al., 2013) (see also Chapter 5), it is unlikely that the N-terminal GFP tag was occluding 
association with the WASH complex. I would speculate that it is the increase in 
endosomal association of the C-terminally tagged VPS35 construct that is causing the 
increased binding to the WASH complex components.  
The interactome of GFP-VPS35 has been elucidated (McGough et al., 2014a), but 
GFP-tagging on one end of a protein can occlude some protein interactors (McNally et 
al., 2017). I therefore used SILAC-based proteomics coupled to a GFP-trap immuno-
precipitation to generate the VPS35-GFP interactome to explore whether any other 
interactors could be identified. The VPS35-GFP interactome is shown in Table 4.2 and 
Figure 4.15. Most of the GFP-VPS35 interactors: the other retromer components, 
WASH complex components, VARP, SDCCA3, TBC1D5, and polycystin-2, were 
identified in the VPS35-GFP interactome. In addition, other interactors were identified 
such as Aven [an inhibitor of caspase activation (Chau et al., 2000)] and LMO7 [a 
protein which contains PDZ, LIM and Calponin Homology domains and localises and 
contributes to the integrity of adherens junctions (te Velthuis and Bagowski, 2007)] . 
However, as suitable antibodies could not be validated I could not confirm these 
interactions through GFP-trap immunoprecipitations. 
GFP-VPS35 interactors that are missing in the VPS35-GFP interactome are identified 
in Table 4.3. Notable validated retromer interactors that are absent in the VPS35-GFP 
interactome include: Ankrd50, FKBP15 and DNAJC15 (McGough et al., 2014a). The 
proteasome proteins in the GFP-VPS35 interactome were originally thought to be an 
artefact of the overexpression of GFP-VPS35; I may have avoided this by using a near 
endogenous level of VPS35-GFP expression (Figure 4.13A). Using a near 
endogenous level of expression may have masked some lower affinity interactions, as 
the binding between VPS35-GFP and Ankrd50 has been validated through 
overexpression of VPS35-GFP in HEK293T cells coupled to a GFP-trap (Figure 4.14).





















A0A024R2H0 TBC1 domain family,  
member 5, isoform CRA 711.34 52.90 1.00 43.00 239.00 323.79 
Q96NW4 Ankyrin repeat domain- 
containing protein 27 (VARP) 192.15 42.24 32 32 73 265.33 
H7C331 Serologically defined  
colon cancer antigen 3 6.47 17.67 2.50 2.50 2.50 210.95 
Q9UBQ0 VPS29 270.79 66.76 1.50 14.00 113.00 203.93 
Q92609 TBC1 domain family  
member 5  726.68 52.90 1.00 43.00 243.00 176.24 
Q53FR4 Vacuolar protein sorting 35  
variant  1698.14 53.52 14.00 50.50 602.00 164.12 
J3KP06 LIM domain only protein 7 37.18 8.96 11.50 12.50 17.00 162.28 
Q4G0F5 VPS26B 406.84 56.25 20.00 23.00 151.00 161.72 
B0QYK0 RNA-binding protein EWS 42.12 11.00 3.50 4.00 10.00 140.20 
Q9NQS1 Cell death regulator Aven  23.22 19.48 4.50 4.50 8.00 136.38 
Q5HYM2 VPS35 1474.94 55.19 2.50 39.00 496.50 117.73 
O75436 VPS26A 1063.87 75.08 9.50 29.50 361.00 97.69 
Q9Y4E1 WASH complex subunit  
FAM21C 287.95 30.13 3.00 34.50 100.50 78.31 
K7EIY1 FAM32A 6.85 32.98 3.00 3.00 3.50 74.59 
F8VXU5 VPS29 278.10 54.67 1.00 13.50 117.00 69.60 
C4AMC7 WASH1 88.84 27.11 3.50 11.00 29.50 62.82 
Q12768 Strumpellin 336.61 44.87 51.00 51.00 131.50 51.99 
Q13563 Polycystin-2 120.24 23.66 19.50 19.50 46.50 41.92 
A6H8X9 Centrosomal protein  
170kDa 8.15 2.85 3.50 3.50 4.00 38.78 
Q641Q2 FAM21A 308.13 32.75 6.00 35.00 103.50 29.84 
B4DI81 Gap junction protein 33.10 25.07 5.50 5.50 10.00 28.43 
A9QQ22 Actin nucleation promoting  
factor  104.81 28.42 2.00 9.50 33.50 27.12 




Q8NDH0 WD repeat-containing  
protein 6 12.01 8.50 5.00 5.00 6.00 19.25 
I6L9E8 Family with sequence  
similarity  
98, member A 35.93 17.47 5.50 7.00 11.00 18.32 
Q59H57 Fusion (Involved in t(12;16)  
in malignant liposarcoma)  
isoform a variant 125.59 31.84 6.50 10.50 49.50 17.19 
B7ZKT9 KIAA1033 protein 209.91 26.92 31.50 32.00 89.50 15.31 
O75190 DnaJ homolog subfamily B  
member 6 17.73 13.26 3.50 3.50 8.50 13.41 
F5GWI9 CCDC53 24.75 24.31 3.50 3.50 7.50 12.04 
R4GN98 Protein S100 35.62 35.89 6.50 6.50 23.00 11.65 
Q8ND56 Protein LSM14 homolog A  1.78 3.89 2.00 2.00 3.00 10.45 
Q14011 Cold-inducible RNA- 
binding protein 22.22 20.93 3.00 3.00 8.50 10.12 
Q5VW36 Focadhesin 69.67 12.05 14.50 21.00 32.00 9.19 
D9ZGF5 Fibroblast growth factor 20.40 26.13 4.50 4.50 9.50 8.62 
A0A0U1RQH7 RNA-binding protein 39 26.22 26.13 5.00 5.00 11.50 6.71 
 
Table 4.2 VPS35-GFP interactome  
Highlighted in green are proteins in the retromer complex; in yellow are proteins in the WASH complex; in blue are other known retromer complex interactors.  
AA= amino acid; PSMs= peptide-to-spectrum matches (the total number of identified peptide sequences). 






Acetolactate synthase-like protein [ILVBL_HUMAN] 
Proteasome (Prosome, macropain) 26S subunit, non-ATPase, 12, isoform CRA_c 
[A6NP15_HUMAN] 
Uncharacterized protein [F5H0J6_HUMAN] 
CDP-diacylglycerol--inositol 3-phosphatidyltransferase [CDIPT_HUMAN] 
DnaJ homolog subfamily C member 13 [DJC13_HUMAN] 
Proteasome subunit alpha type-2 [PSA2_HUMAN] 
Proteasome subunit alpha type-4 [PSA4_HUMAN] 
26S protease regulatory subunit 6B [PRS6B_HUMAN] 
Fatty aldehyde dehydrogenase OS=Homo sapiens [AL3A2_HUMAN] 
Uncharacterized protein [Q05DG7_HUMAN] 
FK506-binding protein 15 [FKB15_HUMAN] 
Ankyrin repeat domain-containing protein 13A [AN13A_HUMAN] 
26S proteasome non-ATPase regulatory subunit 1 [PSMD1_HUMAN] 
Ankyrin repeat domain-containing protein 50 [ANR50_HUMAN] 
Table 4.3 GFP-VPS35 interactome members not present in VPS35-GFP interactome 
 
Figure 4.15 SILAC-based proteomics reveal the VPS35-GFP interactome.  
STRING Analysis of the VPS35-GFP interactome, identifying connections between interactors in the 
dataset. RPE-1 cells, stably expressing GFP-only or VPS35-GFP, were grown in SILAC media 
supplemented with light (R0 K0) or medium (R6 K4) amino acids respectively, for 8 doublings. The 




cells were then subjected to GFP-trap and the immuno-precipitates resolved using SDS-PAGE. The 
co-immunoprecipitated proteins were then identified using mass spectrometry. 
 
4.2.9 The Parkinsonism-linked VPS35 mutations do not perturb retromer 
complex association  
Having validated VPS35-GFP transduced cells as an appropriate model to investigate the N-
terminal Parkinsonism-linked mutations, I undertook site-directed mutagenesis to introduce 
the R32S and G51S mutations. VPS26 binds to the N-terminus of VPS35 (Shi et al., 2006). I 
firstly tested whether the R32S or G51S mutations perturbed retromer complex assembly. I 
transfected HEK293T cells with the VPS35-GFP variants and performed a GFP-trap 
immunoprecipitation (Figure 4.16A). There were no significant differences in the 
VPS35(p.R32S)-GFP and VPS35(p.G51S)-GFP variants’ abilities to bind to VPS26 or 
VPS29 compared to VPS35-GFP (Figure 4.16B).   
 
Figure 4.16 The Parkinsonism-linked VPS35(p.R32S) and VPS35(p.G51S) do not 
perturb retromer complex assembly.  
(A) HEK293T cells were transfected with the indicated GFP-tagged construct and subjected to GFP-
trap. The immuno-precipitates were resolved using SDS-PAGE and immuno-blotted for the indicated 
antibodies. (B) Quantification of the florescent bands, normalised to wild-type VPS35-GFP, using the 
Licor Odyssey Scanner from 3 independent experiments. Error bars indicate standard error. Data 
were analysed using a one-way ANOVA followed by a Dunnett’s post-hoc test.   
 





Figure 4.17 Creation of stably transduced VPS35-GFP lines in VPS35 knockout HeLa 
cells.  
VPS35 knockout HeLa cells, obtained from Dr Florian Steinberg, were lentivirally transduced with 
titres (250µl or 500µl) of the indicated VPS35-GFP constructs. The cells were then lysed, the lysate 
resolved using SDS-PAGE, and immuno-stained for the indicated antibodies. 
 
4.2.10 The Parkinsonism-linked VPS35 mutations do not perturb VPS35 
localisation 
Having gained access to CRISPR-Cas9 gene-edited VPS35 knockout HeLa cells from Dr 
Florian Steinberg, I transduced VPS35-GFP, VPS35(p.R32S)-GFP and VPS35(p.G51S)-
GFP to near endogenous levels (Figure 4.17). Like the siRNA-mediated knockdown of 
VPS35, knockout of VPS35 destabilises the entire retromer complex, causing the whole cell 
levels of VPS26 and VPS29 to decrease (McNally et al., 2017). When I transduced the 
VPS35 knockout cells with VPS35-GFP, the whole-cell levels of the retromer component 
VPS26 also increased (Figure 4.17). Transducing the VPS35 knockout cells with VPS35-
GFP allowed me to examine the localisation of the VPS35-GFP constructs without 
overexpression or an endogenous VPS35 background. Immunofluorescence analysis 
revealed no differences between the VPS35-GFP variants in their colocalisation with: SNX1 




(Figure 4.18A-B); the early endosomal marker, EEA1 (Figure 4.19A and C); the late 
endosomal marker, LAMP1 (Figure 4.19B and C); or FAM21 (Figure 4.20A-B). 
Furthermore, all the VPS35-GFP variants could rescue the localisation of FAM21 when 
reintroduced into the VPS35 knockout cells (Figure 4.20 and C).  
 
Figure 4.18 N-terminal VPS35 Parkinsonism-associated mutations do not perturb 
endosomal association.  
(A) VPS35 knockout HeLa cells, transduced with VPS35-GFP constructs, were fixed with 4% 
paraformaldehyde and immuno-stained with endogenous SNX1. Cells were imaged using a confocal 
microscope. The scale bar indicates 19 µm. (B) Graphs showing the quantified Pearson’s 
colocalisation coefficient (PCC) and Overlap coefficient (OC) from 3 independent experiments (at 
least 25 cells were quantified per experiment). Error bars indicate standard error; data were analysed 




using a one-way ANOVA and a Dunnett’s post-hoc test comparing the mutant constructs to the wild 
type VPS35-GFP construct.   
 
Figure 4.19 N-terminal VPS35 Parkinsonism-associated mutant constructs do not 
have altered early or late endosome localisation. 
VPS35 knockout HeLa cells, transduced with VPS35-GFP constructs, were fixed with 4% 
paraformaldehyde and immuno-stained with endogenous (A) EEA1 or (B ) LAMP1. Cells were 




imaged using a confocal microscope. The scale bar indicates 19 µm. (C) Graphs showing the 
quantified Pearson’s colocalisation coefficient (PCC) and Overlap coefficient (OC) from 3 independent 
experiments (at least 25 cells were quantified per experiment). Error bars indicate standard error; data 
were analysed using a one-way ANOVA and a Dunnett’s post-hoc test comparing the mutant 
constructs to the wild type VPS35-GFP construct.   
 
 




Figure 4.20 Parkinsonism-linked VPS35(p.R32S) and VPS35(p.G51S) rescue the 
localisation of FAM21 in VPS35 knockout HeLa cells. 
(A) VPS35 knockout cells, stably expressing VPS35-GFP constructs from lentiviral transduction, were 
fixed with 4% paraformaldehyde and stained for endogenous FAM21 and SNX1. Cells were imaged 
using a confocal microscope. The scale bar indicates 19 µm. (B) Quantification, from 3 experiments 
with at least 20 cells per experiment, of Pearson’s co-localisation coefficient (PCC) and overlap 
coefficient (OC). Data were analysed using one-way ANOVA followed by a Dunnett’s test, comparing 
the rescue experiments to the VPS35 knockout values; ** P ≤ 0.01; **** P ≤ 0.0001. 
 
4.2.11 The Parkinsonism-linked VPS35 mutations do not perturb the ability of 
VPS35 to bind to candidate proteins 
I then tested the VPS35(p.R32S)-GFP and VPS35(p.G51S)-GFP variants for their ability to 
bind to known VPS35 interactors. I transiently transfected HEK293T cells with the VPS35-
GFP variants and performed a GFP-trap immunoprecipitation experiment (Figure 4.21A). 
No difference in binding to SNX27, Ankrd50, FAM21, strumpellin or WASH1 were identified 
between the VPS35-GFP variants (Figure 4.21B).  
 
 
Figure 4.21 The Parkinsonism-linked VPS35(p.R32S) and VPS35(p.G51S) do not impair 
association with the WASH complex or SNX27.  




(A) HEK293T cells were transfected with the indicated GFP-tagged constructs and subjected to a 
GFP-trap. The immuno-precipitates were resolved using SDS-PAGE and immuno-blotted for the 
indicated antibodies. (B) Quantification of the florescent bands, normalised to wild-type VPS35-GFP, 
using the Licor Odyssey Scanner from 3 independent experiments. Error bars indicate standard error. 
Data were analysed using a one-way ANOVA followed by a post-hoc Dunnett’s test. 
 
 
Figure 4.22 The Parkinsonism-linked VPS35(p.R32S) has a mild impairment in its 
ability to associate with SNX3.  
HEK293T cells were transduced with lentivirus to stably express GFP-only or a VPS35-GFP 
construct. The HEK293T cells were then transiently transfected with constitutively active mcherry-
Rab7(p.Q67L) (A) or mcherry-SNX3 (C) and subjected to an RFP-trap. The immuno-precipitates were 




then resolved using SDS-PAGE and immunoblotted for the indicated antibodies. (B and D) 
Quantification of the relative amounts of immuno-precipitated VPS35-GFP constructs compared to 
wild-type VPS35-GFP from 3 independent experiments. Florescent bands were quantified using a 
Licor Odyssey Scanner; data were analysed through a one-way ANOVA followed by a post-hoc 
Dunnett’s test. Error bars indicate standard error; **p=≤0.01. 
 
As the N-terminal region of VPS35 is known to bind to SNX3 and Rab7 (Rojas et al., 2008; 
Harrison et al., 2014a), I then wished to test for association between those proteins and the 
Parkinsonism-linked VPS35 constructs. However, a GFP-trap of GFP-VPS35 or VPS35-GFP 
did not pull-down endogenous SNX3 or endogenous Rab7 (Figure 4.14). Previous studies 
have only shown the SNX3:VPS35 and the Rab7:VPS35 interaction through pulling down 
SNX3 or Rab7 (not from the opposite direction) (Rojas et al., 2008; Seaman et al., 2009; 
Balderhaar et al., 2010; Harrison et al., 2014a). I therefore transduced HEK293T cells with 
GFP, VPS35-GFP, VPS35(p.R32S)-GFP and VPS35(p.G51S)-GFP. Next, I transfected the 
stable HEK293T lines with mcherry-Rab7(p.Q67L), a constitutively-active Rab7 construct 
(Figure 4.22A), lysed the cells and then performed an RFP-trap immunoprecipitation. There 
was not a significant difference in the co-immunoprecipitation of VPS35-GFP compared to 
VPS35(p.R32S)-GFP or VPS35(p.G51S)-GFP (Figure 4.22B). I also transfected the stable 
HEK293T cells with mcherry-SNX3 (Figure 4.22C), lysed the cells and then performed an 
RFP-trap immunoprecipitation. There was no difference in the co-immunoprecipitation of 
VPS35-GFP compared to VPS35(p.G51S)-GFP. However, there was a small, yet significant, 
decrease in the amount of VPS35(p.R32S)-GFP immunoprecipitated (Figure 4.22D). 
 
4.2.12 Tandem-mass tagging (TMT)-based proteomic analysis reveals no 
significant differences between the interactomes of VPS35-GFP compared to 
VPS35(p.R32S)-GFP or VPS35(p.G51S)-GFP 
To more thoroughly investigate whether the G51S or R32S mutations affect the interactome 
of VPS35, I used an unbiased approach through tandem-mass tagging proteomics coupled 
to a GFP-trap immunoprecipitation. I took advantage of the near-endogenously expressed 
VPS35-GFP variants which had been transduced through lentiviral transduction in the 
VPS35 knockout HeLa cell lines (Figure 4.17). 
Once grown to confluency in a 15cm cell culture dish, I lysed the cells and performed GFP-
trap immunoprecipitations. Dr Kate Heesom then digested the samples with trypsin and 
labelled them with Tandem Mass Tag ten plex reagents before pooling them. After 
preparation, the samples were fractionated into 5 fractions before nano-LC MS/MS analysis. 
The different labels added to the samples enabled the different peptides between conditions 




to be distinguished on the mass spectrometer (Figure 4.23A). 
 
Figure 4.23 Proteomic analysis using tandem mass tag spectrometry reveals slight 
changes in the interactome of the Parkinsonism-linked VPS35(p.R32S) and 
VPS35(p.G51S) mutations.  
VPS35 knockout HeLa cells, stably expressing wild-type VPS35-GFP, and VPS35(p.R32S)-GFP (A) 
or VPS35(p.G51S)-GFP (B) were subjected to a GFP-trap. The immuno-precipitates were then 
subjected to a GFP-trap experiment. The co-immunoprecipitated proteins were then labelled with 
tandem-mass tags, resolved using SDS-PAGE and identified using mass spectrometry. Data 
indicates two independent experiments. An abundance ratio of less than 1 indicates a loss of 
interaction. An abundance ratio of more than one indicates a gain of interaction. Data were filtered by 
excluding proteins with an interaction loss of less than 20% and excluding proteins with an interaction 
gain of less than 1.5-fold. Proteins averaging only 1 detected peptide were also excluded. 




To determine to extent to which my TMT analysis worked, I examined whether the proteins 
identified in the SILAC-generated VPS35-GFP interactome were present (Table 4.4). Many 
of the validated interactors identified through my SILAC-based analysis were also picked up 
in the TMT experiment, such as TBC1D5, other retromer complex components, VARP and 
some WASH complex components. TMT proteomics is less sensitive than SILAC which 
could explain why not all WASH complex components were detected. It should also be noted 
that the SILAC-based interactome analysis of VPS35-GFP was done in RPE-1 cells whereas 
the TMT analysis was done in the VPS35 knockout HeLa cells. This could explain some 
differences.  
Table 4.5 show the differences in the interactome between the VPS35-GFP and the 
VPS35(p.R32S)-GFP interactome and Table 4.6 shows the differences in the VPS35-GFP 
and VPS35(p.G51S)-GFP interactome. 
 
Name of VPS35-GFP interactor identified 









TBC1 domain family, member 5, isoform CRA 100 100 
Ankyrin repeat domain-containing protein 27  100 74.721 
Serologically defined colon cancer antigen 3 N.D. N.D. 
VPS29 100 100 
TBC1 domain family member 5  100 100 
LIM domain only protein 7 22.423 N.D. 
VPS26B 100 83.688 
RNA-binding protein EWS 10.795 11.812 
Cell death regulator Aven  N.D. N.D. 
VPS35 100 100 
VPS26A 100 100 
WASH complex subunit FAM21C 66.721 35.065 
FAM32A N.D. N.D. 
VPS29 100 100 
WASH1 N.D. N.D. 
strumpellin N.D. N.D. 
Polycystin-2 N.D. N.D. 
Centrosomal protein 170kDa N.D. N.D. 
FAM21A N.D. N.D. 
Gap junction protein N.D. N.D. 
Actin nucleation promoting factor  N.D. 23.827 
WD repeat-containing protein 61 13.684 13.653 
Family with sequence similarity 98, member A N.D. N.D. 




Fusion (Involved in t(12;16) in malignant 
liposarcoma) isoform a variant N.D. N.D. 
KIAA1033 protein 44.174 14.203 
DnaJ homolog subfamily B member 6 N.D. N.D. 
CCDC53 N.D. 12.85 
Protein S100 16.347 7.362 
Protein LSM14 homolog A  9.052 N.D. 
Cold-inducible RNA-binding protein N.D. N.D. 
Focadhesin N.D. N.D. 
Fibroblast growth factor N.D. N.D. 
RNA-binding protein 39 14.994 12.07 
 
Table 4.4 Comparison of VPS35-GFP interactors identified through SILAC-based 
proteomics compared to two runs of TMT-based proteomics 
Highlighted in green are retromer complex subunits and in yellow WASH complex subunits. ‘N.D.’ 
indicates ‘not detected’. SILAC (stable isotope labelling with amino acids in cell culture). TMT (tandem 
mass tagging). 
 
4.2.13 VPS35-GFP, VPS35(p.R32S)-GFP and VPS35(p.G51S)-GFP transduction 
rescues lysosomal GLUT1 degradation  
Lastly, I tested whether the constructs could rescue the localisation of GLUT1 when re-
expressed into VPS35 knockout HeLa cells. Indeed, when transduced at near endogenous 
levels (Figure 4.17), the colocalisation between GLUT1 and LAMP1 was dramatically 
reduced when VPS35-GFP, VPS35(p.R32S)-GFP or VPS35(p.G51S)-GFP were expressed 
(Figure 4.24). This indicates that the Parkinson’s disease linked VPS35 variants do not 
perturb retromer-mediated endosome-to-plasma membrane trafficking.  
























Histone H4 OS=Homo sapiens 
GN=HIST1H4A PE=1 SV=2 51.45631 6 33 6 103 5.9455 
Q5VXV3 
SET OS=Homo sapiens GN=SET 
PE=2 SV=1 29.13793 7 9 3.5 290 6.0805 
A0A0U1RRH7 
Histone H2A OS=Homo sapiens 
GN=HIST1H3D PE=3 SV=1 35.29412 5 10.5 2 170 5.041 
Q76LA1 
CSTB protein OS=Homo sapiens 
GN=CSTB PE=2 SV=1 55.10204 4.5 11 4.5 98 3.9075 
Q8N257 
Histone H2B type 3-B OS=Homo 
sapiens GN=HIST3H2BB PE=1 SV=3 45.63492 7 19.5 2 126 3.1355 
Q13011 
Delta(3,5)-Delta(2,4)-dienoyl-CoA 
isomerase, mitochondrial OS=Homo 
sapiens GN=ECH1  
PE=1 SV=2 17.68293 5 5.5 5 328 2.843 
P0C0S5 
Histone H2A.Z OS=Homo sapiens 
GN=H2AFZ PE=1 SV=2 25.78125 3.5 7 1.5 128 2.5465 
P38159 
RNA-binding motif protein, X 
chromosome OS=Homo sapiens 
GN=RBMX PE=1 SV=3 7.800512 4 4.5 4 391 2.3365 
P22626 
Heterogeneous nuclear 
ribonucleoproteins A2/B1  
OS=Homo sapiens GN=HNRNPA2B1 
PE=1 SV=2 45.46742 14 21.5 12 353 2.314 
P68431 
Histone H3.1 OS=Homo sapiens 
GN=HIST1H3A PE=1 SV=2 29.77941 5.5 13.5 1 136 2.309 
E7EMB3 
Calmodulin-2 OS=Homo sapiens 
GN=CALM2 PE=1 SV=1 29.84694 5 6.5 5 196 2.145 
Q8N1N4 
Keratin, type II cytoskeletal 78 
OS=Homo sapiens GN=KRT78 PE=1 
SV=2 10.48077 6.5 12.5 3 520 2.1615 





Malate dehydrogenase OS=Homo 
sapiens GN=MDH2  
PE=2 SV=1 37.42604 11 16.5 11 338 2.1325 
A0A024RBB5 
Cysteine and glycine-rich protein 2, 
isoform CRA_a OS=Homo sapiens 
GN=CSRP2 PE=4 SV=1 67.87565 12 44.5 12 193 0.683 
P35080 
Profilin-2 OS=Homo sapiens GN=PFN2 
PE=1 SV=3 32.14286 4 7.5 2 140 0.666 
P35659 
Protein DEK OS=Homo sapiens 
GN=DEK PE=1 SV=1 4.533333 1.5 1.5 1.5 375 0.4375 
 
Table 4.5 Changes in the VPS35(p.R32S)-GFP interactome compared to VPS35-GFP interactome 




















Histone H2A OS=Homo sapiens  
GN=HIST1H3D PE=3 SV=1 24.35294 5 10.5 2 170 4.4465 
P05089 
Arginase-1 OS=Homo sapiens  
GN=ARG1 PE=1 SV=2 5.745342 1.5 2 1.5 322 2.083 
C9JRZ6 
MICOS complex subunit  
OS=Homo sapiens GN=CHCHD3 
PE=1 SV=1 8.11722 2 2 2 236.5 0.723 
P35659 
Protein DEK OS=Homo sapiens  
GN=DEK PE=1 SV=1 4.533333 1.5 1.5 1.5 375 0.3395 
 
Table 4.6 Changes in the VPS35(p.G51S)-GFP interactome compared to VPS35-GFP interactome 
AA= amino acid; PSMs= peptide-to-spectrum matches (the total number of identified peptide sequences). 





Figure 4.24 Parkinsonism-linked VPS35(p.R32S) and VPS35(p.G51S) rescue the 
localisation of GLUT1 in VPS35 knockout HeLa cells. 
(A) VPS35 knockout cells, stably expressing VPS35-GFP constructs from lentiviral transduction, 
were fixed with 4% paraformaldehyde and stained for endogenous GLUT1 and LAMP1. Cells 
were imaged using a confocal microscope. The scale bar indicates 19 µm. (B) Quantification, 
from 3 experiments with at least 20 cells per experiment, of Pearson’s co-localisation coefficient 
(PCC) and overlap coefficient (OC). Data were analysed using one-way ANOVA followed by a 
Dunnett’s test, comparing the rescue experiments to the VPS35 knockout values; **** P ≤ 
0.0001.  






4.3.1 The VPS26A(p.K297X) truncation mutation uncouples SNX27 from 
the retromer complex 
Proteomic and bioinformatic studies have identified hundreds of potential SNX27-
retromer dependent cargoes which are dependent on SNX27-retromer for their 
endosomal sorting away from lysosomal degradation and have appropriate PDZ 
binding motifs for their association with SNX27 (Steinberg et al., 2013b; Clairfeuille et 
al., 2016). SNX27 is highly expressed in the brain (Kajii et al., 2003) and many 
neuronal receptors, such as NMDA (Wang et al., 2013) and AMPA receptors (Hussain 
et al., 2014; Loo et al., 2014), the β2-adrenergic receptor (Temkin et al., 2011) and 5-
hydroxytryptamine type 4 receptors (Joubert et al., 2004), rely on SNX27-retromer for 
their cell-surface localisation. Homozygous loss of SNX27 in children leads to 
myoclonic epilepsy, defects in psychomotor development and death within 2 years of 
birth (Damseh et al., 2015) and the SNX27 knock-out mice display growth retardation, 
behaviour deficits and die within 4 weeks of birth (Cai et al., 2011). SNX27 dysfunction 
is also associated with Down’s syndrome, where the overexpression of miR-155 
negatively regulates the expression of SNX27 (Wang et al., 2013).  
Cell culture-based experiments where a variant of SNX27 is used which cannot 
associate with the retromer complex display GLUT1 sorting defects (Gallon et al., 
2014a) which are phenocopied in the context of VPS26A(p.K297X) (Figure 4.11). 
Given the fairly drastic neurodevelopmental and childhood-onset symptoms in relation 
to the homozygous loss of SNX27 in mice and human children (Cai et al., 2011; 
Damseh et al., 2015), it might be thought that a patient harbouring this mutation would 
have developed symptoms sooner than an age of onset of 70 years old (Gustavsson et 
al., 2015). One explanation is the difference between a knock-out of SNX27 and a 
failure in SNX27-retromer complex assembly. SNX27 may have retromer-independent 
functions. Furthermore, the VPS26A(p.K297X) mutation was heterozygous –  the 
patient had two wild-type copies of VPS26B and one wild-type copy of VPS26A. 
VPS26A is ubiquitously expressed, while VPS26B is more highly enriched in neuronal 
cells (Bugarcic et al., 2011). When knocked-out in mice, VPS26A is embryonic lethal, 
while VPS26B knockouts are viable (Kim et al., 2010), but there is little to distinguish 
the interactomes between VPS26A and VPS26B (McMillan et al., 2016). There is likely 
to be a large degree of redundancy between the two VPS26 paralogues.  




The K297 and the subsequent residues on VPS26A may stabilise the linker region 
between the two β-sandwich domains of VPS26A, which forms direct contacts to the 
SNX27 PDZ domain (Gallon et al., 2014a). It is possible that the K297X truncation 
destabilises this linker region which perturbs SNX27 association. Since a truncated 
form, lacking residues 301-327 of VPS26A, was used in the Gallon et al., (2014) crystal 
structure, it is also possible that the C-terminal residues may play a greater role, which 
has been masked by the artificial environment in the crystal structure, in SNX27 
binding in vivo. This investigation of the K297X truncation mutation has enhanced our 
understanding of how structurally, the C-terminus of VPS26A plays a scaffolding role 
not only in the recruitment of SNX27, but in the binding of DENND4C and PKD2.  
The data presented here has focused on the severe reduction in association between 
VPS26A(p.K297X) and SNX27. However, VPS26A(p.K297X) also has an enhanced 
binding to PKD2 and DENND4C (Figure 4.9B). PKD2 is a calcium-activated calcium 
channel (Koulen et al., 2002) which is associated with autosomal dominant polycystic 
kidney disease (Rossetti et al., 2007) and DENND4C is a guanine nucleotide exchange 
factor for Rab10 (Yoshimura et al., 2010). DENND4C and PKD2 were identified in the 
retromer interactome, but the functional significance of these interactors (in terms of 
regulating retromer function) is yet to be fully understood (McMillan et al., 2016; Tilley 
et al., 2018). 
The retromer complex’s interaction with DENND4C has not been shown to be direct 
but it is thought to directly interact with the amino-terminus of PKD2 (Feng et al., 2017; 
Tilley et al., 2018). Whether SNX27 and PKD2 compete for a similar binding site in 
VPS26A was investigated in Tilley et al. (2018). GFP-traps of VPS26A variants were 
performed under SNX27-suppressed conditions: this did not enhance the ability of 
VPS26A to immunoprecipitate PKD2 (Tilley et al., 2018). It is possible that 
VPS26A(p.K297X) causes structural changes in the architecture of the retromer 
complex which enhances PKD2 and DENND4C binding, independently of its effect on 
SNX27 binding. 
 
4.3.2 Investigations of the other Parkinsonism-linked retromer mutations 
The VPS26A(p.K93E) and VPS26A(p.M112V) variants of VPS26A have not proved to 
dramatically alter interactions with other proteins (Figure 4.8). They also do not affect 
the endosome-to-plasma membrane sorting of GLUT1 (Figure 4.11) or the endosome-
to-TGN sorting of CIMPR (personal communication from Dr Kirsty McMillan). It is 
possible that the K93E and M112V residues may cause effects on retromer function 




that have not been investigated here. All three of these Parkinsonism-linked variants 
are extremely rare and have not been shown to be causally linked to disease, but have 
also not been found in healthy control databases (Gustavsson et al., 2015; McMillan et 
al., 2017). It is possible that the K93E and M112V mutations are not actually causing 
Parkinsonism disorders.  
Co-expression of the VPS35-GFP variants and mCherry-SNX3 coupled with a GFP-
trap revealed that introducing the R32S mutation in VPS35 causes a slight reduction in 
association with SNX3 (Figure 4.22C-D). This reduction was not repeated in the 
interactome analysis (Figure 4.23A), although SNX3 was not identified as an interactor 
in the GFP-VPS35 (McGough et al., 2014a) or VPS35-GFP interactomes (Table 4.2). 
When highlighting the R32 and G51 residues of VPS35 on the Lucas et al., (2016) 
structure (Figure 4.25), it is unclear why the R32S mutation may subtly affect SNX3’s 
association with the retromer complex. It is possible that the loss of the basic arginine 
residue may cause a subtle structural reconfiguration of VPS35 which slightly impairs 
the interaction with SNX3.  
 
Figure 5.25 The VPS35 ARG32 and GLY51 residues are not in close proximity to 
the SNX3-retromer binding site 
Model of the VPS35 (N-terminal) (red): VPS26A (blue): SNX3 (green): DMT1-II binding motif 
(magenta) crystal structure (Lucas et al., 2016). The VPS35 ARG32 and GLY51 residues are 
coloured in yellow and highlighted.  
 
The same caveats discussed in relation to the VPS26A mutations also apply to the 
R32S and G51S VPS35 mutations – they are extremely rare mutations which have not 
been proven to be causative. The VPS35(p.R32S) mutation has not been found in 
healthy controls but the VPS35(p.G51S) mutation subsequently has (Sharma et al., 
2012; Gustavsson et al., 2015; Bandres-Ciga et al., 2016; McMillan et al., 2017). 
Therefore, it is likely that the VPS35(p.G51S) variant is not causative of the 




Parkinsonism symptoms but the case for VPS35(p.R32S) remains equivocal. Future 
studies may look at: possible post-translational functions of the affected residues (such 
as the ubiquitination of VPS26A LYS93 residue); the trafficking other retromer-
dependent cargoes; cargo trafficking kinetics; and whether the Parkinsonism-linked 
retromer variants affect lysosomal health and α-synuclein degradation. 

















FAM21 binds to areas of basic charge on the 
carboxyl-terminus of VPS35 
  




5.1.1 The WASH complex binds to retromer through a series of acidic 
motifs in FAM21 
The WASH complex is an endosome-localised actin nucleation-promoting factor which 
promotes the polymerisation of branched networks through activating the Arp2/3 
complex (Derivery et al., 2009; Gomez and Billadeau, 2009; Jia et al., 2010) (Section 
1.4.5). The WASH complex is a heteropentameric complex composed of: WASH1, 
FAM21, Strumpellin, CCDC53 and SWIP. A major factor in its endosomal targeting is 
the association of FAM21 to the retromer complex (Harbour et al., 2012; Jia et al., 
2012; McNally et al., 2017). However, even in VPS35 knockout cells, there is a minority 
proportion of FAM21 which, through an unknown mechanism retains an endosomal 
localisation (McNally et al., 2017).  
Little structural information concerning FAM21 is available, but the first 220 amino 
acids are predicted to form a globular ‘head’ domain and the proceeding ∼1100 amino 
acids (the ‘tail’) are predicted to be unstructured and flexible (Derivery et al., 2009). The 
retromer:FAM21 interaction is mediated by a series of 21 acidic L-F-[D/E]3-10-L-F (so-
called LFa) motifs in the FAM21 tail (Jia et al., 2012). The mechanism by which these 
LFa motifs couple to retromer is unknown, but the interaction requires the carboxyl-
terminal half of VPS35 (Helfer et al., 2013).  
As described in (Section 1.4.5), depletion of the WASH complex gives rise to several 
phenotypes, including a ‘collapse’ of the endosomal network, cargo trafficking defects 
and aberrant tubulation. The extent to which the retromer:WASH complex interaction is 
required for the normal functions of the WASH complex has not been determined. It is 
thought that the FAM21 tail can bind to multiple retromer complexes, which may 
promote the recruitment of the WASH complex to areas in which a high concentration 
of cargo is being retrieved, thereby coordinating cargo recognition with the 
polymerisation of branched actin (Harbour et al., 2012; Jia et al., 2012). Branched 
actin-polymerisation has also been proposed to contribute to the segregation of 
retrieval and degradative endosomal subdomains (Derivery et al., 2012; Cullen and 
Steinberg, 2018). 
 




In this chapter, I sought to build upon the observation that acidic LFa motifs in the 
FAM21 tail mediate the retromer:WASH complex interaction. With the hypothesis that 
the FAM21:VPS35 interaction is mediated by electrostatic forces, I used bioinformatic-
based analyses combined to a biochemical mutagenesis screen to identify 
evolutionary-conserved basic residues on VPS35 which are required for the interaction. 
Depletion of WASH complex components lead to pleiomorphic phenotypes (Section 
1.4.5). The model behind the significance of the retromer:WASH complex interaction 
requires further experimental evidence and the extent to which this interaction is 
required for the normal functions of these complexes remains unclear. I therefore 
introduced the VPS35 mutants with perturbed WASH complex association into cells to 
explore the functional consequence of uncoupling this interaction.  
 
  




5.2.1 Bioinformatic search to identify candidate residues in VPS35 that 
may mediate its interaction with FAM21 
The extended and unstructured ‘tail’ of the FAM21 subunit of the WASH complex 
mediates its interaction with the retromer complex (Figure 5.1). This is considered to 
occur via the C-terminus of VPS35 (Helfer et al., 2013) through a series of acidic LFa 
motifs in the FAM21 ‘tail’ (Jia et al., 2012). To identify candidate residues in VPS35 
which may mediate this interaction, I aligned VPS35 homologues from species which 
contain the WASH complex (H. sapiens, M. musculus, D. melanogaster and C. 
elegans) with S. cerevisiae, which does not express the WASH complex. This identified 
basic (arginine and lysine) residues which have been evolutionary maintained in 
species with the WASH complex but not in S. cerevisiae (Figure 5.2). There were also 
several basic residues which were highly evolutionary conserved, even in S. cerevisiae 
(Figure 5.2). Due to the discovery of the LFa repeat in the FAM21 tail (Jia et al., 2012), 
I hypothesised that a major factor in the nature of the interaction will be electrostatic 
binding.  
 
Figure 5.1 FAM21 binds to VPS35 through its extended carboxyl-terminus.  
HEK293T cells were transiently transfected with the indicated GFP-tagged constructs and 
subjected to a GFP-trap. The immuno-precipitates were resolved using SDS-PAGE and 
immuno-blotted with the indicated antibodies. The globular ‘head’ of FAM21 is considered the 
first 220 amino acids; the unstructured tail is the remaining ∼1100 amino acids. 




Figure 5.2 Bioinformatic analysis to identify candidate residues in VPS35 which 
may be important for FAM21 association. 
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Sequence alignment of the VPS35 homologues (starting at residue 467 of H. sapiens VPS35) 
whose species contain the WASH complex (H. sapiens, M. musculus, D. melanogaster and C. 
elegans) and S. cerevisiae (which does not have the WASH complex in its genome). Basic 
residues which are largely conserved in species containing the WASH complex, but not 
conserved in S. cerevisiae are highlighted by a blue arrow. Basic residues largely conserved the 
WASH complex-containing species and S. cerevisiae are highlighted by a green arrow.  
 
To identify whether the basic residues highlighted in the bioinformatic sequence 
alignment may form a surface by which FAM21 could associate, I highlighted all the 
basic residues on VPS35 from the VPS35:VPS29 crystal structure (Hierro et al., 2007). 
Two patches of basic residues, located on two HEAT-repeat domains of VPS35, 
became apparent (Figure 5.3A).   
 
Figure 5.3 The C-terminal half of VPS35 contain two patches enriched in basic 
residues.  
(A) Model of the crystal structure (Hierro et al., 2007) of C-terminal VPS35 (red) bound to 
VPS29 (green). All basic VPS35 residues are coloured in blue. The D620 residue is coloured in 
yellow. (B) model of the crystal structure of C-terminal VPS35 (red) bound to VPS29 (green). 
Residues mutated in VPS35-GFP constructs are coloured in cyan.  
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5.2.2 Immunoprecipitation screen to identify VPS35 mutations which 
perturb FAM21 binding 
From the bioinformatic analysis, I identified candidate basic residues in VPS35 which 
may be important for FAM21 association. Two ‘areas’ had been identified when 
modelling all of the basic residues in the VPS35:VPS29 crystal structure (Hierro et al., 
2007) (Figure 5.3A). The first area contained basic residues that are not conserved in 
yeast. The second area contained basic residues that were conserved in yeast. I 
therefore introduced various point mutations in the VPS35-GFP construct: either 
human to yeast mutations, or charge swap mutations when the basic residues were 
conserved in the VPS35 S. cerevisiae homologue (Table 5.1 and Figure 5.3B).  
I then used a GFP-trap experiment to test the ability of the VPS35-GFP variants to 
immuno-precipitate FAM21. From investigating the first ‘area’ in VPS35 (Figure 5.4A), 
I identified several mutations which perturbed FAM21 binding (Figure 5.4B-C). 
Importantly, these mutations did not cause a failure in retromer complex assembly 
(Figure 5.4B-C). From investigating the second ‘area’ in VPS35 (Figure 5.5A), I 
identified several mutations which also perturbed, but less severely than those 
identified in the first area, FAM21 binding (Figure 5.5B). Again, the mutations did not 
cause a failure in retromer complex assembly (Figure 5.5C). From these data, I have 
identified several residues in VPS35 that, when mutated, cause a significant reduction 
in FAM21 association (Figure 5.6). Importantly, the VPS35(p.D620N) Parkinson’s 
disease-linked mutation displays approximately 50% loss in FAM21 binding (Figure 5.4 
and Figure 5.5), confirming previously published work (McGough et al., 2014b; 
Zavodszky et al., 2014).  
VPS35-GFP variants 
D620N K515S K552H K559Q 
K573N R650E K659E K663E 
K694E R695E K701E K705E 
K552H, K555N, K556L K555N, K556L, K559Q 
Table 5.1 VPS35-GFP variants created through site-directed mutagenesis 
 
To extend my biochemical examination of the VPS35 mutations, I used 
immunofluorescence analysis to verify that the retromer complex was being uncoupled 
from the WASH complex. To avoid compensation from endogenous VPS35, I 
lentivirally transduced VPS35 knockout HeLa cells to create stable cell lines which  




Figure 5.4 Screen of VPS35-GFP variants reveal residues important for FAM21 
binding (area 1).  
(A) Model identifying the mutants (highlighted in blue) created in VPS35 (B) HEK293T cells 
were transfected with the indicated VPS35-GFP constructs and subjected to a GFP-trap. The 
immuno-precipitates were resolved by SDS-PAGE and immuno-blotted for the indicated 
antibodies. (C) The florescent bands were quantified using a Licor Odyssey Scanner; 
quantification shown represents the mean of 3 experiments ± s.e.m; * P ≤ 0.05; ** P ≤ 0.01; ***P 
≤ 0.001; **** P ≤ 0.0001. Immuno-precipitated bands were normalised to wild-type VPS35-GFP 
and analysed using a one-way ANOVA followed by a Dunnett’s test.  




Figure 5.5 Screen of VPS35-GFP variants reveal residues important for FAM21 
binding (area 2).  
(A) (B) HEK293T cells were transfected with the indicated VPS35-GFP constructs and 
subjected to a GFP-trap. The immuno-precipitates were resolved by SDS-PAGE and immuno-
blotted for the indicated antibodies. (C) The florescent bands were quantified using a Licor 
Odyssey Scanner; quantification shown represents the mean of 3 experiments ± s.e.m; * P ≤ 
0.05; ** P ≤ 0.01; ***P ≤ 0.001; **** P ≤ 0.0001. Immuno-precipitated bands were normalised to 
wild-type VPS35-GFP and analysed using a one-way ANOVA followed by a Dunnett’s test.  
 
expressed endogenous levels of VPS35-GFP variants (Figure 5.7). In VPS35 knockout 
cells, FAM21 has a reduced endosomal localisation (McNally et al., 2017). When wild-
type VPS35-GFP was transduced into the VPS35 knock-out cells, the endosomal 
population of FAM21 was markedly increased; however, this rescue was repeated for 
all the VPS35-GFP variants tested (Figure 5.8A). I measured the degree of rescue by 
Chapter 5: FAM21 binds to areas of basic charge on the carboxyl-terminus of VPS35 
154 
 
comparing the colocalisation between FAM21 and the endosomal marker SNX1 
(Figure 5.8B). This suggests that even though I could not biochemically identify an 
interaction between FAM21 and retromer in the verified mutants (Figure 5.4 and 
Figure 5.5), FAM21 could still be recruited to endosomes by the VPS35-GFP variants.  
 
Figure 5.6 Model of residues in VPS35 that are implicated in FAM21 association.  
Model of the C-terminal VPS35 (red) bound to VPS29 (green) crystal structure (Hierro et al., 
2007). Residues that, when mutated, significantly perturb FAM21 binding are coloured in yellow. 
 
 
Figure 5.7 Lentiviral transduction of VPS35-GFP constructs into VPS35 knockout 
HeLa cells.  
Various titres of lentivirus (250µl, 500µl and 1000µl) were added to transduce VPS35 knockout 
HeLa cells; the lysates were resolved using SDS-PAGE and subjected to immuno-blotting using 
the indicated antibodies.  




Figure 5.8 VPS35-GFP constructs with severely perturbed FAM21 association 
rescue the endosomal localisation of FAM21. 
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(A) VPS35 knockout HeLa cells, transduced with the indicated VPS35-GFP constructs, were 
fixed with 4% paraformaldehyde and immuno-stained with endogenous FAM21 and SNX1. 
Cells were imaged using a confocal microscope. The scale bar indicates 19 µm. (B) Graphs 
showing the quantified Pearson’s colocalisation coefficient (PCC) and Overlap coefficient (OC) 
from 3 independent experiments (at least 25 cells were quantified per experiment). Error bars 
indicate standard error; data were analysed using a one-way ANOVA and a Dunnett’s post-hoc 
test comparing the mutant constructs to the wild type VPS35-GFP construct. ** P ≤ 0.01; ***; P 




Figure 5.9 The VPS35(p.K555E, K556E, K559E)-GFP variant loses affinity for the 
WASH complex but retains the ability to assemble into the retromer complex.  
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(A and C) HEK293T cells were transfected with the indicated GFP-tag construct and subjected 
to a GFP-trap. The immuno-precipitates were resolved using SDS-PAGE and immuno-blotted 
with the indicated antibodies. (B and D) The florescent bands were quantified using a Licor 
Odyssey Scanner; quantification shown represents 3 experiments. Immuno-precipitated bands 
were normalised to wild-type VPS35-GFP and analysed using a one-way ANOVA followed by a 
Dunnett’s test; ** P ≤ 0.01; *** P ≤ 0.001; **** P ≤ 0.0001. 
 
5.2.3 Introduction of VPS35(p.K555E, K556E, K559E)-GFP causes a loss in 
endosomal WASH complex association 
Unpublished results from the Cullen lab have identified that electrostatic interactions 
can require charge inversions to fully uncouple two interactions in cells and to see a 
functional phenotype. Considering this, I created, via site-directed mutagenesis, a 
VPS35(p.K555E, K556E, K559E)-GFP instead of VPS35(p.K555N, K556L, K559Q)-
GFP. This mutant again, in GFP-nanotrap immunoprecipitations, displayed a greatly 
perturbated interaction with FAM21 but could still assemble into the retromer complex 
(Figure 5.9A-B). Furthermore, this severe perturbation in association was also seen 
with the other WASH complex members (WASH1, SWIP, Strumpellin and CCDC53) 
(Figure 5.9C-D), verifying that retromer associates with the WASH complex via 
FAM21.  
 
Figure 5.10 Lentiviral transduction of VPS35(p.K555E, K556E, K559E)-GFP into 
VPS35 knockout HeLa cells.  
Lentiviral transduction of VPS35-GFP constructs into VPS35 knockout HeLa cells. Various titres 
of lentivirus (50µl, 100µl, 250µl and 500µl) added to transduce the cells; the lysates from these 
titres were resolved using SDS-PAGE and subjected to immuno-blotting using the indicated 
antibodies. 





Figure 5.11 Introduction of VPS35(p.K555E, K556E, K559E)-GFP does not rescue 
the endosomal localisation of FAM21.  
(A) VPS35 knockout HeLa cells, transduced with the indicated VPS35-GFP constructs, were 
fixed with 4% paraformaldehyde and immuno-stained with endogenous FAM21 and SNX1. 
Cells were imaged using a confocal microscope. The scale bar indicates 19 µm. (B) Graphs 
showing the quantified Pearson’s colocalisation coefficient (PCC) and Overlap coefficient (OC) 
from 3 independent experiments (at least 25 cells were quantified per experiment). Error bars 
indicate standard error; data were analysed using a one-way ANOVA and a Dunnett’s post-hoc 








Figure 5.12 Introduction of VPS35(p.K555E, K556E, K559E)-GFP does not rescue 
the endosomal localisation of WASH1. 
(A) VPS35 knockout HeLa cells, transduced with the indicated VPS35-GFP constructs, were 
fixed with 4% paraformaldehyde and immuno-stained with endogenous WASH1 and SNX1. 
Cells were imaged using a confocal microscope. The scale bar indicates 19 µm. (B) Graphs 
showing the quantified Pearson’s colocalisation coefficient (PCC) and Overlap coefficient (OC) 
from 3 independent experiments (at least 25 cells were quantified per experiment). Error bars 
indicate standard error; data were analysed using a one-way ANOVA and a Dunnett’s post-hoc 
test comparing the mutant constructs to the wild type VPS35-GFP construct; *** P ≤ 0.001. 
 
I then lentivirally transduced the charge-swap VPS35-GFP variants into VPS35 
knockout HeLa cells to near endogenous levels (Figure 5.10) and analysed the 
localisation of FAM21 in these stably transduced cells (Figure 5.11A). Comparing the 
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colocalisation between FAM21 and SNX1 between the VPS35-GFP variant-rescued 
cells, I found that the VPS35(p.K555E, K556E, K559E)-GFP transductions did not 
rescue the endosomal localisation of FAM21, whereas wild-type VPS35-GFP did 
(Figure 5.11B). Additionally, when I analysed the localisation of another WASH 
complex member, WASH1 (Figure 5.12A), the VPS35(p.K555E, K556E, K559E)-GFP 
transduced cells did not rescue the colocalisation between WASH1 and SNX1 (Figure 
5.12B).  
 
5.2.4 Investigating the functional significance of the VPS35:FAM21 
interaction 
Having identified VPS35 mutations which dramatically perturb WASH complex binding 
and do not rescue the endosomal localisation of FAM21 in VPS35 knockout cells, I 
wished to examine the functional consequence of uncoupling the retromer complex 
from the WASH complex. For this, I utilised the endosome to plasma-membrane cargo, 
GLUT1. In VPS35 knockout cells, GLUT1 colocalises with LAMP1; when rescued with 
VPS35-GFP, GLUT1 re-localises to the cell surface (Figure 5.13A). When 
VPS35(p.K555E,K556E,K559E)-GFP was introduced into the VPS35 knockout cells, 
GLUT1 also re-localised to the cell surface (Figure 5.13A-B). There was also not an 
obvious GLUT1 re-localisation into other intracellular compartments, such as the TGN, 
following VPS35(p.K555E,K556E,K559E)-GFP transduction (Figure 5.13A).  




Figure 5.13 Introduction of VPS35(p.K555E, K556E, K559E)-GFP does rescue the 
GLUT1 trafficking defect.  
(A) VPS35 knockout HeLa cells, transduced with the indicated VPS35-GFP constructs, were 
fixed with 4% paraformaldehyde and immuno-stained with endogenous GLUT1 and LAMP1. 
Cells were imaged using a confocal microscope. The scale bar indicates 19 µm. (B) Graphs 
showing the quantified Pearson’s colocalisation coefficient (PCC) and Overlap coefficient (OC) 
from 3 independent experiments (at least 25 cells were quantified per experiment). Error bars 
indicate standard error; data were analysed using a one-way ANOVA and a Dunnett’s post-hoc 
test comparing the mutant constructs to the wild-type VPS35-GFP construct; **** P ≤ 0.0001. 




Figure 5.14 Knock-down of FAM21 in HeLa cells do not cause a significant 
increase in GLUT1 colocalisation with LAMP1 or TGN46. 
(A) HeLa cells were suppressed using siRNA targeting VPS35 and FAM21. After adherence to 
coverslips, the cells were fixed using 4% paraformaldehyde and immuno-stained with 
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endogenous GLUT1, LAMP1 and TGN46. The scale bar indicates 29 µm. (B) Graphs showing 
the quantified Pearson’s colocalisation coefficient (PCC) and Overlap coefficient (OC) from 3 
independent experiments (at least 20 cells were quantified per experiment). Error bars indicate 
standard error; data were analysed using a one-way ANOVA and a Dunnett’s post-hoc test 
comparing the mutant constructs to the wild type VPS35-GFP construct; ** P ≤ 0.01. (C) HeLa 
cells, suppressed using the indicated siRNAs, were lysed and resolved using SDS-PAGE and 
immuno-blotted with the indicated antibody. 
 
To take a step back, I investigated the functional consequence of FAM21 depletion on 
GLUT1 localisation. Recently, FAM21 knockdown has been shown to cause the TGN 
(Lee et al., 2016) or LAMP1 (Kvainickas et al., 2017b) re-localisation of GLUT1 
(depending on the cell line utilised). When I treated HeLa cells with siRNA targeting 
VPS35, GLUT1 re-localised to a LAMP1-positive compartment, with no effect on 
GLUT1 re-localisation to the TGN (Figure 5.14). In contrast, FAM21 depletion did not 
affect the localisation of GLUT1, either towards the LAMP1- or TGN46-positve 
compartments in HeLa cells (Figure 5.14). The Lee et al. (2016) paper used RPE-1 
cells to investigate the consequence of FAM21 depletion. I therefore repeated the 
experiment using RPE-1 cells. VPS35 suppression increased the colocalisation of 
GLUT1 with the LAMP1- and TGN46-postive compartments (Figure 5.15). FAM21 
suppression caused a less pronounced increase in GLUT1 colocalisation with LAMP1 
and a more pronounced increase with TGN46 (Figure 5.15).  
As I could only see an effect of FAM21 suppression on GLUT1 localisation using RPE-
1 cells (at the suppression levels achieved using siRNA), I sought to investigate 
whether VPS35(p.K555E,K556E,K559E)-GFP would affect the localisation of GLUT1 in 
RPE-1 cells. To do this, I overexpressed VPS35-GFP variants in RPE-1 cells to 
outcompete (an effect already seen in Figure 4.3 and Figure 4.13A) endogenous 
VPS35 (Figure 5.16). Overexpression of VPS35(p.K555E,K556E,K559E)-GFP caused 
a significant decrease in FAM21 colocalisation with the endosomal marker SNX1 
(Figure 5.17). Overexpression of VPS35-GFP did not cause a significant decrease in 
colocalisation of FAM21 with SNX1, although there was a consistent trend towards the 
colocalisation being lower.  
I then investigated whether overexpressing VPS35-GFP or 
VPS35(p.K555E,K556E,K559E)-GFP has an effect on the localisation of GLUT1. The 
re-localisation of GLUT1 to a TGN46-postive compartment was the most striking 
phenotype seen in the FAM21 suppression experiments in RPE-1 cells (Figure 5.15). I 
therefore quantified the colocalisation between GLUT1 and TGN46. However, no re- 
localisation of GLUT1 was seen in the context of VPS35(p.K555E,K556E,K559E)-GFP 
overexpression in RPE-1 cells (Figure 5.18).  




Figure 5.15 Knock-down of FAM21 in RPE-1 cells causes a significant increase in 
GLUT1 colocalisation with LAMP1 and TGN46. 
(A) RPE-1 cells were suppressed using siRNA targeting VPS35 and FAM21. After adherence to 
coverslips, the cells were fixed using 4% paraformaldehyde and immuno-stained with 
endogenous GLUT1, LAMP1 and TGN46. Scale bar indicates 29 µm. (B) Graphs showing the 
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quantified Pearson’s colocalisation coefficient (PCC) and Overlap coefficient (OC) from 3 
independent experiments (at least 20 cells were quantified per experiment). Error bars indicate 
standard error; data were analysed using a one-way ANOVA and a Dunnett’s post-hoc test 
comparing the mutant constructs to the wild-type VPS35-GFP construct; * P ≤ 0.05; ** P ≤ 0.01; 
*** P ≤ 0.001. (C) RPE-1 cells, suppressed using the indicated siRNAs, were lysed and resolved 
using SDS-PAGE and immuno-blotted with the indicated antibody. 
 
 
Figure 5.16 Overexpression of VPS35-GFP variants in RPE-1 cells outcompetes 
endogenous VPS35 for assembly into the retromer complex. 
Lentivirus were added to RPE-1 cells to overexpress the VPS35-GFP variants; the lysates from 
these cells were resolved using SDS-PAGE and subjected to immuno-blotting using the 
indicated antibodies.  




Figure 5.17 Overexpressing VPS35(p.K555E,K556E,K559E)-GFP in RPE-1 cells 
causes a decrease in endosomal association of FAM21.  
(A) RPE-1 cells, stably overexpressing VPS35-GFP constructs through lentiviral transduction, 
were fixed with 4% paraformaldehyde and immuno-stained for endogenous FAM21 and SNX1. 
Scale bars indicate 29 µm. (B) Graphs showing the quantified Pearson’s colocalisation 
coefficient (PCC) and Overlap coefficient (OC) from 3 independent experiments (at least 25 
cells were quantified per experiment). Error bars indicate standard error; data were analysed 
using a one-way ANOVA and a Dunnett’s post-hoc test comparing the mutant constructs to the 
wild type VPS35-GFP construct; *** P ≤ 0.001. 
ar 




Figure 5.18 Overexpressing VPS35(p.K555E,K556E,K559E)-GFP in RPE-1 cells 
does not increase the TGN localisation of GLUT1.  
(A) RPE-1 cells, stably overexpressing VPS35-GFP constructs through lentiviral transduction, 
were fixed with 4% paraformaldehyde and immuno-stained for endogenous GLUT1 and TGN46. 
Scale bars indicate 29 µm. (B) Graphs showing the quantified Pearson’s colocalisation 
coefficient (PCC) and Overlap coefficient (OC) from 3 independent experiments (at least 25 
cells were quantified per experiment). Error bars indicate standard error; data were analysed 
using a one-way ANOVA and a Dunnett’s post-hoc test comparing the mutant constructs to the 
wild-type VPS35-GFP construct. 




Figure 5.19 Reintroducing VPS35(p.K555E,K556E,K559E)-GFP into VPS35 
knockout HeLa cells causes a mild enlargement of the overlap between retrieval 
and degradative subdomains on enlarged endosomes.  
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(A and D) VPS35 knockout HeLa cells, transduced with the indicated VPS35-GFP constructs, 
were transiently transfected with BFP-Rab5(p.Q79L) to enlarge endosomes. Cells were 
methanol fixed and immuno-stained for VPS35 and Hrs. Images were taken on a confocal 
microscope. Scale bars indicate 13 µm in A and 19 µm in D. (B, C, E and F) Areas of interest 
with line scans from A and D. Volocity software was used to measure the area of the different 
channels and to calculate the amount of overlap between the VPS35 and Hrs channels. (G) 
Quantification of the percentage overlap between the Hrs and VPS35 channels from 3 
independent experiments. 40 enlarged vesicles were quantified per condition per experiment. 
Data were analysed using a students t-test and the error bars indicate s.e.m.; * P ≤ 0.05. 
 
5.2.5 The retromer-WASH complex interaction contributes to the 
maintenance of endosomal subdomains 
The WASH complex and its actin-polymerisation ability has been proposed to maintain 
and regulate the formation of endosomal subdomains, possibly through binding to 
multiple retromer complexes (Jia et al., 2012; Cullen and Steinberg, 2018; Simonetti 
and Cullen, 2018a). I therefore examined whether the connection between retromer 
and the WASH complex is necessary for the segregation of the degradative and 
retrieval endosomal subdomains. Transfection of constitutively active Rab5(p.Q79L) 
creates enlarged, swollen endosomes, allowing the distinction between retrieval and 
degradative subdomains (Barbieri et al., 1996; McNally et al., 2017). Into VPS35 
knockout HeLa cells transduced at endogenous levels with VPS35-GFP variants 
(Figure 5.16), I transfected BFP-Rab5(p.Q79L) (Figure 5.19). On enlarged 
endosomes, the Hrs and VPS35 channels could be segmented into apparent areas 
and the percentage overlap between VPS35 and Hrs could be measured (Figure 5.19 
B, C, E and F). When VPS35-GFP was transduced into the VPS35 knockout cells, an 
average of 21.14% ± 1.90% of VPS35 overlapped with Hrs in the enlarged vesicles 
(Figure 5.19G). This compared to an average of 28.37% ± 1.46% of overlap when 
VPS35(p.K555E, K556E, K559E)-GFP was transduced, a significant increase (Figure 
5.19G).  
I then examined whether this partial break-down in endosomal subdomain segregation 
could be phenocopied by FAM21 suppression. I therefore used siRNA-mediated 
suppression coupled to BFP-Rab5(p.Q79L) transfection to identify whether the overlap 
of endogenous VPS35 with Hrs is increased in the FAM21 suppressed HeLa cells 
(Figure 5.20). Under non-targeting suppression, endogenous VPS35 averaged an 
overlap of 22.12% ± 1.03% with Hrs (Figure 5.20G). Under FAM21 suppression, 
endogenous VPS35 had an overlap of 29.23% ± 1.92% with Hrs, again, a significant 
increase (Figure 5.20G).  
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Figure 5.20 FAM21 suppression causes a mild enlargement of the overlap 
between retrieval and degradative subdomains on enlarged endosomes.  
(A) HeLa cells, suppressed using either non-targeting or FAM21 siRNA, were transiently 
transfected with BFP-Rab5(p.Q79L) to create enlarged endosomes. The cells were methanol 
fixed and immuno-stained for VPS35 and Hrs. The images were taken on a confocal 
microscope and the scale bar indicates 10.3 µm in A and 19 µm in D. (B, C, E and F) Areas of 
interest with line scans from A and D. Volocity software was used to measure the area of the 
different channels and to calculate the amount of overlap between the VPS35 and Hrs 
channels. (G) Quantification of the percentage overlap between the Hrs and VPS35 channels 
from 3 independent experiments. 40 enlarged vesicles were quantified per condition per 
experiment. Data were analysed using a students t-test and the error bars indicate standard 
error; * P ≤ 0.05. 
 
5.2.6 TMT-based proteomics do not reveal novel changes in the 
VPS35(p.K555E, K556E, K559E)-GFP interactome 
The K297X mutation in VPS26A caused not only severe perturbed binding to SNX27, 
but also intriguingly enhanced PKD2 and DENND4C binding (either directly or 
indirectly) (Figure 4.9). To examine whether uncoupling the WASH complex from the 
retromer complex caused any unexpected changes in the VPS35 interactome, I turned 
to TMT-based proteomics combined with a GFP-trap immunoprecipitation. I compared 
the interactome of VPS35-GFP with VPS35(p.K555E, K556E, K559E)-GFP. The 
proteomics confirmed the decrease in association of the WASH complex components 
FAM21, SWIP and Strumpellin (Table 5.2). The other WASH complex components 
were also decreased but were not identified in all 3 mass-spectrometry repeats and so 
were filtered out of the final dataset. The other consistent decreases in the 
VPS35(p.K555E, K556E, K559E)-GFP interactome are not thought to be true 
interactors of VPS35 as shown by the VPS35-GFP interactome (Table 4.1) or the 
previous GFP-VPS35 interactome (McGough et al., 2014a). The addition of the K555E, 
K556E and K559E mutations does not therefore appear to increase the association of 
VPS35 with other accessory proteins (Table 5.2). 
  




















P62805 Histone H4 OS=Homo sapiens GN=HIST1H4A 
PE=1 SV=2 
51.45631 6 33 6 103 0.1105 
A0A0U1RR
H7 
Histone H2A OS=Homo sapiens GN=HIST1H3D 
PE=3 SV=1 
35.29412 5 10.5 2 170 0.1515 
P51991 Heterogeneous nuclear ribonucleoprotein A3 
OS=Homo sapiens  
GN=HNRNPA3 PE=1 SV=2 
11.90476 4.5 7.5 3 378 0.225 
A8K962 cDNA FLJ77827, highly similar to Human upstream 
binding factor  
(hUBF) OS=Homo sapiens PE=2 SV=1 
5.693717 4.5 5 4.5 764 0.2395 
P05204 Non-histone chromosomal protein HMG-17 
OS=Homo sapiens  
GN=HMGN2 PE=1 SV=3 
30 5.333333 4 5 90 0.247889 
A0A096LPC
5 
WASH complex subunit 2C OS=Homo sapiens 
GN=WASHC2C PE=1 SV=1 
3.355705 4 4 4 1341 0.25 
A0A024R03
6 
Disabled homolog 2, mitogen-responsive 
phosphoprotein (Drosophila), isoform CRA_a 
OS=Homo sapiens GN=DAB2 PE=4 SV=1 
7.662338 4.5 5 4.5 770 0.271 
A0A087X25
6 
WASH complex subunit 4 OS=Homo sapiens 
GN=WASHC4 PE=1 SV=1 
5.074572 6.5 7 6.5 825.5 0.329 
A0A0S2Z4Z
6 
Serine/arginine repetitive matrix 1 isoform 2 
(Fragment)  
OS=Homo sapiens GN=SRRM1 PE=2 SV=1 
2.614379 2 2 2 918 0.332 
P78406 mRNA export factor OS=Homo sapiens GN=RAE1 
PE=1 SV=1 
15.21739 5.5 5.5 5.5 368 0.3325 
Q53EL1 Protein KIAA0196 variant (Fragment) OS=Homo 
sapiens PE=2 SV=1 
10.56701 12 12.5 12 1164 0.3455 
 
Table 5.2 Average change in the VPS35(p.K555E, K556E, K559E)-GFP interactome (TRIP) compared to the VPS35-GFP interactome 
(WT)  
AA= amino acid; PSMs= peptide-to-spectrum matches (the total number of identified peptide sequences). Highlighted in yellow are WASH complex 
components. 
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5.2.7 The mechanism of VPS35-independent endosomal association of 
FAM21 is not dependent on VPS34 
The interaction between VPS35 and FAM21 has been suggested to be essential for the 
endosomal recruitment of the WASH complex (Harbour et al., 2012; Jia et al., 2012). 
This view has been re-examined following the creation of VPS35 knockout HeLa cells, 
which still have a notable proportion of FAM21 remaining on endosomes (Figure 5.8A) 
(McNally et al., 2017). The retromer-independent mechanism of FAM21 endosomal 
recruitment is unknown but the WASH complex has been shown to directly interact with 
liposomes made from purified bovine brain lipids (Derivery et al., 2009). I therefore 
tested whether endosomal PI3P may be the mediator of retromer-independent FAM21 
recruitment. 
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Figure 5.21 VPS34 inhibition causes swelling of the early endosomal 
compartment. 
HeLa cells were treated with DMSO or 1µM VPS34IN1 (a VPS34 inhibitor) for 4 hours prior to 
4% paraformaldehyde fixation and immuno-staining with endogenous LAMP1 and EEA1. The 
scale bars indicate 19 µm. 
 
The synthesis of PI3P via the class III PI3-kinase VPS34 is fundamental in endosomal 
maturation and the recruitment of endosomal effector proteins (Raiborg et al., 2013; 
Jean and Kiger, 2014). I therefore utilised a VPS34-specific inhibitor, VPS34-IN1 (Bago 
et al., 2014). Unlike traditionally-used inhibitors, such as wortmannin, which are 
promiscuous in the inhibition of PI3-Kinases (Ferby et al., 1996), VPS34-IN1 is a 
selective and cell permeable VPS34 inhibitor (Bago et al., 2014).  
VPS34-IN1 treatment has been shown to prevent the association of a FIVE-domain 
containing construct onto endosomes (Bago et al., 2014) but its effect on endosomal 
morphology hasn’t been documented. I therefore treated HeLa cells with VPS34-IN1, 
which caused an enlargement of EEA1-positive endosomes but no striking difference in 
LAMP1 staining (Figure 5.21). This phenotype is consistent with other studies, which 
suppressed VPS34 through RNAi (Johnson et al., 2006; Jaber et al., 2016). VPS34-IN1 
treatment also decreased the endosomal population of the PI3P-binder SNX1 (Figure 
5.22A). The endosomal populations of FAM21 and VPS35 did not decrease; instead 
they localised around enlarged vesicles (Figure 5.22A). The endosomal population of 
VPS35 is dependent on the PI3P-binder SNX3, and Rab7 (Rojas et al., 2008; Harterink 
et al., 2011; Harrison et al., 2014b). Rab7 may therefore be sufficient for the 
endosomal recruitment of VPS35 and the endosomal population of VPS35 is likely to 
be sufficient for the endosomal recruitment of FAM21. To determine whether the 
VPS35-independent mechanism of FAM21’s association with endosomes via PI3P, I 
treated VPS35 knockout HeLa cells with VPS34IN1. SNX1 again largely lost its 
endosomal population (Figure 5.22B). However, FAM21 retained its association 
around swollen, enlarged endosomes (Figure 5.22B).  
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Figure 5.22 VPS34 inhibition causes the dissociation of SNX1 from endosomes 
but not FAM21.  
(A) HeLa cells were treated with DMSO or 1µM VPS34IN1 (a VPS34 inhibitor) for 4 hours prior 
to 4% paraformaldehyde fixation and immuno-staining with endogenous FAM21, SNX1 and 
VPS35. (B) VPS35 knockout HeLa cells were treated with DMSO or 1µM VPS34IN1 for 4 hours 
prior to 4% paraformaldehyde fixation and immuno-staining with endogenous FAM21, SNX1 
and VPS35. The scale bars indicate 19 µm. 
 
  




5.3.1 Mechanism of endosomal WASH complex recruitment 
VPS35 knockout HeLa cells have a decreased endosomal population of FAM21, but 
there is still a substantial population on endosomes (McNally et al., 2017). Therefore, 
contrary to the previous model, there is a retromer-independent mechanism of WASH 
complex recruitment. Depleting endosomes of PI3P through the inhibition of VPS34 did 
not displace the remaining FAM21 from endosomes (Figure 5.22B). FAM21 has been 
shown to be promiscuous in its binding to phospholipids in a PIP-strip assay (Derivery 
et al., 2009), so it is possible that alternative lipids are mediating its endosomal 
association. Alternatively, the VPS34 inhibitor, VPS34-IN1, may not have removed a 
sufficient quantity of endosomal PI3P. This seems unlikely as the endosomal 
localisation of the PI3P-binding SNX1 was substantially decreased (Figure 5.22B). The 
retromer-independent endosomal localisation of FAM21 may also be through a 
different protein:protein interaction. It is known to associate with multiple endosomal 
proteins, including RME-8 and SNX27, both of which have their own intrinsic 
membrane-binding properties (Steinberg et al., 2013a; Freeman et al., 2014). Recently, 
a paper was published which showed that knockdown of Hrs causes a decrease in 
endosomal association of WASH1 (MacDonald et al., 2018). It will be interesting to see 
whether a knockdown or knockout of Hrs in the VPS35 knockout HeLa cells displaces 
the remaining endosomal FAM21. It should be noted that Hrs binds to PI3P via its 
FYVE domain (Hayakawa et al., 2004) which may indicate that the VPS34-IN1 
treatment should have affected the endosomal localisation of Hrs. However, a probe of 
GFP-4x-FYVE(Hrs) could still localise to endosomes in VPS34 knockout MEFs 
(Devereaux et al., 2013). 
 
5.3.2 Mechanism of the VPS35:FAM21 association 
The C-terminus of VPS35 and its interaction with VPS29 has been shown to be 
important for the VPS35 interaction with FAM21 (Helfer et al., 2013) through the acidic 
LFa repeats within the FAM21 tail (Jia et al., 2012). VPS29 binding may stabilise the C-
terminus of VPS35 in a specific conformation, which may promote FAM21 association. 
In this chapter, I have identified several basic residues in VPS35, which I hypothesise 
interact with the acidic LFa repeats within the FAM21 tail, which are important for the 
retromer-WASH complex association (Figures 5.4-5.6). Interestingly, a 
VPS35(p.R524W) Parkinson’s disease linked mutation, which maps to the first basic 
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‘area’ in VPS35 (Figure 5.3A) has been reported to perturb FAM21 association (Follett 
et al., 2016). 
I focused on the potential electrostatic interactions implied by the discovery of the 
acidic LFa repeats in the FAM21 tail (Jia et al., 2012). However, the hydrophobic 
leucine and phenylalanine elements of the LFa motifs have not been examined here. I 
therefore modelled the hydrophobicity of the VPS35 surface from the Hierro et al. 
(2007) structure (Figure 5.23). This modelling revealed hydrophobic pockets (in red) in 
close proximity to the basic residues (in green) that I have identified to be important for 
FAM21 association (Figure 5.23). The extent to which these hydrophobic pockets 
contribute to forming the VPS35-FAM21 association will need future examination. The 
definitive way to test the mechanism of binding will be through a structural approach. 
Expression and purification of the retromer components and the FAM21 tail, coupled to 
x-ray crystallography. However, the unstructured and flexible nature of the FAM21 tail 
makes a crystallography approach difficult.  
 
Figure 5.23 Modelling of the hydrophobicity surface of VPS35 
Model of the hydrophobicity surface of the C-terminus of VPS35 onto the VPS35 crystal 
structure bound to VPS29 (Hierro et al., 2007). The basic residues identified to be important for 
FAM21 association are highlighted in green. 
 
Interestingly, several of the lysine residues in VPS35 found to be important for FAM21 
association, including K515, K555 and K701, were recently described to undergo 
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Parkin-mediated polyubiquitylation (Williams et al., 2018). This polyubiquitination did 
not promote proteasomal-mediated degradation of the retromer complex or influence 
its steady-state levels (Williams et al., 2018). The authors suggest that this 
ubiquitylation of VPS35 may regulate retromer-dependent endosomal sorting. It would 
be interesting to investigate whether the ubiquitylation of these lysine residues 
regulates the FAM21-retromer complex interaction. It is tempting to speculate that the 
addition of the polyubiquitin chains either mask the basic charges required for the 
electrostatic interaction or causes steric hindrance which prevents the interaction.  
Recently, a cryo-electron tomography structure of the C. thermophilium pentameric 
retromer complex was solved (Kovtun et al., 2018). This provided definitive data, at 
least in yeast, that backed-up past studies suggesting that the trimeric retromer 
complex dimerises (Hierro et al., 2007; Lucas et al., 2016; Kovtun et al., 2018). In this 
arch-like dimer, the C-termini of the two VPS35 proteins form a dimerization interface, 
with VPS29 at the apex and VPS26 closest to the membrane (Figure 5.24C) (Kovtun 
et al., 2018). This dimerization region is in a similar area to the residues I found to be 
important for FAM21 association. I therefore modelled the cryo-electron tomography 
structure to highlight the locations of the residues I found to be important for FAM21 
association. Firstly, I used bioinformatic software to align the C. thermophilium VPS35 
sequence to others, including H. sapiens VPS35 (Figure 5.24A). This allowed me to 
determine the C. thermophilium equivalent of the H. sapiens residues important for 
FAM21 association (Figure 5.24B). There are some limitations to this analysis. Firstly, 
fungal retromer exists as a pentameric complex whereas H. sapiens retromer has 
diverged into two more loosely-associated complexes (Kvainickas et al., 2017a; 
Simonetti et al., 2017; Cullen and Steinberg, 2018). This may limit the comparisons that 
can be made between this structure and the H. sapiens equivalent. Secondly, C. 
thermophilium, like S. cerevisiae, does not contain a WASH complex and several of the 
equivalent C. thermophilium residues are not basic in charge. I am therefore making an 
assumption that the equivalent mammalian residues are broadly located in a similar 
position.  
The residues I found to be most important for FAM21 association face away from the 
membrane, along the peak of the two retromer homodimers (Figure 5.24C). This 
supports the notion that the FAM21 tail may straddle the interaction between the two 
retromers on the side facing away from the membrane. It is difficult to tell whether 
these residues are involved in retromer dimerization. Future computational or 
experimental studies may be able to answer this question. However, if the residues I 
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identified in human cells were critical for retromer complex dimerization, you might 
expect that they would be conserved to a greater degree between species.  
 
Figure 5.24 Modelling of the identified residues which affect FAM21 binding onto 
the retromer dimer interface 
(A) Sequences of H. sapiens, M. musculus, S. cerevisiae and C. thermophilium VPS35 
homologues were aligned using ESPript 3.0 online software (Robert and Gouet, 2014). The H. 
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sapiens residues which, when mutated, were found to decrease binding to FAM21 are indicated 
using arrows. (B) Table showing the C. thermophilium equivalent residues which in H. sapiens 
are important for FAM21 binding. (C) Modelling of the C. thermophilium retromer complex dimer 
bound to Vps5 which was solved using Cryo-Electron Tomography (Kovtun et al., 2018). The C. 
thermophilium equivalent residues which in H. sapiens are important for FAM21 binding are 
highlighted in purple and the equivalent D620 residue is highlighted in blue.  
 
The VPS35(p.D620N) mutation causes a 50% decrease in the retromer-WASH 
complex interaction (McGough et al., 2014b; Zavodszky et al., 2014) (Figure 5.9). This 
acidic aspartate residue does not fit my electrostatic model of interactions between the 
basic VPS35 residues and the acid clusters in the FAM21 tail. The C. thermophilium 
equivalent of the highly evolutionary-conserved D620 residue is located in the vicinity 
of the dimerization surface, facing towards the membrane (Figure 5.24). Kovtun and 
colleagues speculate that the D620N mutation may perturb retromer dimerization; it is 
possible that the aspartate to asparagine change causes a conformational change 
which perturbs retromer dimerization. Again, future computational or experimental 
studies will need to test this.  
My conclusions from the in silico modelling of the C. thermophilium cryo-electron 
tomography retromer structure is predicated on several assumptions and has its 
limitations. To definitively show the importance of the residues involved in the retromer-
WASH complex interaction and the residues needed for retromer dimerization, a 
structural biology approach will be needed. The FAM21 tail is predicted to be flexible 
and unstructured which makes crystallisation difficult (Jia et al., 2010). The only 
structure (22 Å) that exists for the WASH complex, solved using electron microscopy, 
cut off the FAM21 tail (Jia et al., 2010). It is possible that its interaction with the 
retromer complex may stabilise the structure of the FAM21 tail, making crystallisation 
more feasible. However, it is likely that cryo-electron microscopy will be the most 
practical approach to achieving it. It would be especially interesting if a mammalian 
retromer version of the Kovtun et al. (2018) cryo-electron tomography structure, with 
the addition of FAM21 (or at least its retromer-binding tail region) was solved. The LFa 
repeats in the FAM21 tail are thought to enable FAM21 to bind to multiple retromer 
complexes (Jia et al., 2012). It is an intriguing possibility that a dimer of retromer 
complexes may be needed for the binding of the FAM21 tail.   
5.3.3 Functional significance of the WASH-retromer complexes interaction 
Protein:protein interactions are essential for endosomal retrieval and recycling (Cullen 
and Steinberg, 2018). Mutations in SNX27 that prevent retromer binding cause a 
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GLUT1 sorting defect (Gallon et al., 2014a). A mutation in VPS26A which prevents 
assembly with SNX27 cause a GLUT1 sorting defect (Figure 4.11). Mutations in SNX3 
which prevents its assembly into the SNX3-retromer causes a Wnt phenotype (Figure 
3.6) and a defect in DMT1-II trafficking (Lucas et al., 2016). Therefore, I hypothesised 
that perturbing the retromer-WASH complex association may cause a defect in GLUT1 
recycling. However, this was not the case (Figure 5.13 and Figure 5.18).  
It has been reported that in RPE-1 cells, FAM21 suppression causes a GLUT1 
trafficking defect where it accumulates in the TGN (and specifically not in LAMP1-
postive vesicles) (Lee et al., 2016). It has also been reported that in U2OS cells, 
FAM21 suppression causes a GLUT1 trafficking defect where it accumulates in 
LAMP1-positive late endosomes/lysosomes (Kvainickas et al., 2017b). These 
phenotypes could be replicated (both at the same time) in RPE-1 cells (Figure 5.15) 
but not HeLa cells (Figure 5.14). It is possible that the suppression levels achieved in 
HeLa cells were not enough to cause a GLUT1 trafficking defect. It is also possible that 
there are discrepancies between the phenotypes in different cell types. CRISPR-Cas9 
mediated knockouts in HeLa cells and RPE-1 cells may provide some clarity on this 
issue. However, the suppression of FAM21 in HeLa cells causes the TGN-
accumulation of β2-Adrenergic receptor, another endosome-to-plasma membrane 
SNX27-retromer cargo (Varandas et al., 2016). Other cargoes which could be followed 
up and have been reported to be dependent on the WASH complex include CIMPR 
(Gomez and Billadeau, 2009), α5 integrin (Zech et al., 2011) and the low-density 
lipoprotein receptor (Bartuzi et al., 2016).  
To investigate whether uncoupling the WASH and retromer complexes cause a GLUT1 
phenotype in RPE-1 cells, I overexpressed the VPS35-GFP variants to outcompete 
endogenous VPS35 for insertion into the retromer complex (Figure 5.18). This 
overexpression experiment was crude compared to reintroducing the variants into 
VPS35 knockout cells. Ideally, a knockout VPS35 RPE-1 line would have been created 
where the VPS35-GFP variants could be expressed at endogenous levels with no 
endogenous level of VPS35 background.  
Although there was no GLUT1 trafficking phenotype when retromer was uncoupled 
from the WASH complex, this association seems to contribute to the segregation of the 
retrieval and degradative endosomal subdomains (Figure 5.19). The partial loss of 
subdomain segregation was also phenocopied by the suppression of FAM21 (Figure 
5.20). The data collected for this relies on the accuracy of the overlaps between 
channels which is limited by the resolution of confocal microscopy; super resolution 
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microscopy would provide a greater level of resolution. Electron microscopy has 
confirmed that these enlarged endosomes have only one vacuole and are formed 
through the fusion of several endosomes (Barbieri et al., 1996), but the extent to which 
the retrieval and degradative subdomains are maintained following the Rab5(p.Q79L) 
overexpression is difficult to measure. Nevertheless, an overlap between VPS35 and 
Hrs of 22.12% ± 1.03% (Figure 5.20F) is in agreement with a previous report 
examining the overlap between C. elegans VPS35 and HRS in naturally-large 
coelomocyte endosomes (Norris et al., 2017).  
This is the first experimental evidence that the WASH complex as well as its interaction 
with retromer is linked to the segregation of endosomal subdomains. The WASH 
complex has been suggested to contribute to the architecture of the subdomains 
through its interaction with multiple retrieval complexes, including retromer, retriever 
(via the CCC complex), SNX27 and the SNX-BAR complex (via RME-8) (Simonetti and 
Cullen, 2018a). Secondly, it has been proposed to concentrate these retrieval 
complexes and transmembrane cargo through the creation of branched filamentous 
actin (Simonetti and Cullen, 2018a). It would be interesting for future studies to knock-
in an actin-polymerisation-dead WASH1 mutant through CRISPR-Cas9 to investigate 
whether actin-polymerisation is required for the maintenance of endosomal subdomain 
segregation. 
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In this thesis, I have provided further insight into some of the molecular interactions of 
retromer and their functional significance. In Chapter 3, I defined residues within 
sorting nexin-3 (SNX3) which are critical for the formation of the SNX3-retromer. 
Through a collaboration with the Korswagen lab, the formation of SNX3-retromer was 
shown to be necessary for the formation of Wnt morphogenic gradients. I also 
established a model of how SNX3-retromer may couple to a membrane deformation 
complex (the MON2:DOPEY1/2:ATP9A flippase complex) to initiate membrane 
bending and promote carrier formation. In Chapter 4, I presented data showing that the 
Parkinsonism-associated retromer mutation, VPS26A(p.K297X), exhibits a severe 
perturbation in its assembly with SNX27. In Chapter 5, I identified a series of basic 
residues on the carboxyl-terminus of VPS35 which are required for the association 
between retromer and the WASH complex. Uncoupling retromer from the WASH 
complex, or suppressing the WASH complex subunit FAM21, resulted in an increase in 
the overlap between the retrieval and degradative endosomal subdomains. In this 
chapter, I expand upon some of the topics explored in my previous chapters and 
highlight some future questions I consider to be important for the field to address.  
 
6.1 Cargo recognition by retromer 
 
6.1.1 Retromer cargo adaptors 
As discussed in Section 1.4.3, retromer can associate with cargo adaptors such as 
SNX27 and SNX3 to enable it to recognise a wider variety of cargoes. In contrast to the 
SNX27-retromer, which is required for the cell surface localisation of hundreds of 
cargoes (Steinberg et al., 2013b), only a handful of validated metazoan SNX3-retromer 
cargoes have been validated: Wntless (Belenkaya et al., 2008; Franch-Marro et al., 
2008; Pan et al., 2008; Yang et al., 2008; Harterink et al., 2011; Zhang et al., 2011), 
transferrin receptor (Xu et al., 2001; Chen et al., 2013), DMT1-II (Lucas et al., 2016), 
polycystin-2 (Feng et al., 2017) and the C. elegans bone morphogenic protein type I 
receptor SMA-6 (Gleason et al., 2014). This is likely due to the lack of global proteomic 
studies investigating the SNX3-retromer. However, as the endosomal association of 
retromer is diminished upon knockdown or knockout of SNX3, or the uncoupling of 
SNX3 from retromer (Harterink et al., 2011; Lucas et al., 2016), it is likely that the 
SNX3-retromer is required for the endosomal sorting of various retromer cargoes. 
Furthermore, the SNX3 association with retromer causes a conformational change in 
VPS26 which reveals a binding pocket for cargoes with a Φ-X-[L/M/V] sorting motif (Φ 
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indicates an aromatic residue; x indicates any amino acid), which is present in several 
published retromer cargoes (Lucas et al., 2016).  
 
6.1.2 Retromer dimerization and the formation of retromer coats 
Recently published cryo-electron tomography data show that the fungal retromer can 
form dimers (Kovtun et al., 2018). This dimerization has also been previously 
suggested in the mammalian retromer (Hierro et al., 2007; Lucas et al., 2016). In the 
Kovtun et al. (2018) model, Vps26 form contacts with the SNX-BAR component Vps5 
which is assembled on the membrane; retromers can dimerise via the 
homodimerization of the carboxyl-terminus of Vps35 (Figure 5.24). As described in 
Section 1.4.1, the situation in yeast and in metazoans are different: metazoan retromer 
is not thought to form a stable complex with the SNX-BAR complex. However, if an 
equivalent higher metazoan retromer assembly is formed, how do the retromer cargo 
adaptors fit into this model?  
The SNX27-retromer is assembled through direct contacts between VPS26 and the 
PDZ-domain of SNX27 (Gallon et al., 2014a) (Section 4.3.1). If modelled into the 
Kovtun et al. (2018) yeast retromer (including the Vps5 component) coat, the cargo-
binding ability of SNX27 is thought to be preserved (Simonetti and Cullen, 2018b). This 
is consistent with SNX27-retromer cargoes, such as GLUT1 and β2-adrenergic 
receptor, being dependent on the SNX-BAR complex for their endosomal sorting into 
tubular carriers (Temkin et al., 2011; Steinberg et al., 2013b), likely facilitated by an 
interaction between SNX27 and SNX1 (Steinberg et al., 2013b).  
For SNX3-retromer, the cargo binding pocket induced by its assembly would be 
occluded if formed into a higher order assembly with the SNX-BAR complex (Simonetti 
and Cullen, 2018b). This suggests that SNX3-retromer-dependent cargoes could not 
be captured in the retromer coat as proposed by the Kovtun et al. (2018) model. This is 
consistent with the SNX3-retromer-dependent, SNX-BAR complex-independent, 
endosomal sorting of Wntless from the endosomes to the TGN (Figure 3.11A) 
(Harterink et al., 2011; Zhang et al., 2011). It is also consistent with the lack of Wntless 
enrichment in tubular carriers and the identified SNX3-postive, clathrin-decorated 
vesicular carriers (Harterink et al., 2011). In Chapter 3, I have proposed a model in 
which SNX3-retromer couples to a MON2:DOPEY1/2:ATP9A flippase complex which 
generates initial membrane curvature and may recruit a clathrin coat via the MON2 
interaction with GGA adaptors (Figure 3.18).  
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It is possible that the SNX3-retromer (or SNX27-retromer) may, through their PX 
domains, be able to assemble into analogous dimeric assemblies (to the Kovtun et al. 
model) on the endosomal membrane independently of the SNX-BAR complex 
(Simonetti and Cullen, 2018b). Equally, the SNX-BAR complex may be able to form a 
cargo-enriched coat without retromer cargo enrichment. The SNX-BAR complex can 
mediate cargo retrieval and recycling of the cargoes CIMPR and IGF1R independently 
of retromer (Kvainickas et al., 2017a; Simonetti et al., 2017). Recent experimental 
findings in the Cullen lab have now defined the structural mechanism for the SNX-BAR 
complex association with cargoes and identify a binding motif in the cytosolic-facing 
‘tail’ of various cargoes (Boris Simonetti, unpublished).  
 
6.2 Endosomal subdomains 
 
6.2.1 The mechanism of cargo leakage into the degradative pathway 
following retrieval complex perturbation 
In general, disrupting the function of endosomal retrieval complexes, either through 
knockdowns (Figure 3.12A), knockouts (Figure 4.24A) or the perturbation of specific 
protein:protein interactions such as the formation of the SNX27-retromer (Figure 4.11), 
results in cargo leakage into the degradative pathway. However, whether cargoes are 
targeted for degradation and sequestered within intralumenal vesicles is unclear.  
In S. cerevisiae, the deletion of retrieval complexes has been coupled to the 
perturbation of ESCRT function (through the deletion of the S. cerevisiae equivalent of 
HRS: vps27; see Section 1.3.1). The double deletion strains: vps27Δ snx3Δ (Strochlic 
et al., 2008) and vps27Δ vps35Δ strains (Arcones et al., 2016)  resulted in cargo (Frt1-
GFP and Chs3-GFP respectively) accumulating on the limiting membrane of the 
vacuole (the yeast equivalent of the lysosome) and to the class E compartment 
(aberrant endosomes). These data are consistent with a model where deletion of 
ESCRT in the context of retrieval complex perturbation results in cargo accumulation in 
the endosomal network and the limiting membrane of lysosomes. This suggests that 
only the luminal-facing domain of cargoes would be degraded in this context. It will be 
interesting for future experiments to repeat a deletion analysis of ESCRT-0 in 
combination with retrieval complexes in a mammalian context.  
An interesting experiment from the Fässler lab investigated the SNX17-dependent (See 
Section 1.4.6) retrieval of β1-integrin (Bottcher et al., 2012). The trafficking of a β1-
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integrin mutant unable to bind to SNX17 resulted in its progression down the 
degradative pathway. When all the lysine residues of the β1-integrin tail were 
mutated into arginine residues (to prevent their ubiquitylation), the recycling of β1-
integrin (which was unable to bind to SNX17) was rescued. The SNX17-dependent 
retrieval of β1-integrin has subsequently been shown to be dependent on the 
retriever complex (Section 1.4.6) (McNally et al., 2017). These data from the Fässler 
lab are consistent with the idea that without sequence-dependent retrieval or 
ubiquitylation-mediated inclusion into ILVs, β1-integrin will enter the recycling pathway 
through a ‘bulk flow’ mechanism. Whether this is a β1-integrin specific phenomenon 
requires further investigation.  
 
6.2.2 Coordination of the endosomal retrieval complexes 
As discussed in Section 1.3.2.1, the main retrieval complexes on endosomes are 
thought to be retromer, retriever, the CCC complex and the SNX-BAR complex. These 
are all thought to function on the same endosomal retrieval subdomains (McNally et al., 
2017). Are the differential cargoes recognised by these complexes enriched in the 
same tubulovesicular carriers? The role of the WASH complex and actin polymerisation 
seems to be key in this discussion. All endosomal retrieval complexes so far directly or 
indirectly bind to the WASH complex (McNally and Cullen, 2018). Furthermore, the 
addition of an actin binding domain has been shown to be sufficient to promote cargo 
recycling (Puthenveedu et al., 2010; MacDonald et al., 2018). It is possible that the 
retrieval complexes link cargoes to the endosomal retrieval subdomain, where cargoes 
are corralled by branched actin filaments promoted by the WASH complex (Simonetti 
and Cullen, 2018a), until their recycling. This is a simplified view and it is possible that 
there are subtle differences in the localisation of these proteins: for example, the 
SNX3-retromer is thought to act in an earlier endosomal compartment compared to the 
SNX-BAR complex (Burd and Cullen, 2014b). Also, there are some cargoes, such as 
Wntless, which do not get enriched into tubular carriers (Harterink et al., 2011). The 
WASH complex also seems to contribute to the segregation of the endosomal retrieval 
and degradative subdomains (Figure 5.19 and Figure 5.20). The mechanism for this, 
as well as other phenotypes exhibited to the perturbation of the WASH complex, may 
lie in its promotion of branched-actin polymerisation, though more work is required to 
show this. The WASH complex is a heteropentameric assembly and there are hints in 
the literature, especially in the case of FAM21, which suggests that they may have 
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functions independent of the promotion of branched actin polymerisation (Lee et al., 
2016; Shin et al., 2017). This will be an interesting avenue for future studies to explore.  
Future work will be required to reconcile the cooperative and independent functions of 
endosomal retrieval and recycling complexes. For example, there are retromer cargoes 
(SNX27-retromer cargoes) which require the SNX-BAR complex for their recycling, but 
as discussed in Section 6.1.2, there are retromer cargoes which are independent of 
the SNX-BAR complex, and SNX-BAR complex cargoes independent of retromer. 
Furthermore, the retriever cargo β1-integrin has a mild trafficking defect in retromer 
knockouts (likely due to the decreased endosomal association of the WASH complex) 
and proteomic studies have identified cargoes which are lost from the cell surface 
dependent on both retromer and retriever (McNally et al., 2017). Potential cross-talk 
between retromer and retriever may be due to their cargo adaptors SNX27 and SNX17 
(respectively) both containing FERM domains and therefore may potentially recognise 
some similar cargoes. Establishing the coordination of the different retrieval and 
recycling complexes is a fundamental question in the years to come. 
 
6.3 Neuroprotection by retromer 
 
6.3.1 Retromer promotes microglial health 
Although much study has been focused on retromer’s role in neuronal cells, there is 
increasing evidence that retromer activity may be essential for functional microglia. 
Overactivation of the microglial inflammatory response is thought to be a hallmark of 
neurodegenerative disorders (Hickman et al., 2018). As is the case in neuronal 
samples of patients with Alzheimer’s disease (Small et al., 2005), VPS35 is 
downregulated in their microglial cells as well (Lucin et al., 2013). This decrease in 
retromer levels is thought to result in decreased phagocytic activity due to reduced 
surface localisation of microglial phagocytic receptors (Lucin et al., 2013). Retromer 
depletion is also thought to increase the inflammatory response mediated by microglial 
cells through the endosome to cell surface sorting of Trem2 (triggering receptor 
expressed on myeloid cells 2), an innate immune receptor which downregulates 
microglial activation (Yin et al., 2016). A recent paper used a mouse model which could 
conditionally deplete VPS35 in microglia (Appel et al., 2018). This resulted in an 
increase in hippocampal neural progenitor proliferation but a decrease in neuronal 
differentiation, suggesting a role for microglial VPS35 in promoting neurogenesis 
(Appel et al., 2018). This is interesting especially considering retromer’s role in Wnt 
Chapter 6: General discussion 
190 
 
signalling (Section 6.3.2). These mice also displayed memory deficits and a 
depressive phenotype (Appel et al., 2018); all these phenotypes are consistent with 
Alzheimer’s disease pathogenesis.  
 
6.3.2 Neurodegeneration and aberrant Wnt signalling 
As described in Section 3.1, Wnt signalling is a master controller of not just various 
developmental processes, but for adult tissue homeostasis too. In the nervous system, 
this includes axon pathfinding, dendritic development and assembly of the synapse 
(Salinas, 2012) as well as adult neurogenesis (Bengoa-Vergniory and Kypta, 2015). In 
Alzheimer’s and Parkinson’s disease, numerous studies have described the 
downregulation of the Wnt signalling pathway in their pathogenesis (Libro et al., 2016).   
It is intriguing that both abnormal retromer function and aberrant Wnt signalling have 
both been linked to neurodegenerative disorders. Retromer has been connected to Wnt 
signalling via three different routes: Wnt secretion through the trafficking of the Wnt 
chaperone Wntless (SNX3-retromer) (Section 3.1), modulating the surface localisation 
and activity of the Wnt-activated polycystin channel complex (SNX3-retromer) (Feng et 
al., 2017), and in modulating the surface localisation and function of receptors of the 
planar cell polarity non-canonical Wnt pathway (SNX27-retromer) (Cullen and Strutt 
labs, unpublished). The trafficking of Wntless is the best characterised link that 
retromer has to Wnt signalling and it is interesting to note that mice with conditional 
(homozygous nulls are embryonic lethal) Wntless knockouts display severe 
abnormalities of the midbrain and hindbrain (Carpenter et al., 2010). It would be 
interesting for future studies to investigate the Parkinson’s disease-causing retromer 
mutation, VPS35(p.D620N), in the context of aberrant Wnt secretion or downstream 
signalling. As the protein levels of retromer components are thought to be decreased in 
Alzheimer’s and Parkinson’s disease, it would also be interesting to investigate Wnt 
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